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 Volumetric muscle loss (VML) is a traumatic injury in skeletal muscle resulting in the 
bulk loss of more than 20% of the muscle’s volume. Included in the bulk loss of muscle is the 
skeletal muscle niche comprised of nerve bundles, vasculature, local progenitor cells, basal 
lamina, and muscle fibers, overwhelming innate repair mechanisms. The hallmark of VML 
injury is the excessive accumulation of non-contractile, fibrotic tissue and permanent functional 
deficits. Though predominant in the younger demographic, the elderly population is also 
captured within VML injuries. There are many factors that change with aging in skeletal muscle 
that may further hinder recovery and regeneration following VML. In an attempt to further our 
understanding on how age affects VML treatments, comparisons between young and aged 
animals following VML injury and repair were made. Presented in this dissertation is a summary 
of the current state of the tissue engineering field in skeletal muscle and explores strategies for 
repairing not only VML but also understanding what age-associated changes in skeletal muscle 
preclude effective tissue repair. The future directions and potential approaches to further the 
field’s understanding of VML repair in the aging microenvironment along with the remaining 
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A. Skeletal Muscle Review 
 Comprising approximately 40% of total body weight, skeletal muscle is one of the most 
plastic and dynamic tissues in the human body. Additionally, it is seen as one of the biggest 
reservoirs for amino acids, accounting for roughly 50-75% of all body proteins (Frontera & 
Ochala, 2015). Mechanically, skeletal muscle has the main function of providing locomotor 
movement as well as providing skeletal stability, preventing damage and misalignment at the 
joints. Structurally, skeletal muscle is a highly organized, hierarchical tissue composed of tightly 
apposed bundles of multi-nucleated fibers.  Generally, skeletal muscle is comprised of bundles of 
muscle fibers, resident muscle cells, nerve fibers, blood vessels, non-contractile tissue such as 
fat, and the extracellular matrix (ECM).  
Individual muscles are surrounded by a sheath of connective tissue called the epimysium. 
Within those muscles are fibers that are arranged into bundles that are surround by their own 
layer of connective tissue called the perimysium. Further down are single muscle fibers that are 
surrounded by a cell membrane, or the sarcolemma. The bundle containing these connective 
tissue sheaths and membranes are typically referred to as a fascicle and originate at proximally 
located tendon plates and terminate at distal insertion points (Lieber & Friden, 2000). For the 
purposes of this paper, the aforementioned connective tissues will be referred to as the ECM 
unless noted otherwise.  
  Connecting the sarcolemma to the myofibrils is a complex of myofilament proteins, 
referred to as a sarcomere, that is necessary for normal muscle function (Frontera & Ochala, 




components of the sarcomere include the thin filament protein actin, thick filament protein 
myosin, intermediate linking proteins providing mechanical stability such as dystrophin, titin, 
and nebulin (Frontera & Ochala, 2015; Monroy et al., 2012; Ottenheijm & Granzier, 2010), and 
the Z disk which functions as an anchor point for myofilaments within the sarcomere (Frontera 
& Ochala, 2015). Any absence or dysfunction of one of these proteins are associated with 
instability in muscle structure leading to sarcolemmal damage or muscle weakness. A common 
example of this is the absence of dystrophin found in neuromuscular disorders such as Becker 
and Duchenne muscular dystrophies (G. D. Thomas, 2013).  
 The basic mechanism of muscle contraction is known as the sliding filament theory 
involving the transmission of forces generated by the actin-myosin cross-bridges within the 
muscle fiber (A. F. Huxley & Niedergerke, 1954; H. Huxley & Hanson, 1954). Adenosine 
triphosphate (ATP) is the main source of energy used in muscle action, which is produced by 
muscle cells via the metabolism of carbohydrates and fats (Romijn et al., 1993). To describe 
briefly, in the resting state myosin is tightly bound to actin at a 45º angle with respect to each 
other. As ATP binds to myosin, it is dissociated from actin and proceeds to hydrolyze ATP into 
ADP and a phosphate group. As a result, the head of the myosin molecule swings and weakly 
binds to actin on a different binding site. Release of the phosphate group bound to the myosin 
molecule initiates the power stroke of myosin, causing it to rotate on its hinge and pushing the 
actin filament past it. At the end of the stroke, ADP is released from myosin causing it to resume 
its previous tightly bound state on actin. The generated force is transmitted all the way down to 
the z disk and movement is finally produced when the force reaches the myotendinous junction, 
tendons, and finally the joints (Frontera & Ochala, 2015; A. F. Huxley & Niedergerke, 1954; H. 




B. Muscle Injury and Repair 
 Following damage such as tears, contusions, and lacerations (Garrett, 1996; M. J. 
Jarvinen & Lehto, 1993), skeletal muscle has the capacity to repair itself through a series of 
critical events in the repair process. These events can broadly be categorized into the following 
phases: degradation, inflammation, repair, remodeling, and maturation (Charge & Rudnicki, 
2004; T. A. Jarvinen, Jarvinen, Kaariainen, Kalimo, & Jarvinen, 2005). Degradation occurs 
immediately following injury as the sarcolemma (muscle cell plasma membrane) is ruptured 
causing an influx of cytosolic calcium ions which activate calcium-dependent proteases, further 
degrading the membrane (Fredsted, Gissel, Madsen, & Clausen, 2007; Tidball, 2011). 
Additionally, as necrosis of damaged muscle fibers begin, a structure comprised of cytoskeletal 
material referred to as the contraction band acts to seal the area off to localize the necrosis as 
well as forming a protective barrier to allow for the repair of the damaged sarcolemma (T. A. 
Jarvinen et al., 2005).  
 The inflammatory phase is initiated as activated satellite cells, fibroblasts, and the 
damaged and necrotized ends of myofibers release host biomolecules that act as chemotractants 
for immune cell extravasation via damaged blood vessels at the site of injury (Baoge et al., 2012; 
T. A. Jarvinen et al., 2005; Tidball, 1995, 2011; Toumi & Best, 2003). During the acute phase of 
inflammation, the first and most abundant cell population consist of polymorphonuclear 
leukocytes such as neutrophils that act to debride the damaged site (Brickson, Hollander, Corr, 
Ji, & Best, 2001; Brickson et al., 2003; Hurme, Kalimo, Lehto, & Jarvinen, 1991). Within 24 
hours, the concentration of polymorphonuclear leukocytes rapidly decline and are replaced with 
invading monocytes that ultimately transform into phagocytic macrophages, commonly referred 




St Pierre & Tidball, 1994; Tidball, 2011). M1 macrophages are considered to be pro-
inflammatory, releasing cytokines such as interferon gamma (IFN-γ) and tumor necrosis factor 
alpha (TNF-α) among others in order to further promote immune cell migration, activation of 
inflammatory signaling via NF-κβ, and furthering muscle damage via increased nitric oxide 
production (Nguyen & Tidball, 2003; Villalta, Nguyen, Deng, Gotoh, & Tidball, 2009). 
 Following M1 macrophages are their non-phagocytic, anti-inflammatory counterparts, the 
M2 macrophages, which reach peak concentrations approximately 4 days post-injury 
(Krippendorf & Riley, 1993; St Pierre & Tidball, 1994). M2 macrophages have been known 
however to linger up to 2 weeks at the injury site, which also coincides with the terminal 
differentiation of muscle satellite cells, suggesting a role of M2 macrophages in regulating 
muscle repair and regeneration (St Pierre & Tidball, 1994). This is consistent with what was 
reported in a macrophage depletion study using the loading/re-loading model in mice. The study 
demonstrated that the depletion of macrophages during re-loading of muscle resulted in a 
significant reduction in growth and differentiation as well as prevention of the repair of damaged 
muscle cell membranes (Tidball & Wehling-Henricks, 2007).  
 Coinciding with shifts in the inflammatory response, the repair phase of regeneration 
occurs, primarily involving the migration, proliferation, and differentiation myogenic progenitor 
cells including satellite cells at sites of muscle injury. Satellite cells are widely accepted as the 
main contributor to skeletal muscle regeneration (Zammit et al., 2002). Satellite cells normally 
reside between the plasma and basement membrane of myofibers in a quiescent state, until they 
are activated by muscle injury (Cossu & Biressi, 2005). A hallmark of satellite cells is their self-
renewal ability, which replenishes the remaining satellite cell population either by proliferation 




account for only 1-5% of total myonuclei (Alameddine, Dehaupas, & Fardeau, 1989), they have 
been demonstrated to be extremely competent in generating new myofibers following muscle 
injury (Collins et al., 2005).  Following injury, a mixture of wound healing cytokines released by 
immune cells as well as mitogens from damaged muscle activate and induce the proliferation of 
satellite cells as well as migration towards the injury site (Allen & Boxhorn, 1989; Bischoff, 
1986). In addition, a family of muscle-specific transcription factors referred to as myogenic 
regulatory factors (MRFs) regulate the proliferation and differentiation of satellite cells (Pavlath, 
Dominov, Kegley, & Miller, 2003; Suelves, Lluis, Ruiz, Nebreda, & Munoz-Canoves, 2004). 
Following injury, activated satellite cells are characterized by the high expression of MyoD and 
Myf5, committing them to differentiation (Cooper et al., 1999; Pavlath et al., 2003; Smith, 
Janney, & Allen, 1994; Yablonka-Reuveni & Rivera, 1994). Transient down-regulation of MyoD 
and Myf5 give rise to increasing expression of myogenin (MyoG) and MRF4, characterizing the 
terminal differentiation of myoblasts(Karalaki, Fili, Philippou, & Koutsilieris, 2009). Myogenin 
has been associated with terminal differentiation and the fusion of myogenic precursor cells to 
new or existing myofibers while MRF4 promotes early differentiation and myotube formation 
(Launay et al., 2001). 
 Concurrent with the repair phase, the extracellular matrix at the site of injury is 
remodeled and turned-over through the actions of metalloproteinases (MMPs) and their 
antagonists, tissue inhibitors of metalloproteinases (TIMPs).  The regulation of MMPs and 
TIMPs are highly regulated throughout the muscle repair process as the balance of ECM 
degradation and synthesis is vital to normal muscle regeneration (Casar et al., 2004; Velleman, 
1999). The degradation of ECM into fragments and the growth factors that are released during 




(K. Thomas, Engler, & Meyer, 2015). Among these cells, the resident myofibroblasts are the 
main contributors to skeletal muscle ECM. They are responsible for the deposition of the two 
predominant fibrous collagen types in interstitial connective tissue (type I and III) but have also 
been shown to secrete collagens found in the basal lamina (type IV and VI) (Kuhl et al., 1984; 
Zou, Zhang, Sabatelli, Chu, & Bonnemann, 2008). 
In skeletal muscle, the two main MMPs during remodeling have been identified as MMP-
2 and MMP-9 and it has been proposed that these MMPs are differentially expressed transiently 
throughout the regenerative process (Kherif et al., 1999). Specifically, MMP-2 is concomitantly 
activated with de novo myofiber formation and MMP-9 is expressed in the early stages of 
regeneration involving inflammation and satellite cell activation (Kherif et al., 1999). 
Interestingly, activated satellite cells are capable of synthesizing and secreting MMP-2 and 9, 
suggesting that satellite cells are involved in the degradation of their own niche, allowing them to 
migrate to the site of injury (Kuhl et al., 1984; Zou et al., 2008).  
 
C. Volumetric Muscle Loss 
 When extreme trauma occurs resulting in the bulk loss of tissue (<20% of muscle’s 
mass), the regenerative capacity of muscle is overwhelmed leading to excessive scar tissue 
deposition and permanent functional deficits (Garg, Ward, et al., 2015; Mase et al., 2010; 
Terada, Takayama, Yamada, & Seki, 2001; Turner & Badylak, 2012). These injuries, referred to 
as volumetric muscle loss (VML), can result from both military (Corona, Rivera, Owens, Wenke, 
& Rathbone, 2015; B. D. Owens et al., 2008) and civilian trauma (Grogan, Hsu, & Skeletal 




trauma to the soft tissues, the condition can be further exacerbated as a consequence of excision 
and debridement of necrotic muscle tissue in cases involving extremity compartment syndrome 
from crush injuries. The absence of the contractile properties of the remaining muscle was 
reviewed by Turner and Badylak in 2012 where they reported that due to a dense cap of scar 
tissue forming between the damaged myofibers, denervation of the distal tissue occurs due to the 
absence of neuromuscular junctions (Turner & Badylak, 2012).  Aside from the permanent loss 
of contractile tissue, the most challenging clinical problem is the multi-factorial nature of VML 
resulting in the concomitant loss of the myogenic cell population as well as changes to the 
muscle’s architecture and composition (Corona et al., 2018; Corona, Garg, et al., 2013; Corona, 
Wu, et al., 2013). 
With VML injuries, treating the injury itself may not be sufficient as there may be injury-
associated changes to the remaining musculature that may preclude effective repair. A study 
highlighting the complexity of VML injuries was performed by Garg et al. found that the 
magnitude of functional deficits from VML were dependent on joint angle and muscle length 
(Garg, Ward, et al., 2015). Specifically, they reported that strength deficits were significantly 
worse at joint angles where the muscle was in a shortened position (i.e. dorsiflexion of the TA 
muscle). In addition, reductions in myofiber length, increased intramuscular collagen and 
scarring, and reduction in range-of-motion were observed. “This study highlights the complexity 
of VML injury: Not only the gross loss of muscle tissue but also architectural and histologic 
adaptations of the remaining tissue underlie the persistent functional deficits” (Garg, Ward, et al., 
2015). Regeneration of de novo muscle fibers would be insufficient in restoring functional 
capacity to muscle as demonstrated by this study and would “require therapies that maximize the 




tissue, and integrate these tissues to re-establish the intrinsic properties of the original muscle” 
(Garg, Ward, et al., 2015; Mase et al., 2010; J. G. Owens et al., 2011). 
 The current surgical standard of care for VML is the use of autologous muscle flap 
transfers in addition to rehabilitative regiments (Greene & Beatty, 1988; Mase et al., 2010; J. G. 
Owens et al., 2011). Flap transfer procedures have been used in various limbs including the 
forearm (Fan et al., 2008), elbow (Vekris et al., 2008), and lower extremities (C. H. Lin, Lin, 
Yeh, & Chen, 2007) following traumatic injuries requiring limb salvage. However, due to the 
size of the tissue required, these complex procedures are often associated with significant donor 
site morbidity. Moreover, the majority of flap transfers are non-functional and are mainly for 
cosmetic purposes though functional free muscle transplantations have been explored with 
limited success. Flap and free autografts are distinguished by flap autografts remaining attached 
to the muscle origin to preserve systemic blood supply (Klebuc & Menn, 2013).  
 
Muscle Flap Transfers 
First performed experimentally in 1970 by Tamai et al. and clinically by Harii et al. in 
1976, free muscle transplantation with microsurgical techniques became widely used for the 
reconstruction of soft-tissue defects and functional replacement of damaged muscles (Harii, 
Ohmori, & Torii, 1976; Tamai, Komatsu, Sakamoto, Sano, & Sasauchi, 1970). Muscle flap 
transfer procedures have been explored for their advantages over local skin and fasciocutaneous 
flaps for the treatment of complex soft tissue traumas. Muscle flaps demonstrate the ability to fill 
in the dead space remaining in wound sites while the dense capillary network facilitates 




muscle flaps have demonstrated rapid collagen deposition and allows for greater tissue ingrowth 
when compared to skin or fasciocutaneous flaps (Calderon, Chang, & Mathes, 1986; Chang & 
Mathes, 1982; Gosain, Chang, Mathes, Hunt, & Vasconez, 1990).  
 There have been many conflicting reports on the reinnervation of transplanted muscles 
and their effects on functional recovery and muscle maintenance (Brunelli, Monini, & Brunelli, 
1990; Chiu, Chen, Spielholtz, & Beasley, 1991; McNamara, Garrett, Seaber, & Goldner, 1987). 
It was initially believed that the motor nerve was solely responsible for contractility and muscle 
maintenance (TOWER, 1931, 1939). However, it was also suggested that the trophic influence 
was a function of the sensory nerve fibers (FORBES & COBB, 1926). In 1945, Gutmann 
experimentally showed that motor nerve repair promptly after denervation mitigated loss to 
contractility and trophic maintenance of the affected muscle (Gutmann, 1945). Gutmann further 
demonstrated that sensory muscle reinnervation by neurorrhaphy of a sensory nerve to a motor 
nerve was insufficient to maintain muscle mass or contractility, supporting the claim that the 
motor nerve is responsible for muscle maintenance and contractility (Gutmann, 1945). Later in 
1970, Zalewski’s findings were in agreement with Gutmann when experiments showed that 
reinnervation by sensory or symphathetic neurons could not preserve mass or contractility 
(Zalewski, 1970).  These studies were performed in an ideal setting with unaltered anatomic 
position of the muscle as well as with an undisturbed vascular pedicle. The findings from 
Gutmann and Zalewski prompted Thompson in 1971(Thompson, 1971a, 1971b) to explore the 
effects of innervation of transplanted muscle which prompted other researchers in the area to 
follow suit.  
Interestingly, the previous findings supporting the motor nerve as the sole contributor to 




was demonstrated by Harii et al. (Harii et al., 1976). Harii et al. used autologous gracilis muscle 
transplantation to treat a patient with facial palsy and reported that despite prompt motor 
reinnervation of the transplanted muscle, the muscle atrophied by approximately 50% following 
8 months of recovery. Similarly, in a rat model of muscle transplantation used by Zhang et al., 
gracilis muscle flap transplantation was used to study the effects of reinnervation of transplanted 
muscle using various microsurgical techniques including anastomosis and neurorrhaphy (Zhang 
et al., 1997). They found that denervated gracilis muscle in situ and transplanted decreased to 
28.4% and 31.6% of their initial masses, respectively. Interestingly, motor neurotization of 
muscle in situ yielded bulk preservation of 83.2%, however, motor and sensory neurotization of 
transplanted muscle resulted in only 38.5% and 38.4% preservation, respectively and not 
significantly better than the denervated control flaps (Zhang et al., 1997). Though Zhang’s 
findings demonstrated that motor nerves had better bulk preservation and trophic influence on 
muscle, it was also the first study to experimentally show that sensory neurons could still 
contribute to muscle maintenance, albeit to a lesser degree. These findings motivated further 
studies into sensory neurotization as a potential therapeutic treatment for the bulk preservation of 
denervated muscle. 
Though sensory innervation was previously shown to be not as effective in muscle 
preservation, it was not until the past decade where a clinically relevant procedure using sensory 
nerves was developed. Termed ‘sensory protection’, the Bain group in 2001 first demonstrated 
that sensory neurotization of denervated gastrocnemius and soleus muscles in rats resulted in 
higher preservation of mass and superior histological appearance compared to non-protected 
muscles (Bain, Veltri, Chamberlain, & Fahnestock, 2001). However, isometric force did not 




sensory neurons are incapable of forming functional neuromuscular junctions (Gutmann, 1945). 
Despite this, Bain et al. reported that temporary sensory protection followed by motor 
neurotization can significantly improve force production in muscle and the first clinical 
application of this technique was reported in 2008 by the same group (Bain, Hason, Veltri, 
Fahnestock, & Quartly, 2008). This technique is not without drawbacks as there are still 
concerns regarding changes in the nerve microenvironment with the engraftment of sensory 
neurons that may create a sub-optimal environment for axonogenesis and myelination (Sulaiman 
et al., 2002). Furthermore, the bulk of the evidence for the preservation ability of sensory 
neurons in muscle is provided by very few sources. Though a significant amount of progress has 
been made in the field, there still remains a need for more rigorous clinical studies examining the 
effects of sensory neurotization and its effect on facilitating reinnervation and mass 
preserveration. As such, the use of muscle flap transfers for treating severe soft tissue traumas 
such as VML will remain ineffective in restoring functional capacity. 
 
Rehabilitation Therapy 
 In the military medical system, the main form of therapeutic strategy for VML 
management is physical rehabilitation as most tissue engineering strategies being researched 
have yet to be realized in the clinic (Mase et al., 2010; J. G. Owens et al., 2011). By using 
aggressive rehabilitation programs as reported by Owens et al., all of the patients in the study 
were able to return to weight lifting while 80% of the cohort were able to return to running 
activities (J. G. Owens et al., 2011). Immediately after discharge from the hospital, patients 
underwent strength training to develop the force-generating capacity that is required for sports 




abnormal increase in pain with regimen progression (J. G. Owens et al., 2011). Even with the 
wide variety of injuries from explosive devices, high-velocity gunshot wounds, and motor 
vehicle collisions, the fact that the majority of the patients were able to return to sports activities 
and re-deploy in a few of the cases lends clinical value to rehabilitation programs, especially if 
they were to be used in conjunction with a tissue-engineered repair strategy. 
 There is no guarantee that general rehabilitation programs will impart beneficial effects in 
terms of muscle recovery following VML and VML-like injuries. Though physical rehabilitation 
has been investigated for the recovery of skeletal muscle damage due to conditions such as 
age(Betik, Baker, Krause, McConkey, & Hepple, 2008; Seene & Kaasik, 2012) and metabolic 
conditions like diabetes(Armstrong & Ianuzzo, 1977; Suga et al., 2014), there still remains a 
need for such investigations specifically for VML.  In a study performed by Aurora et al. in 
2014, the response of VML injured muscle to physical activity was investigated in order to aid in 
developing an appropriate rehabilitation regimen for VML injuries (Aurora, Garg, Corona, & 
Walters, 2014). The primary findings from the study reported that voluntary wheel running male 
adult Lewis rats following VML promoted approximately a 17% increase in maximal isometric 
torque as well as a 13% increase in weight of the injured muscle compared to sedentary controls, 
reflecting a 31% recovery of the functional deficit which is similar to force recovery following 
decellularized ECM transplantation following VML (Aurora et al., 2014; Corona, Wu, et al., 
2013). However, no morphological changes were observed with regards to hypertrophy and 
hyperplasia, which may have indicated that the observed functional improvements were due to 
improved force transmission rather than force generation (Aurora et al., 2014). As demonstrated 
by the group before in an earlier study (Corona, Wu, et al., 2013), ECM remodeling and 




from the study provided valuable insight into the changes in VML injured muscle following 
physical rehabilitation and brought attention to other important parameters to investigate such as 
magnitude of physical activity in the form of resistance exercise and timing of the 
implementation of the rehabilitation program following injury. 
 
D. Tissue Engineered Strategies 
 Great strides have been made in the advancement of tissue engineering as a field in the 
past couple of decades, but despite the extensive effort of researchers there are still many 
obstacles in translating exploratory strategies to the clinic. Cell and scaffold-based strategies 
have been extensively employed in the repair and regeneration of a variety of tissues including 
cartilage, skin, cardiac, and bone in the clinic (Chambers, Rimington, Rajani, Hodson, & 
Shabbo, 2007; Falanga & Sabolinski, 1999; Harding, Sumner, & Cardinal, 2013; Oryan, Alidadi, 
Moshiri, & Maffulli, 2014; Song & Ott, 2011). However, there is a lack of therapies available for 
the repair and regeneration of muscle following extensive musculoskeletal trauma, though there 
are a number of research groups developing cell and scaffold-based technologies to address this 
issue (Carosio et al., 2013; Mertens, Sugg, Lee, & Larkin, 2014; Tedesco & Cossu, 2012). 
Similar to therapies in other tissues, skeletal muscle constructs must be biocompatible with the 
host environment, promote cell adhesion, proliferation, and differentiation, and also be able to 
deliver additional biomolecules such as growth factors. The challenge, however, comes when 
examining the components of skeletal muscle that need to be recapitulated through therapy.  
Repair constructs must be able to mimic the highly aligned architecture of native skeletal 




Valentin, Turner, Gilbert, & Badylak, 2010). In pre-clinical animal models where engineered 
skeletal muscle constructs were used, contractile function restoration was demonstrated via 
remodeling of the construct and formation of functional fibrotic structures that retained 
continuity in muscle architecture allowing for effective force transmission through the muscle 
(Aarimaa et al., 2004; Corona, Wu, et al., 2013). Construct design must also accommodate 
sufficient diffusion of oxygen and nutrients to the muscle if they are to provide a sustainable 
environment for seeded cell viability (Cittadella Vigodarzere & Mantero, 2014). Lastly, due to 
the permanent denervation of the distal fibers following VML and VML-like injuries, it is 
essential for repair strategies to be able to regenerate not only de novo muscle tissue but new 
motor endplates as well to restore functional capability in order to avoid atrophy (T. A. Jarvinen 
et al., 2007; T. A. Jarvinen et al., 2005). The importance of neurogenesis during muscle 
regeneration was investigated in the 1970s and 1980s, first by Benoit and Belt then by Foster and 
Carlson in studies using bupivacaine to induce muscle necrosis while preserving satellite cells, 
nerves, and vasculature (Benoit & Belt, 1970; Foster & Carlson, 1980). In the model, new 
myofiber formation was observed 3 days after bupivacaine injection with presence of newly 
forming motor endplates resulting in restoration of muscle function (Jirmanova & Thesleff, 
1972). However, in a separate study where bupivacaine was injected in addition to denervation, 
the regenerating muscle was devoid of any contractile function (B. M. Carlson & Faulkner, 1996, 
1998). In addition to conferring control to new muscle, motor endplates have also been shown to 
have chemotropic and stimulating effects influencing muscle fiber type, alignment, and size 
(Donghui et al., 2010; Grubic, Komel, Walker, & Miranda, 1995; Lefeuvre, Crossin, Fontaine-




 Despite these challenges, the biological and synthetic scaffolds being used in pre-clinical 
animal models have been demonstrated to be reliable platforms upon which regenerative 
therapies can be developed. These strategies aim to improve muscle regeneration by not only 
providing the mechanical/architectural cues absent following injuries, but they also act as a 
substrate for host and transplanted cells to carry out their regenerative processes. Biological 
scaffolds such as decellularized ECM scaffolds have been shown to promote muscle regeneration 
and functional improvement in patients suffering from traumatic injuries (Porzionato et al., 2015; 
Sicari et al., 2014). The combination of cells such as myogenic precursors, mesenchymal stem 
cells, and muscle satellite cells with scaffolds have also shown great promise as they similarly 
contribute to myogenesis, modulate the inflammatory response, and help maintain an 
environment conducive for regeneration (Borselli, Cezar, Shvartsman, Vandenburgh, & Mooney, 
2011; B. N. Brown, Valentin, Stewart-Akers, McCabe, & Badylak, 2009; Garg, Ward, Rathbone, 
& Corona, 2014; Machingal et al., 2011). Synthetic scaffolds such as PGA (polyglycolic acid), 
PLA (polylactic acid), and PLGA (poly(lactic-co-glycolic acid)) (Cronin et al., 2004; Hoque et 
al., 2009; Lesman et al., 2011) are popular as they can be formed into constructs with specific 
patterning or alignment in order to manipulate cell behavior  (Guex, Birrer, Fortunato, Tevaearai, 
& Giraud, 2013). Another benefit of synthetic constructs is that they can be easily engineered to 
facilitate the controlled release of growth factors and drugs to aid in muscle regeneration 
(Grasman, Do, Page, & Pins, 2015). However, the main disadvantage of synthetic scaffolds 
compared to decellularized xenogeneic and autologous tissue scaffolds is that they have poorer 
affinity for cellular binding, often requiring protein coatings to promote adhesion, and have 
higher risk of a foreign body response due to degradation products or the polymer itself (Yang, 




Decellularized ECM Scaffold Strategies 
 Decellularized tissue scaffolds for tissue repair in recent years has been of particular 
interest due to the scaffolds sharing similar properties of the native tissue as well as being able to 
facilitate remodeling of de novo tissue and host cell infiltration (Merritt et al., 2010; Turner et al., 
2010). Cellular antigens are recognized by the host system as foreign bodies and therefore induce 
an immune response. However, components of the ECM are remarkably conserved across 
species post-decellularization, which have made decellularized ECM scaffolds an attractive 
option in the area of regenerative medicine. The challenge and goal of decellularization protocols 
is to be able to retain the composition, bioactivity, and mechanical integrity of the remaining 
ECM during the decellularization process (Gilbert, Sellaro, & Badylak, 2006). Other factors to 
consider carefully are the host of origin of the tissue from which the ECM will be isolated and 
the method of decellularization as these factors can affect composition and structure of the ECM 
leading to changes in host response to the implanted scaffolds (Gilbert et al., 2006). The most 
effective protocols incorporate a combination of physical, chemical, and enzymatic treatments in 
order to lyse the cell membranes, separate the ECM from the cellular components, and solubilize 
the components for removal with subsequent rinse and sterilization steps (Gilbert et al., 2006).   
 These biologic scaffolds have seen success in both pre-clinical animal studies and in 
human clinical trial applications (S. F. Badylak, 2004; F. Chen, Yoo, & Atala, 1999; Dellgren, 
Eriksson, Brodin, & Radegran, 1999; Kolker, Brown, Redstone, Scarpinato, & Wallack, 2005; 
Wainwright, 1995).  Based out of the University of Pittsburgh, Dr. Stephen Badylak and his 
group were among the first researchers exploring the value of tissue-based scaffolds and grafts as 
regenerative biomaterials in small and medium pre-clinical animal models. The focus of his work 




(Stephen F. Badylak, 1993). Prior to his investigations into orthopedic soft tissue applications, 
his investigations included the use of SIS in the repair of small and large diameter arteries (S. F. 
Badylak, Lantz, Coffey, & Geddes, 1989; Lantz, Badylak, Coffey, Geddes, & Blevins, 1990), 
veins (Sandusky, Badylak, Morff, Johnson, & Lantz, 1992), and skin (Stephen F. Badylak, 
1993). 
 In one of the first studies exploring the feasibility of using SIS as a biomaterial to repair 
localized orthopedic injuries, Badylak and colleagues evaluated the tissue reponse to SIS when it 
was used to repair an Achilles tendon defect in a canine model (S. F. Badylak et al., 1995). In the 
study, a 1.5cm long segment of Achilles tendon was excised from 20 dogs and the resulting 
defect was filled with a cylindrical piece of SIS that was sutured into place. Animals were 
sacrificed at 1, 2, 4, 8, 16, 24, and 48 weeks post-repair and neotendons were collected to 
monitor mechanical, biochemical, and morphological parameters (S. F. Badylak et al., 1995). 
Mechanically, the repaired tendons were observed to be stronger than both the musculotendinous 
origin and boney insertion, bearing loads of at least 1000N before rupturing when compared to 
the non-repaired group (S. F. Badylak et al., 1995). At one and two weeks post-repair, excised 
tendon samples showed dense infiltration of immune cells as well as a “richly vascular 
connective tissue matrix material” and was only observed within the anastomosis site and the 
area immediately adjacent (S. F. Badylak et al., 1995). At the later timepoints, the connective 
tissue appeared to have been remodeled into organized sheets that were aligned to the weight-
bearing load. Additionally, the absence of significant populations of lymphoid and plasma cells 
was inconsistent with immune rejection of the SIS material, lending great value and potential of 
the material to be investigated in other repair applications (S. F. Badylak et al., 1995). Most 




tissue integration making it an attractive option for development as it was not associated with 
any of the complications normally associated with synthetic and other biomaterials.  
 Subsequent studies involving the use of the porcine SIS scaffold led to investigations in 
the repair of urinary tract replacement procedures (Shalhav et al., 1999), meniscal regeneration 
(Cook, Tomlinson, Kreeger, & Cook, 1999), and bone regeneration (Suckow, Voytik-Harbin, 
Terril, & Badylak, 1999; Winkler, Swaim, Sartin, Henderson, & Welch, 2002). However, the 
first use of porcine SIS in muscle repair was performed in 1995 by Prevel et al. in a rodent model 
of abdominal wall defects (Prevel et al., 1995). A 2x2-cm full-thickness defect was excised from 
the rodent abdominal wall. A patch of porcine SIS graft material was then sutured into the defect 
and the animals were left to recover for 1 week, 2 weeks, 4 weeks, 2 months, and 3 months prior 
to euthanization. To assess treatment efficacy, histological analysis was performed and it was 
revealed that the SIS graft had integrated into the host tissue with minimal inflammation by 2 
months. Similar to studies using SIS biomaterials, there was no evidence indicating a host-
rejection response to the material (Prevel et al., 1995).  
 In the realm of VML repair, in 2012 the Badylak group developed a murine model of 
VML in the quadriceps muscle and demonstrated the response to repair using a bioscaffold-
based approach (Sicari et al., 2012). In the study, female C57/BL/6 mice aged 6-8 weeks had a 
4x3mm full thickness segment of their tensor fasciae latae muscle along with a portion of the 
underlying rectus femoris muscle resected and then the defect was filled with a 4x4x3mm 
porcine SIS-ECM sheet implant. Histological analysis at the repair site at 7 days post-surgery 
showed dense populations of neutrophils and mononuclear cells around the defect site and the 
outer edges of the scaffold. In addition, evidence of angiogenesis and neurogenesis was found in 




derived ECM was found to be integrating with the remodeled ECM implant and appeared to be 
cellularized. At 56 days, the ECM was completely populated with cells including desmin-
positive skeletal muscle cells. On the contrary, the unrepaired group in the study exhibited 
deposits of dense connective tissue consistent with scar tissue formation with a distinct layer of 
host-derived neo-matrix at the margins of the defect site (Sicari et al., 2012). This study clearly 
demonstrated the potential of decellularized matrix scaffolds as therapies for VML injuries as the 
implanted scaffolds were able to integrate with the surrounding host tissue, promoted 
constructive remodeling of the defect site, and allowed for the recruitment of immune and 
progenitor cells to the site without illiciting an overt foreign body response.  
 Extending their previous research into VML repair in both mice and humans (Sicari et al., 
2014), the Badylak group conducted a clinical study using several different tissue-derived ECM 
scaffolds of porcine origin to repair VML injuries in a 13-paitent cohort (Dziki et al., 2016). The 
injured muscle compartment of each patient was identified wherein scar tissue debridement and 
selective tenolysis was performed prior to the implantation of one of three ECM bioscaffolds: 
porcine urinary bladder matrix (UBM, MatriStem, ACell, Columbia, MD, USA), porcine SIS 
(BioDesign, Cook Medical, Bloomington, IN, USA) or porcine dermis (XenMatrix, C.R. Bard, 
Warwick, RI, USA) (Dziki et al., 2016). All bioscaffolds were suture with contact to adjacent 
native healthy tissue and secured under tension with suture.  Tissue biopsies taken at 6-8 weeks, 
10-12 weeks, and 24-28 weeks post-surgery showed progressive evidence of de novo muscle 
formation and neovascularization verified by the presence of desmin+ cells with centrally located 
nuclei and CD146+NG2+ perivascular stem cells. The presence of β-III tubulin+ nerve bundles 
by 6 months after surgery within the repair site was suggestive of innervation and neurogenic 




ranging from 20-140% at 6 months post-surgery which was attributed to ECM implantation. 
However, all patients underwent aggressive physical therapy programs pre-operatively and 
during recovery from VML repair which may have had a positive impact on bioscaffold 
remodeling leading to increased vascularization and innervation. These findings are supported by 
previous studies investigating the effects of mechanical loading following VML repair with 
ECM scaffolds (Ballotta, Driessen-Mol, Bouten, & Baaijens, 2014; Gentile et al., 2014; Gilbert 
et al., 2007; Turner, Badylak, Weber, & Badylak, 2012). However, the improved functional 
outcomes are likely attributed to improved force transduction via scar tissue remodeling as 
documented by Aurora and Corona (Aurora, Roe, Corona, & Walters, 2015; Corona, Wu, et al., 
2013). Further, the use of acellular bioscaffolds such as the urinary bladder matrix used in this 
study alone were demonstrated to be insufficient in generating an appreciable amount of de novo 
skeletal muscle and was suggested that for significant muscle regeneration to occur, repair 
strategies needed to incorporate progenitor cell populations and develop more effective 
myoconductive scaffolds (Aurora et al., 2015).  
 
Decellularized Muscle-Derived ECM Scaffold Strategies 
 Though decellularization of tissues has been shown to be non-immunogenic and 
acellular, there may be benefits to using a scaffold derived from the target tissue of interest. 
Specifically for muscle, the remnant structure following decellularization may facilitate the 
integration of peripheral nerves due to the already existing neural pathways in the scaffold 
(Borschel, Dennis, & Kuzon, 2004).  Further, the remaining vascular system in acellular skeletal 
muscle scaffolds could be used to perfuse the constructs allowing for improved growth and force 




skeletal muscle tissue engineering have shown a favorable response to the use of skeletal muscle-
derived ECM strategies for muscle regeneration with extensive work being performed assessing 
their host bioactivity and histocompatibility (Borschel et al., 2004; Corona, Wu, et al., 2013; 
DeQuach et al., 2012; Perniconi et al., 2011).   
 In a study by Borschel et al., the myogenic potential and force production capability of 
acellular muscle scaffolds seeded with and without C2C12 myoblasts was explored (Borschel et 
al., 2004). Acellular scaffolds were created from extensor digitorum longus muscles excised 
from adult C57-BL6 mice. Repopulated and acellular scaffolds were cultured for a period of  3 
days in growth medium and then for 3 weeks in differentiation medium. Force production in the 
myoblast populated muscle scaffolds was substantially lower than normal EDL muscle output 
but was enough to demonstrate that the seeded cells were able to proliferate and differentiate into 
fused myofibers within the acellular muscle scaffolds. These findings were further substantiated 
with histological analysis using toluidine blue staining to confirm cell proliferation and electron 
micrograph imaging to examine microscale structures within the populated and non-populated 
acellular scaffolds. The non-populated scaffolds were devoid of the key muscle cytoskeletal 
elements actin and myosin as well as having a loosely organized matrix. However, with the 
populated scaffolds, researchers found the existence of the filamentous proteins actin and myosin 
and further observed that they had assembled into a sarcomeric pattern (Borschel et al., 2004). 
Though tested in vitro, these findings were significant in that they addressed some of the major 
hurdles facing the development of constructs that are to be clinically relevant. 
 While it was demonstrated previously to be feasible to produce highly complex organs 
such as the rodent heart in vitro (Ott et al., 2008), an in vivo skeletal muscle transplantable had 




anterior (TA) muscles of adult sex-matched BALB/C mice and transplanted them into syngeneic 
hosts to be assessed for histocompatibility, bioactivity, and host integration in a murine model 
(Perniconi et al., 2011). An incision was made in the hindlimb to expose the TA epimysium to 
allow for the excision of the TA. The distal tendon and a fragment of the proximally inserted 
muscle on the TA were left intact to anchor the scaffold. Mice were given 2  and 4 weeks to 
recover after which the grafted materials were harvested for histological analysis. 
Immunostaining revealed that at 2 weeks post-implantation there were signs overt inflammation 
within and around the scaffold, which was further specified to be infiltration of CD45+ cells 
comprised mostly of macrophages via flow cytometry, indicating that immune cell infiltration 
was restricted to the implanted material. In 4 week grafted material, the degree of inflammation 
appeared to be decreased to control levels. The presence of muscle interstitial stem cells was also 
confirmed within grafted materials. Scattered nascent myofibers exhibiting centrally located 
nuceli preferentially located in the mid-belly and distal regions of the scaffold demonstrated its 
myogenic capability. These findings were further validated with protein expression of myosin 
heavy chain and sarcoglycan and mRNA expression of muscle-specific late differentiation 
markers (Ott et al., 2008). Taken with other studies that use ECM from other tissues to 
regenerate muscle that morphologically and functionally mimic native tissue (Turner et al., 2010; 
Valentin et al., 2010; Vindigni et al., 2004), ECM has consistently shown the ability to form de 
novo tissue, in part due to contributions of the migration of tissue-resident progenitor cells to the 
implant site. The added value of this study is that it demonstrates that muscle-derived ECM itself 
has pro-myogenic qualities supporting an environment favorable for myofiber formation. 
Findings from other researchers highlighting the impact of niche regulation on tissue-resident 




properties that aid in its myogenic activity (Ferraro, Celso, & Scadden, 2010; Pelosi et al., 2007; 
Vindigni et al., 2004). 
 The use of muscle-derived ECM scaffolds in VML repair has been of great interest to the 
military due to the high incidence of extremity trauma in veterans returning from active war 
zones and the lack of an effective treatment to restore functional tissue following reconstructive 
surgery (Andersen et al., 2014; Mase et al., 2010; B. D. Owens et al., 2008; J. G. Owens et al., 
2011; Ramasamy, Harrisson, Clasper, & Stewart, 2008). However, trauma research at the U.S. 
Army Institute of Surgical Research (USAISR) led by the Walters and Corona groups have made 
great advancements in the development of VML repair strategies using muscle-derived ECM 
scaffolds. The Walters group’s initial work in VML yielded a standardized rat model of VML 
(Wu, Corona, Chen, & Walters, 2012) upon which various treatment strategies have been tested 
(Aurora, Corona, & Walters, 2016; Corona, Garg, et al., 2013; Corona, Ward, Baker, Walters, & 
Christ, 2014). Specifically, the model involves the creation of a VML defect (~20% of muscle’s 
mass) in the tibialis anterior muscle of a rat. More importantly, there has been thorough 
documentation of the response to VML injury itself and to the implantation of muscle ECM 
scaffolds during VML repair (Aurora et al., 2015; Corona et al., 2014; Corona, Wu, et al., 2013; 
Garg, Corona, & Walters, 2015). Wu et al. demonstrated in the standardized rat VML model that 
following VML injury at 2 and 4 months, significant atrophy to the unrepaired muscles occurred 
(22.7% and 19.5% reduction in mass compared to uninjured controls at 2 and 4 months) while 
also being accompanied by a reduction in peak isometric torque of 28.4% and 32.5% at 2 and 4 
months respectively (Wu et al., 2012). In addition, they observed the characteristic deposition of 
scar tissue at the VML injury site as well as ongoing remodeling and repair as indicated by the 




have been observed to be consistent across similar VML studies (Corona, Wu, et al., 2013; 
Kasukonis, Kim, Washington, & Wolchok, 2016).  
 In terms of functional recovery following repair, scaffold-only repair has been incapable 
of promoting an appreciable amount of muscle regeneration resulting in significant increases to 
contractile function (Aurora et al., 2015; Corona et al., 2014). Despite reports of improved 
functional outcomes following VML repair with muscle-derived ECM and other ECM scaffolds, 
the force improvements are most likely attributed to a “bridging” of the defect site by scar tissue 
deposition as demonstrated by Corona et al. (Corona, Wu, et al., 2013). In that study performed 
by Corona et al., a VML defected created in the tibialis anterior muscle of a rat was left 
untreated, repaired with muscle ECM, or repaired with muscle ECM with a delayed injection of 
bone marrow stem cells (Corona, Wu, et al., 2013). Interestingly, it was found that untreated 
VML injury resulted in extensive fiber damage and remodeling that visibly extended from the 
defect site to the underlying musculature. However, repair with the muscle ECM (with and 
without BMSC delivery) appeared to attenuate the damage to the remaining musculature which 
was associated with the observed functional improvements at 2 and 4 months post-treatment. No 
significant de novo myofiber formation was observed in this study, though there have been 
varying reports on the degree of myofiber generation following scaffold-mediated repair ranging 
from abundant and modest levels (Corona et al., 2012; Machingal et al., 2011; Merritt et al., 
2010) to low or non-existent levels (Conconi et al., 2005; Turner et al., 2010). However, the 
characteristic deposition of mostly collagen I-enriched scar tissue at the VML repair site was 
observed; findings that are consistent with the use of ECM scaffolds to repair similar complex 
injuries (Gamba et al., 2002; Kim, Kasukonis, Brown, Washington, & Wolchok, 2016; Turner et 





 The use of cells in tissue-engineered therapies can have tremendous value compared to 
acellular scaffolds when considering rejuvenating the native cell population in cases such as 
VML injuries. Due to their multipotency, mesenchymal stem cells have the ability to aid in the 
repopulation and subsequent proliferation and differentiation into target tissue cells once 
implanted. In various studies, the delivery of quiescent muscle satellite cells have shown to 
promote greater regeneration compared to culture-derived myoblasts (DiMario & Stockdale, 
1995; Rossi et al., 2011).  These studies, however, focused on the therapeutic effects that the 
degree of maturation of immature cells (quiescent vs. activated cells) may have whereas the 
therapeutic potential in delivering a construct in combination with active precursor cells has been 
explored to a lesser extent. The greatest advantage of using a tissue-engineered scaffold in 
conjunction with myogenic precursor cells is that such a strategy aids in recapitulating the 
cellular and mechanical environment following VML injury. For instance, a study led by Corona 
from the Christ research group from Wake Forest University is particularly interesting as it 
combines both acellular scaffold and in vitro cultured myofbers and cells (Corona et al., 2012). 
The treatment strategy included the use of a porcine urinary bladder matrix, which was seeded 
with a mix of primary cells isolated from tibialis anterior and soleus muscle. The seeded 
constructs were then pre-conditioned in a stretch bioreactor in order to proliferate and 
differentiate the cells (Corona et al., 2012). The three separate constructs tested in the study 
consisted of a single seeding of cells that were proliferated during pre-conditioning (TEMR-
1SP), a seeding of cells that were differentiated under pre-conditioning (TEMR-1SPD), and 2 
seedings of cells that were proliferated and differentiated (TEMR-2SPD). Significant functional 




non-repaired controls with the TEMR-2SPD group exhibiting the highest force recovery. It was 
also observed that both magnitude and time course of recovery was dependent on the TEMR 
construct used with the TEMR-1SPD and TEMR-2SPD constructs providing a 62% and 110% 
increase in peak force values when compared to non-repaired controls at 2 months post-injury. 
Additionally, TEMR-1SPD and TEMR-2SPD groups exhibited a 39% and 28% improvement in 
peak force between 1 and 2 months post-injury. Morphologically, TEMR-1SPD and TEMR-
2SPD repaired muscle samples appeared to have an increased cellular presence within the 
scaffold area, an increase in muscle tissue formation at both the repair site and within the 
scaffold, and a presence of vascular and neural structures at the tissue-construct interface 
(Corona et al., 2012).  
 These findings are particularly interesting as they illustrate the unique benefits of a 
hybrid construct containing both pre-conditioned proliferating and differentiating cell 
populations. Specifically, Corona et al. found that actively proliferating cells contributed to 
accelerated functional recovery while the presence of differentiated myotubes is critical in 
maintaining continuous functional recovery (Corona et al., 2012). Compared to strategies using 
acellular scaffolds to form de novo muscle tissue, it is plausible that hybrid constructs such as the 
TEMR would require a shorter time to promote new tissue growth contributing to functional 
recovery ((Corona et al., 2012)). An alternative to the delivery of stem or progenitor cells is the 
use of autologous minced muscle grafts as a means of introducing not only muscle progenitor 
cells but other muscle-native cells and native ECM to the VML site (Corona, Garg, et al., 2013; 
Goldman & Corona, 2017; Goldman, Henderson, & Corona, 2017; Hurtgen et al., 2017; B. 




The first experiments detailing the regenerative capacity of minced muscle fragments 
were performed by Studitsky (Studitsky, 1964) and Carlson (B. M. Carlson, 1968) in their 
respective seminal publications. Studitsky’s most significant finding was that minced muscle 
tissue was observed to enter a state of plasticity and thereby increased the survivability and 
development of transplanted minced tissue in injury sites (Studitsky, 1964). Carlson’s study in 
1968 confirmed Studitsky’s previous findings by implanting minced muscle to regenerate rat and 
frog muscles following complete removal of the gastrocnemius muscle (B. M. Carlson, 1968). 
Carlson confirmed the regeneration of muscle and restoration of anatomical organization in both 
frog and rat specimens, though it was noted that regeneration appeared to occur at approximately 
twice the rate in the rats compared to the frogs (B. M. Carlson, 1968). An important finding from 
the study, however, was the observation of normal regeneration in the acute phases of healing 
but then cycles of degeneration of newly formed myofibers within the tissue regenerates. At the 
end of the study, it was reported that most of the muscle regenerates were reduced to “a 
tendinous structure with only a few scattered muscle fibers…” (B. M. Carlson, 1968). This was 
attributed in part to the lack of innervation in the late phases of regeneration as previous reports 
have demonstrated in detail that early muscle differentiation can occur independent of 
innervation but is necessary for the latter stages of differentiation (Striganova, 1958; 
Zhenevskaya, 1962).  
 In recent reports, the delivery of satellite cells via transplantation of single muscle fibers 
has been demonstrated to be a potent technique to not only produce myogenically competent 
progeny but to increase satellite cell engraftment and survivability as well (Collins et al., 2005; 
Hall, Banks, Chamberlain, & Olwin, 2010; Tateyama, Fujihara, Misu, & Itoyama, 2009). 




due to the simplicity of the procedure compared to single myofiber isolation and lends itself to 
facile integration with treatment strategies for use in the clinic. Corona et al. in 2013 first 
explored the use of autologous minced muscle grafts for VML repair (Corona, Garg, et al., 
2013). Following VML defect creation in the TA muscle of Lewis rats, it was observed that 
orthotopic transplantation of minced muscle autografts into the wound bed promoted myofiber 
regeneration by 8 and 16 weeks post-repair. Interestingly, by 8 weeks the regenerated fibers 
exhibited signs of innervation, which was further validated via a glycogen depletion study. 
Fibers were also reported to have similar cross-sectional areas as uninjured muscle fibers when 
compared to literature (Corona, Garg, et al., 2013). Functional capacity was restored to 
approximately 55% of the functional deficit present in unrepaired TA muscles (Corona, Garg, et 
al., 2013). In an earlier study that transplanted decellularized muscle-derived ECM to repair a 
VML defect (Corona, Wu, et al., 2013), functional recovery at 16 weeks post-repair was reported 
to be approximately 20%. It is clear that minced muscle autografts contribute to an increase in 
functional tissue as evidenced by the two-fold increase in functional recovery over scaffold-alone 
repair.  
 Building off the minced muscle graft approach for VML repair, Kasukonis et al. 
demonstrated that the combinatorial therapy of minced muscle grafts and decellularized ECM 
scaffolds was able to significantly improve functional outcomes as well as exert transcriptional 
regulation over myogenesis following VML repair (B. Kasukonis et al., 2016). The use of a 25% 
minced muscle graft in this study was motivated by previous work from Corona et al. exploring 
minced muscle graft volume expansion approaches for the treatment of VML (Ward, Ji, & 
Corona, 2015). In that study, Corona et al. observed that using approximately 50% of the VML 




recovery to that of a 100% minced muscle graft with hydrogel carrier (Ward et al., 2015). By 
utilizing a <50% minced muscle graft, Kasukonis et al. hoped to evaluate whether a 
decellularized skeletal muscle scaffold (DSM) could improve the regenerative abilities of the 
sub-optimal amount of minced muscle graft used in the study. Not only did DSM and 25% 
minced muscle repair improve functional outcomes that were comparable to what was observed 
with the use of 50% minced muscle by Corona et al. (~50% force recovery), significant 
improvements in the restoration of muscle mass and upregulation of myogenic gene expression 
were also observed (B. Kasukonis et al., 2016). These findings warrant further investigation into 
the development of DSM scaffolds as carriers for minced muscle grafts. Specifically, it is of 
great interest whether these scaffolds act merely as vehicles for the minced muscle or if there are 
any significant matrix-minced muscle interactions that modulate satellite cell activity for the 
benefit of myogenesis and VML repair. 
 
Synthetic and Natural Polymer Strategies  
 The benefit in using natural and synthetic polymers in the development of engineered 
skeletal muscle constructs is the ability to control the mechanical and spatial properties of the 
material during fabrication. Another advantages of synthetic materials is the ability to 
incorporate growth factors into the bulk structure of these polymers allowing for controlled 
release of these factors into the site of injury (Niu, Feng, Wang, Guo, & Zheng, 2009; 
Prabaharan & Jayakumar, 2009). Biomaterial development for skeletal muscle tissue engineering 
has explored a large variety of materials ranging from synthetic polymers such as poly(glycolic 
acid) (PGA) (Saxena, Marler, Benvenuto, Willital, & Vacanti, 1999; Saxena, Willital, & Vacanti, 




Christ, Atala, & Yoo, 2008); to natural polymers such as alginate (Borselli et al., 2010), collagen 
(Hurd, Bhatti, Walker, Kasukonis, & Wolchok, 2015; Kroehne et al., 2008), and fibrin 
(Marcinczyk et al., 2018; Page et al., 2011).  
 The spatial patterning of constructs, especially highly aligned patterns of electrospun 
nanofibers mimicking the native architecture of muscle, provides control over cellular behavior, 
which can be of great benefit in terms of being able to enhance certain phases of myogenesis. In 
vitro studies exploring spatially patterned constructs for musculoskeletal engineering 
applications have demonstrated that highly aligned cultures of myoblasts seeded onto aligned 
nanofiber scaffolds have increased proliferation and more readily fuse into multi-nucleated 
myofibers (Choi et al., 2008; Guex et al., 2013; Zatti et al., 2012)  than cultures using randomly-
oriented fibers. These effects are augmented when additional scaffold properties are 
incorporated, as was the case with Chen et al. who fabricated electrically conductive 
PCL/polyaniline (PCL/PANi) nanofiber scaffolds to evaluate their potential use in engineering 
regenerative strategies for skeletal muscle (M. C. Chen, Sun, & Chen, 2013). Chen et al. 
observed synergistic effects of topographical and electrical cues on myotube formation with 
significant increases in myotube formation and maturation (15% and 18% increases, 
respectively) when compared with non-conductive or randomly oriented conductive scaffolds. 
Similar electrically conductive scaffolds have been demonstrated to increase differentiation and 
myogenic gene expression in myoblasts (Jun, Jeong, & Shin, 2009), increase alignment and 
proliferation in osteoblasts (Shao et al., 2011), and increase adhesion and proliferation of cardiac 
myoblasts (Bidez et al., 2006). Synthetic constructs that provide multiple environmental cues 
will be indispensable in the further development of tissue engineering strategies due to the 




 Despite imparting beneficial effects on functional outcomes, synthetic biomaterials are 
limited due to their poor bioactivity, often requiring the addition of coatings to promote cell 
adhesion or incorporation of natural polymers to attenuate the host immune response (Choi et al., 
2008; Wolf et al., 2014). An interesting approach exploring the development of a more bioactive 
scaffold leveraged the porous architecture of polyurethane (PU) foams to act as a sacrificial 
template for the deposition of ECM from rat myoblasts (Hurd et al., 2015). Myoblasts were 
cultured on fibronectin coated PU foams for 4 weeks after which the foams were dissolved in 
solvent to isolate the resulting ECM material. Collagen I, collagen IV, and laminin were all 
detected to be present in the resulting material, all of which are present in the basement 
membrane of skeletal muscle (Gillies & Lieber, 2011). Materials such as these are uniquely 
suited to be used in the repair of VML and VML-like injuries as they can provide the bioactive 
signaling cues that are missing due to the disruption to the basement membrane following VML 
injury. However, Hurd et al. reported the mechanical strength of the foam template ECM to be 
approximately one-third of decellularized muscle ECM, which may lack the structural support to 
withstand mechanical loading during regeneration (Hurd et al., 2015). 
 Unlike their synthetic counterparts, natural polymers intrinsically possess bioactivity as 
well as the ability to form molecules such as proteoglycans which enhance cell migration, 
proliferation, and differentiation via binding of growth factors (Bidarra, Barrias, & Granja, 2014; 
A. C. Brown & Barker, 2014; Walters & Stegemann, 2014). Among these biopolymers, alginate 
(Hill, Boontheekul, & Mooney, 2006b; Liu et al., 2013), collagen (Chevallay & Herbage, 2000; 
Rhim et al., 2007), and fibrin (Heher et al., 2015; Marcinczyk et al., 2018; Matsumoto et al., 




 Initial exploration into the applications of alginate-based biomaterials were to utilize 
them as encapsulating agents for the delivery of proteins in order to mimic paracrine signaling 
between cells (Edelman, Mathiowitz, Langer, & Klagsbrun, 1991; Sugamori & Sefton, 1989). 
Due to its ability to maintain steady release profiles of desired proteins and its tunable 
mechanical properties (Boontheekul, Kong, & Mooney, 2005; Drury, Boontheekul, & Mooney, 
2005), it remains as an ideal candidate for controlled delivery systems for various tissue 
engineering applications such as the delivery of pancreatic islet cells (Opara, Mirmalek-Sani, 
Khanna, Moya, & Brey, 2010), to promote osteogenesis via mesenchymal stem cell delivery 
(Zhou & Xu, 2011), and revascularization of various tissues (Drewa, Adamowicz, & Sharma, 
2012; Iwasa, Engebretsen, Shima, & Ochi, 2009; Macchiarini et al., 2008). Within skeletal 
muscle regeneration, in vitro investigations found that the stiffness of the gels (~45 kPa) 
significantly increased myoblast proliferation and differentiation (Boontheekul, Hill, Kong, & 
Mooney, 2007). As a delivery vehicle, alginate has been demonstrated to be able to transport and 
release various growth factors crucial to muscle regeneration including VEGF (Shvartsman et al., 
2014; Wang et al., 2014), IGF-1 (Borselli et al., 2010),  and HGF and FGF-2 (Hill, Boontheekul, 
& Mooney, 2006a; Hill et al., 2006b). In vivo, the combined delivery of VEGF and IGF-1 in an 
alginate gel carrier was observed to improve host progenitor cell survival and vascularization in 
the acute phases of regeneration (Borselli et al., 2010; Shvartsman et al., 2014). Further, delivery 
of both VEGF and IGF-1 increased force production approximately 4-5 fold compared to blank 
control gels (Borselli et al., 2010). However, this study used a less severe injury model than a 
VML with ischemia induced muscle injury. Additionally, alginate gels have only, thus far, been 
implanted on the surface of injury sites (Borselli et al., 2011) and even though they have been 




conclusions can be drawn on their efficacy when presented with a more complex in vivo 
environment as in VML cases. 
 In skeletal muscle, collagen I gels have been used as cell delivery vehicles for myoblasts 
which have been shown to promote cell migration out of the porous gels to the ends of existing 
myofibers (Carnio et al., 2011). Without modifications to collagen assembly within gels, the 
result of implantation following injury is a suboptimal healing response characterized by 
increased immune cell infiltration into the site and an absence of myogenesis (van Wachem, 
Brouwer, & van Luyn, 1999). However, collagen constructs with tunable internal structures such 
as the parallel pore collagen sponge developed by Korehne et al. can promote aligned myotube 
growth and development in vitro, which can later be transplanted into an in vivo injury site 
(Kroehne et al., 2008). In the study, 6mm x 3mm x 2.5mm collagen sponges were seeded with 
C2C12 myoblasts which were allowed to proliferate for 1 day before switching to differentiation 
medium for an additional 5-6 days, after which the cultured regenerates were sutured into the 
muscle bed where the tibialis anterior muscle was located prior to excision. It was observed that 
the implanted regenerates were able to integrate into the surrounding host tissue as well as 
having the ability to contract under stimulation (Kroehne et al., 2008). These results suggest that 
rather than the material itself, the alignment of the constructs used to repair large tissue defects 
appear to impart greater effects to improve myogenesis compared to similar materials with no 
alignment. In addition, with the absence of any significant regenerative outcomes resulting from 
the implantation of collagen materials/scaffolds, their uses are limited to in vitro development of 
partial tissue regenerates and acting as vehicles for the delivery of growth factors such as VEGF 
(Frey, Jansen, Raschke, Meffert, & Ochman, 2012) or HGF, IGF-1, and FGF2, which have been 




 Fibrin, a branched fibrillary polymer, is another attractive biopolymer material upon 
which muscle regenerative strategies can be developed due to its role in vivo as the provisional 
matrix that is deposited during wound healing as well as its inherent bioactivity (A. C. Brown & 
Barker, 2014; Chiron et al., 2012; Clark, 2001). Though its biodegradation has been observed to 
be approximately 3 weeks in vivo, its structural integrity can be augmented via incorporation of 
polymers such as PLLA/PLGA or polyethylene glycol (PEG) to slow the degradation rate 
(Lesman et al., 2011). Additionally, an alternative to hybridizing fibrin with synthetic polymers 
is manipulating the degree of cross-linking (ultraviolet or chemically-induced) (Grasman, 
Pumphrey, Dunphy, Perez-Rogers, & Pins, 2014). Several studies have demonstrated the ability 
of myoblast seeded fibrin gels to improve myoblast survival post-transplantation and promote 
differentiation into myofibers that are able to integrate into the uninjured host tissue (Beier, 
Kneser, Stern-Strater, Stark, & Bach, 2004; Beier et al., 2006; Gerard, Forest, Beauregard, Skuk, 
& Tremblay, 2012). Further, it was found that implanting a myoblast-loaded fibrin gel sheaths in 
the proximity of native blood vessels increased vascular perfusion into the constructs (Borschel, 
Dow, Dennis, & Brown, 2006). In addition, the resulting tissue explants isolated from the gel 
sheaths were found to resemble functional muscle tissue capable of contraction while 
maintaining their mechanical integrity through testing (Borschel et al., 2006). Despite these 
findings, with the lack of in vivo functional measurements it is difficult to say whether the 
amount of regeneration and angiogenesis resulting from treatment would be effective in treating 
larger volumetric defects in muscle.  
 In a VML injury setting, fibrin has been utilized in many forms including microthreads 
(Grasman, Page, & Pins, 2017), hydrogels (Gilbert-Honick, Iyer, et al., 2018), and microbeads 




to deliver growth factors (Cornwell & Pins, 2010; Grasman et al., 2015) and cells (Gilbert-
Honick, Ginn, et al., 2018; Page et al., 2011) to the site of injury to augment the regenerative 
process. In a study that leveraged both the delivery capability and tunable structure of fibrin, 
researchers were able to seed adult adipose stem cells (ASCs) onto fibrin microfiber bundles 
prior to implantation into a VML defect in a murine model (Gilbert-Honick, Ginn, et al., 2018). 
Interestingly, in vitro experiments assessing the pro-myogenic potential of the ASC seeded fibrin 
microfiber bundles revealed that the seeded constructs were able to produce aligned and 
elongated ASCs that expressed markers for skeletal muscle but failed to mimic native muscle 
characteristics. When the bundles were implanted in place of both TA and EDL muscles in vivo, 
a significant reduction in fibrosis at the implant site was observed (Gilbert-Honick, Ginn, et al., 
2018). Further, compared to acellular fiber bundles, seeded bundles exhibited increased markers 
for embryonic myosin as well as the mature muscle marker myosin heavy chain. However, due 
to the lack of functional muscle measurements as well as histological analysis of the regenerating 
construct/tissue explants, no meaningful conclusions can be drawn from a clinically relevant 
standpoint. As the majority of non-modified fibrin materials degrade in vivo within 3 weeks upon 
implantation, the resulting de novo myofibers are often randomly oriented and disorganized 
unlike the highly aligned surrounding host tissue, giving rise to poor functional outcomes and 
regeneration. Despite this, the development of biopolymer scaffolds such as fibrin and those 
mentioned previously still hold great value when thinking towards combinatorial tissue 







E. Aging Skeletal Muscle 
  Closely associated with aging is the gradual decline of cellular activity ultimately leading 
to physiological changes that contribute to the impairment of normal regenerative processes. 
This has been documented in various tissues such as skin during wound healing (D. R. Thomas, 
2001), angiogenesis in various tissues and organs (Edelberg & Reed, 2003; Lahteenvuo & 
Rosenzweig, 2012), and remyelination of axons in the central nervous system (Franklin, Zhao, & 
Sim, 2002; Sim, Zhao, Penderis, & Franklin, 2002). In skeletal muscle, the predominant change 
with aging is the overall loss of muscle strength, muscle mass, and decline in regenerative 
potential. Underlying the loss in strength is a reduction in the number of functional motor units, 
particularly fast-fatigueable motor units (Kung et al., 2014; Larsson, 1995). The progressive loss 
in muscle mass, often referred to as sarcopenia, and decline in regenerative capacity is largely 
due in part to the reduced activity and numbers of satellite cells associated with aging (Brack & 
Rando, 2007; Conboy & Rando, 2005; Snow, 1977). Specifically, a decrease in sensitivity to 
signals initiating the activation, proliferation, and renewal capability of satellite cells has been 
documented with aging (Brack & Rando, 2007; Gopinath & Rando, 2008; Kuang, Gillespie, & 
Rudnicki, 2008). Also, associated with sarcopenia is the marked decrease in capillary density and 
circulating levels of angiogenic factors that may have negative implications regarding 
metabolism, endocrine function, and muscle contractility (Olfert, Baum, Hellsten, & Egginton, 
2016). Though these major changes in aging skeletal muscle have implications regarding the 
regenerative capacity of muscle, it is equally as important to understand the more subtle changes 







 One of the major changes in the extracellular matrix with aging is the significant increase 
in interstitial connective tissue (Marshall, Williams, & Goldspink, 1989). According to Marshall 
et al., there is approximately a two-fold increase in endomysial collagen when comparing mice 
aged 3 weeks and 26 weeks (Marshall et al., 1989). Further, there is also a marked increase in the 
fibrotic response during muscle regeneration (B. M. Carlson & Faulkner, 1989; Ullman, Ullman, 
Sommerland, Skottner, & Oldfors, 1990). Concomitant with increased fibrosis is the thickening 
of the external lamina surrounding satellite cells resulting in reduced satellite cell numbers 
(Snow, 1977). This increased fibrogenesis in aging muscle has been attributed to increased Wnt 
signaling and possibly to Wnt-like proteins present in the serum (Brack et al., 2007). 
Specifically, Brack et al. exposed young and aged satellite cells to serum in a heterochronic 
pairing. When aged cells were exposed to serum from young animals, there was a significant 
reduction in the myogenic-to-fibrogenic conversion of the aged satellite cells. Assessing the 
effects of Wnt signaling on myogenic cell fate, Wnt3A protein was added to young serum which 
resulted in an increase in the fibrogenic conversion of young satellite cells while administration 
of a Wnt inhibitor into aged serum decreased the fibrogenic conversion of aged progenitors in 
vitro (Brack et al., 2007). Though it was discovered that age-related changes in the muscle 
microenvironment were responsible for increased fibrosis and altered cell fate in aging muscle 
progenitors, this study identified a potential therapeutic target to improve the regenerative 
response while reducing fibrosis.  
Aside from fibrosis, ECM and ECM-associated molecules also play a direct role in 
communicating with the cells that interact with it in order to regulate the migration, proliferation, 




include laminins that are associated with the external lamina (B. M. Carlson, 1995; Maley, 
Davies, & Grounds, 1995), proteoglycans that are necessary for the binding of specific growth 
factors to their receptors (Muramatsu, Muramatsu, & Kojima, 2006; Schultz & Wysocki, 2009), 
and proteolytic fragments such as collagen I and IV, fibronectin, and elastin which induce 
chemotaxis of inflammatory cells (Adair-Kirk & Senior, 2008). Changes in ECM composition 
and remodeling activity also are affected with aging. It was found that due to the increased levels 
of matrix metalloproteinases (MMP) and reduced basement membrane protein synthesis, there is 
a thinning of the basement membrane  (Callaghan & Wilhelm, 2008; Frantz, Stewart, & Weaver, 
2010). Moreover, as a result of cellular senescence, fibroblasts in aged tissue are resistant to 
apoptotic cues and typically express increased levels of ECM-associated proteins such as 
fibronectin, MMPs, growth factors, and cytokines in addition to elevated levels of plasminogen 
activator inhibitor (PAI)(Coppe, Desprez, Krtolica, & Campisi, 2010) and reactive oxygen 
species (ROS)(Untergasser, Madersbacher, & Berger, 2005). Together, these factors result in a 
chronic inflammatory environment in aging tissue which can further lead to elastin degradation 
and a modified collagen network in the ECM resulting in aberrant cellular function (Callaghan & 
Wilhelm, 2008; Freund, Orjalo, Desprez, & Campisi, 2010; Nomura, 2006; Sprenger, Plymate, 
& Reed, 2008). 
 
Innervation 
 Accompanying sarcopenia, myofiber atrophy, and reduction in muscle strength and 
quality is the age-related deterioration of the neuromusculuar junction, decline in motor unit 
numbers, and neuromuscular junction instability (Hepple & Rice, 2016). Gutmann and 




neuromuscular junctions as was observed in aged rodents (Gutmann & Hanzlikova, 1966). Their 
findings were later confirmed as the same changes were observed in eldery humans in a study 
conducted by the Oda group (Oda, 1984). Specifically, in older subjects increased fragmentation 
of end-plates and increased pre-terminal axon branching at the end-plates were observed, which 
may explain the increased fatigability associated with aging skeletal muscle. 
 Closely associated with the progressive loss in muscle strength with aging is the decline 
in the number of functional motor units. Previously, electrophysiological techniques were used to 
estimate numbers of motor units in the tibaialis anterior muscle of three age cohorts: young 
adults (~25 years) older adults (~65 years), and very old adults (~80 years) (McNeil, Doherty, 
Stashuk, & Rice, 2005). When comparing motor unit estimates between young and older adults 
which were separated by ~40 years, there was approximately a 40% decline in motor unit 
numbers in the older adults. In the very old group, which represented a 15-year difference 
compared to the older adult group, there were 33% fewer motor units. These results support the 
notion that a rapid decline in muscle function and muscle mass follows the loss of motor units. 
Interestingly, studies have found that a decline in muscle strength with aging occurs prior to 
significant losses in muscle mass (Goodpaster et al., 2006). Goodpaster et al. observed that even 
after significant muscle loss had occurred, the reduction in strength was far greater than what 
could be accounted for solely from muscle atrophy (Goodpaster et al., 2006). Overall, these 
observations implicate motor unit loss as the contributor to loss of muscle strength preceding the 
loss of muscle mass. 
 Through much of the life span of an adult, muscle has been shown to undergo repeated 
cycles of denervation and reinnervation leading to alterations in the neuromuscular junction. This 




preceded by reinnervation by either the original motor neuron associated with the myofiber or 
through axonal branching of an adjacent motor neuron (Hepple & Rice, 2016). At the cellular 
level, this cycle of denervation-reinnervation result in significant changes in the components of 
the neuromuscular junction, namely in the narrowing of terminal axons (Jang & Van Remmen, 
2011), altered distribution of post-synaptic membrane proteins (Samuel, Valdez, Tapia, 
Lichtman, & Sanes, 2012), and excessive sprouting of terminal axons (Balice-Gordon, 1997). An 
interesting study of note, Deschenes et al. set out to determine whether myofiber atrophy was 
secondary to age-related myofiber denervation and whether the activity level in muscle affected 
its sensitivity to age-related denervation (Deschenes, Roby, Eason, & Harris, 2010). Muscles 
from aged rats that were lightly recruited exhibited signs of denervation with no change in 
myofiber size and composition while muscles that were heavily recruited showed no signs of 
denervation nor changes in myofiber profile. The researchers were able to confirm that changes 
in neuromuscular junction did indeed occur prior to myofiber atrophy and that increased activity 
could possibly delay age-related denervation and atrophy (Deschenes et al., 2010). However, as 
previous studies have demonstrated that the early phases of regeneration can progress 
independent of innervation until the late differentiation and fusion phases, the effects of poor 
innervation ostensibly should have little impact on the regenerative process but will pose a 
challenge later in overall muscle maintenance and myofiber survival (B. M. Carlson, 1995; 
McGeachie & Grounds, 1989).   
 
Vasculature 
 Resulting from regions of impaired or altered hemodynamics as is observed in aging 




and severely compromises endothelial cell (EC) and smooth muscle cell function (SMC) (Dai et 
al., 2004). ECs in flow regions promoting atherosclerotic plaque development have been shown 
to be more prone to apoptosis as well as upregulating the activation of inflammatory NF-κβ 
signaling and preventing the expression of transcription factors (KLF4) acting in an 
atheroprotective manner (Dai et al., 2004; Y. Z. Jiang et al., 2014). In advanced atherosclerosis, 
SMCs exhibited low proliferation rates and increased senescence attributed to growth factor 
insensitivity and increased expression of cell cycle inhibitors (Patel et al., 2001). Moreover, 
senescent SMCs promote a pro-inflammatory environment via release of pro-inflammatory 
cytokines and MMPs while depositing reduced amounts of ECM into the vessel walls (Gardner, 
Humphry, Bennett, & Clarke, 2015). This inflammatory environment is especially detrimental to 
regenerative signaling pathways in aging skeletal muscle. Specifically, high levels of TGF-ß and 
its effector pSmad3 found in aging muscle was observed to increase the expression of several 
cyclin dependent kinase inhibitors that lead to the reduced activation of aged satellite cells (M. E. 
Carlson, Hsu, & Conboy, 2008). Additionally, endogenous TGF-ß/pSmad3 was found to have an 
antagonistic relationship with Notch, a protein involved in molecular signaling regulating 
satellite cell activity. The Notch signaling pathway and its role in regulating satellite cell activity 
as well as changes in Notch signaling with advanced aging is discussed in further detail in the 
following section. 
   
Satellite Cells and Regeneration 
 The gradual decline in regenerative capacity with age in skeletal muscle can be attributed 
to the decline in satellite cell activity as they are largely responsible for the regenerative potential 




has produced many confounding reports ranging from a reduction in numbers (Bockhold, 
Rosenblatt, & Partridge, 1998), to no change (Conboy, Conboy, Smythe, & Rando, 2003), and to 
an increase in numbers (Gibson & Schultz, 1983). Regardless, there is a consensus that more 
important than satellite cell numbers is the ability of satellite cells to produce fusion-competent 
progeny that can contribute to muscle regeneration, which carries greater value than any 
observed perturbations in the number of muscle satellite cells. The age-associated decline in 
satellite cell function is thought to be caused by either intrinsic changes such as cellular 
senescence leading to insensitivity to environmental signals or changes in the environmental cues 
directing satellite cells down the myogenic program. One of the more well-documented 
mechanisms by which satellite cell activity is regulated involves the Notch signaling pathway, 
which has been shown to exert regulatory control over the cell cycle of many cells including 
satellite cells (Charge & Rudnicki, 2004; Conboy et al., 2003; C. Jiang et al., 2014). 
 There are marked changes associated with aging in the Notch signaling pathway that may 
account for the reduction in satellite cell activity in skeletal muscle. Under normal conditions 
such as in younger muscle, there is an upregulation of both Notch and its ligand, Delta, following 
muscle injury promoting satellite cell proliferation and inhibiting differentiation (Conboy & 
Rando, 2002). Once a pool of proliferating satellite cells have formed, the Notch antagonist, 
Numb, is upregulated while Notch is downregulated, causing satellite cells to exit the cell cycle 
and commit to differentiation (Conboy & Rando, 2002). However, in response to injury in aged 
skeletal muscle, it is reported that there is a failure to upregulate Delta leading to diminished 
myogenic potential (Conboy et al., 2003). Additionally, there is a distinct difference in the levels 
of Notch and Numb between young (high levels) and aged (low levels) muscles that highlight the 




Cameron-Smith, 2007; Conboy et al., 2003). In vitro forced activation of Notch was able to 
restore the proliferative abilities of aged satellite cell leading to efficient tissue repair similar to 
what was observed in young satellite cells. Similar results were observed when Notch was 
activated ex vivo regardless of Delta ligand upregulation (Conboy et al., 2003). These findings 
are significant as Conboy et al. demonstrate that the diminished regenerative potential in aging 
skeletal muscle is not an irreversible process and they identify a potential target for therapeutic 
strategies restoring regenerative potential in aging muscle.  
Moreover, the previously reported results suggest that a decline in environmental cues 
and not dysfunction intrinsic to the cell is responsible for the impaired regenerative potential in 
aging muscle. These observations are in agreement with previous reports proposing the age-
associated decline in environmental cues as the cause of the decline in regenerative capacity in 
old skeletal muscle (B. M. Carlson & Faulkner, 1989; Zacks & Sheff, 1982). In these studies, 
muscles were transplanted heterochronically (old to young, young to old) and isochronically (old 
to old, young to young) in order to identify whether intrinsic or extrinsic changes associated with 
aging were the cause of declining regeneration in aging muscle. It was found that old muscles 
grafted into young hosts recovered just as well as young muscles grafted into young hosts. 
Further, skeletal muscle mass and strength were well preserved in aged muscles grafted into 
young hosts similar to observations from young muscles grafted into young hosts (B. M. Carlson 
& Faulkner, 1989).  Conboy et al. utilized a similar heterochronic transplantation model in mice 
to determine whether the young environment contains systemic factors that contribute to 
myogenesis and if the aged-associated decline in satellite cell activity can be rescued by 
exposure to factors found in the young environment (Conboy et al., 2005). Young mice (2-3 




host’s cells contributed to regeneration. The young host heterochronic and isochronic pairings 
exhibited robust regeneration as demonstrated by the presence of centrally located nuclei and 
embryonic myosin heavy chain (eMHC) expressing myofibers. The aged mice (19-26 months) in 
isochronic pairings failed to form myotubes and contained large regions of fibrotic repair tissue. 
However, in the aged heterochronic parabionts, regeneration was comparable to that of both 
young heterochronic and isochronic pairings (Conboy et al., 2005). Notably, the improved 
regeneration in the aged muscle was exclusively due to the contribution of the aged satellite cells 
as only 0.1% of regenerated myotubes were GFP+. Further, an upregulation of Delta in aged 
satellite cells from aged heterochronic parabionts was observed and were similar to Delta levels 
in both young pairings, though a slight inhibition of Delta expression was observed in young 
heterochronic parabionts. Together, the data suggests that there are factors in the young 
environment that are able to restore molecular signaling pathways critical to muscle regeneration 
in aging muscle and that the majority of the intrinsic regenerative capabilities of aged progenitors 
are conserved but the systemic environment in which they reside prohibit efficient tissue repair 
(Conboy et al., 2005).  
 
Hormonal Changes 
 With increasing age, there is a decrease in the levels of circulating hormones and 
anabolic stimuli such as testosterone (Harman et al., 2001), growth hormone, and IGF-1 (Abbasi, 
Drinka, Mattson, & Rudman, 1993) that contribute to the loss of muscle mass and strength 
possibly as a result of decreased satellite cell activity. Due to this, androgenic interventions have 
been found to be attractive options to mitigate age-related decline in skeletal muscle. In a study 




month old mice, various improvements in aging muscle regeneration was reported (Serra et al., 
2013). Researchers observed an increase in satellite cell activation and in the number of 
proliferating satellite cells in the injured tibialis anterior muscles of castrated 2-month and 24-
month old mice as well as increased cross-sectional area in regenerating fibers (Serra et al., 
2013). The sham counterparts on the other hand exhibited significantly lower levels of satellite 
cell activation and proliferation, which reduced/delayed the rate of regeneration in aged muscles. 
Despite the fact that this investigation was limited to only the early stages of myogenesis, it 
demonstrates the potential application of this type of treatment in augmenting the declining 
regenerative response observed in aging skeletal muscle. 
 Testosterone has been shown to stimulate various molecular signaling pathways to 
improve satellite cell activity and muscle mass maintenance. A report by Kovacheva et al. 
demonstrated testosterone’s ability to stimulate Notch signaling while preventing apoptotic 
signaling in muscle (Kovacheva, Hikim, Shen, Sinha, & Sinha-Hikim, 2010). One of the more 
salient findings from this study was that testosterone administration in aging animals clearly 
inhibited the activation of JNK signaling, which is responsible for inducing cell apoptosis 
following injury or in aging (Braga et al., 2008; Sinha-Hikim, Braga, Shen, & Sinha Hikim, 
2007). Additionally, there was an observed decrease in myostatin expression which antagonizes 
Akt signaling-mediated skeletal muscle hypertrophy (Amirouche et al., 2009; Morissette et al., 
2006) and decreased 4-HNE expression which is a marker of oxidative stress that decreases 
satellite cell life-span and proliferative capacity (Renault, Thornell, Butler-Browne, & Mouly, 
2002). However, no effect on p38 MAPK signaling was found with testosterone in aging 
animals, which is consistent with previous studies indicating that the regulation of cellular 




target tissue (Hsieh, Rosenblatt, & Papaconstantinou, 2003; A. Lin & Dibling, 2002). Finally, an 
increase in Notch 1 expression in aged muscle was observed with testosterone administration 
with concomitant increases in proliferating cell nuclear antigen (PCNA) and myogenin 
expression, indicating increased satellite cell proliferation and differentiation (Kovacheva et al., 
2010). Taken together, these results suggest that testosterone supplementation in aging muscle 
could rescue the regenerative potential of satellite cells by stimulating molecular signaling 
pathways that are akin to what would be found in a younger skeletal muscle microenvironment. 
 Testosterone derivatives such as nandrolone decanoate have also been shown to improve 
muscle regeneration in low testosterone conditions. Following contusion injuries, nandrolone 
decanoate was found to increase muscle twitch and tetanic force 2 weeks post-injury and 
improved the growth of regenerating myofibers 25 days post-injury (Ferry et al., 1999). In 
another study, nandrolone injection in castrated mice exhibited increased expression of IGF-1, 
MyoD, and cyclin D1 following bupivacaine-induced muscle injury (White, Baltgalvis, Sato, 
Wilson, & Carson, 2009). Based on these results, researchers suggested that nandrolone 
improved muscle regeneration through an IGF-1-mediated mechanism. IGF-1 is known to 
promote myoblast proliferation and differentiation (Coolican, Samuel, Ewton, McWade, & 
Florini, 1997; Jacquemin, Butler-Browne, Furling, & Mouly, 2007) and its receptor in muscle 
(IGF-1R) appears to be essential in mediating the effects of testosterone on progenitor cell 
proliferation and differentiation (White et al., 2009). Notwithstanding the beneficial effects to 
skeletal muscle regeneration, the main drawback of nandrolone is that it has potent anabolic 
effects while its androgenic effects are weak and its use is associated with various side effects 
including reducing native testosterone biosynthesis (Barone et al., 2017; Kicman, 2008; Nagata 





 The goal of this research is to provide evidence to the following fundamental premise: 
age-associated changes in skeletal muscle will negatively affect muscle recovery following VML 
injury and the response to repair with tissue engineered strategies. The following investigations 
were performed to explore our fundamental premise:  
1) Examine the effect of age on the response to recovery following volumetric muscle loss.  
Hypothesis: Age will increase the force loss following VML injury. 
2) Examine how age affects the response to repair of VML injury using minced muscle 
autografts co-delivered with DSM (DSM+MM). 
Hypothesis: Age will decrease the amount of force recovered following VML repair. 
3) Investigate the regenerative outcomes following VML repair with co-delivery of the anabolic 
steroid nandrolone decanoate in aged animals.  
Hypothesis: Nandrolone decanoate administration will reverse the decrements to force 
recovery following VML repair in aged animals. 
VML investigations thus far have utilized various young animal models in developing 
tissue repair strategies. With what is known about the declining regenerative potential and 
various deleterious changes in skeletal muscle associated with aging, it is a possibility that 
treatment strategies that have proven successful in younger animal models will not be effective 
in older animal models. As per this gap in knowledge, we saw an opportunity to address the 
potential differences in recovery after VML injury and VML repair in the aging animal 




The use of the DSM+MM repair strategy has been demonstrated previously to increase 
myogenic gene expression, reduce fibrosis during regeneration, and significantly improve 
functional outcomes in a young rat model of VML. We hope to study the changes in the 
microenvironment of aging animals and how they affect the response to VML injury and repair 
in order to better inform future research in developing not only tissue engineering strategies for 
VML repair but also the effects of aging on muscle regeneration in VML. Moreover, many 
researchers have employed the use of testosterone and other hormone replacement therapies to 
combat age-associated muscle wasting and functional decline. Testosterone has also been shown 
to improve regenerative outcomes in aging animals, restoring the response to injury to levels 
seen in younger animals. We will use this as an adjunct to our current DSM+MM therapy in 
order to further improve regeneration in aging animals.  
A brief outline of our approach is as follows: 
 Develop an aged model of VML injury and investigate differences in VML recovery between 
young and aged animals. 
 Investigate differences in the regenerative and functional outcomes following VML repair 
using DSM co-delivered with MM autografts between young and aged animals. 
 The final study will use the anabolic steroid nandrolone decanoate as an adjunctive treatment 
to DSM+MM repair and explore the effects on regenerative and functional outcomes 
between young and aged animals. 
  
 





Aarimaa, V., Kaariainen, M., Vaittinen, S., Tanner, J., Jarvinen, T., Best, T., & Kalimo, H. 
(2004). Restoration of myofiber continuity after transection injury in the rat soleus. 
Neuromuscul Disord, 14(7), 421-428. doi: 10.1016/j.nmd.2004.03.009 
Abbasi, A. A., Drinka, P. J., Mattson, D. E., & Rudman, D. (1993). Low circulating levels of 
insulin-like growth factors and testosterone in chronically institutionalized elderly men. J 
Am Geriatr Soc, 41(9), 975-982.  
Adair-Kirk, T. L., & Senior, R. M. (2008). Fragments of extracellular matrix as mediators of 
inflammation. Int J Biochem Cell Biol, 40(6-7), 1101-1110. doi: 
10.1016/j.biocel.2007.12.005 
Alameddine, H. S., Dehaupas, M., & Fardeau, M. (1989). Regeneration of skeletal muscle fibers 
from autologous satellite cells multiplied in vitro. An experimental model for testing 
cultured cell myogenicity. Muscle Nerve, 12(7), 544-555. doi: 10.1002/mus.880120705 
Allen, R. E., & Boxhorn, L. K. (1989). Regulation of skeletal muscle satellite cell proliferation 
and differentiation by transforming growth factor-beta, insulin-like growth factor I, and 
fibroblast growth factor. J Cell Physiol, 138(2), 311-315. doi: 10.1002/jcp.1041380213 
Amirouche, A., Durieux, A. C., Banzet, S., Koulmann, N., Bonnefoy, R., Mouret, C., . . . 
Freyssenet, D. (2009). Down-regulation of Akt/mammalian target of rapamycin signaling 
pathway in response to myostatin overexpression in skeletal muscle. Endocrinology, 
150(1), 286-294. doi: 10.1210/en.2008-0959 
Andersen, R. C., Wilson, K. W., Bojescul, J. A., Mickel, T. J., Gordon, W. T., & Potter, B. K. 
(2014). Open, combat-related loss, or disruption of the knee extensor mechanism: 
treatment strategies, classification, and outcomes. J Orthop Trauma, 28(11), e250-257. 
doi: 10.1097/BOT.0000000000000121 
Armstrong, R. B., & Ianuzzo, C. D. (1977). Exercise-induced muscle glycogen depletion and 
repletion in diabetic rats. Life Sci, 20(2), 301-308.  
Aurora, A., Corona, B. T., & Walters, T. J. (2016). A Porcine Urinary Bladder Matrix Does Not 
Recapitulate the Spatiotemporal Macrophage Response of Muscle Regeneration after 





Aurora, A., Garg, K., Corona, B. T., & Walters, T. J. (2014). Physical rehabilitation improves 
muscle function following volumetric muscle loss injury. BMC Sports Sci Med Rehabil, 
6(1), 41. doi: 10.1186/2052-1847-6-41 
Aurora, A., Roe, J. L., Corona, B. T., & Walters, T. J. (2015). An acellular biologic scaffold does 
not regenerate appreciable de novo muscle tissue in rat models of volumetric muscle loss 
injury. Biomaterials, 67, 393-407. doi: 10.1016/j.biomaterials.2015.07.040 
Badylak, S. F. (1993). Small Intestinal Submucosa (SIS): A Biomaterial Conducive to Smart 
Tissue Remodeling. In E. Bell (Ed.), Tissue Engineering: Current Perspectives (pp. 179-
189). Boston, MA: Birkhäuser Boston. 
Badylak, S. F. (2004). Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. 
Transpl Immunol, 12(3-4), 367-377. doi: 10.1016/j.trim.2003.12.016 
Badylak, S. F., Lantz, G. C., Coffey, A., & Geddes, L. A. (1989). Small intestinal submucosa as 
a large diameter vascular graft in the dog. J Surg Res, 47(1), 74-80.  
Badylak, S. F., Tullius, R., Kokini, K., Shelbourne, K. D., Klootwyk, T., Voytik, S. L., . . . 
Simmons, C. (1995). The use of xenogeneic small intestinal submucosa as a biomaterial 
for Achilles tendon repair in a dog model. J Biomed Mater Res, 29(8), 977-985. doi: 
10.1002/jbm.820290809 
Bain, J. R., Hason, Y., Veltri, K., Fahnestock, M., & Quartly, C. (2008). Clinical application of 
sensory protection of denervated muscle. J Neurosurg, 109(5), 955-961. doi: 
10.3171/JNS/2008/109/11/0955 
Bain, J. R., Veltri, K. L., Chamberlain, D., & Fahnestock, M. (2001). Improved functional 
recovery of denervated skeletal muscle after temporary sensory nerve innervation. 
Neuroscience, 103(2), 503-510.  
Balice-Gordon, R. J. (1997). Age-related changes in neuromuscular innervation. Muscle Nerve 
Suppl, 5, S83-87.  
Ballotta, V., Driessen-Mol, A., Bouten, C. V., & Baaijens, F. P. (2014). Strain-dependent 
modulation of macrophage polarization within scaffolds. Biomaterials, 35(18), 4919-




Baoge, L., Van Den Steen, E., Rimbaut, S., Philips, N., Witvrouw, E., Almqvist, K. F., . . . 
Vanden Bossche, L. C. (2012). Treatment of skeletal muscle injury: a review. ISRN 
Orthop, 2012, 689012. doi: 10.5402/2012/689012 
Barone, R., Pitruzzella, A., Marino Gammazza, A., Rappa, F., Salerno, M., Barone, F., . . . 
Pomara, C. (2017). Nandrolone decanoate interferes with testosterone biosynthesis 
altering blood-testis barrier components. J Cell Mol Med, 21(8), 1636-1647. doi: 
10.1111/jcmm.13092 
Beier, J. P., Kneser, U., Stern-Strater, J., Stark, G. B., & Bach, A. D. (2004). Y chromosome 
detection of three-dimensional tissue-engineered skeletal muscle constructs in a 
syngeneic rat animal model. Cell Transplant, 13(1), 45-53.  
Beier, J. P., Stern-Straeter, J., Foerster, V. T., Kneser, U., Stark, G. B., & Bach, A. D. (2006). 
Tissue engineering of injectable muscle: three-dimensional myoblast-fibrin injection in 
the syngeneic rat animal model. Plast Reconstr Surg, 118(5), 1113-1121; discussion 
1122-1114. doi: 10.1097/01.prs.0000221007.97115.1d 
Benoit, P. W., & Belt, W. D. (1970). Destruction and regeneration of skeletal muscle after 
treatment with a local anaesthetic, bupivacaine (Marcaine). J Anat, 107(Pt 3), 547-556.  
Betik, A. C., Baker, D. J., Krause, D. J., McConkey, M. J., & Hepple, R. T. (2008). Exercise 
training in late middle-aged male Fischer 344 x Brown Norway F1-hybrid rats improves 
skeletal muscle aerobic function. Exp Physiol, 93(7), 863-871. doi: 
10.1113/expphysiol.2008.042069 
Bidarra, S. J., Barrias, C. C., & Granja, P. L. (2014). Injectable alginate hydrogels for cell 
delivery in tissue engineering. Acta Biomater, 10(4), 1646-1662. doi: 
10.1016/j.actbio.2013.12.006 
Bidez, P. R., 3rd, Li, S., Macdiarmid, A. G., Venancio, E. C., Wei, Y., & Lelkes, P. I. (2006). 
Polyaniline, an electroactive polymer, supports adhesion and proliferation of cardiac 
myoblasts. J Biomater Sci Polym Ed, 17(1-2), 199-212.  
Bischoff, R. (1986). A satellite cell mitogen from crushed adult muscle. Dev Biol, 115(1), 140-
147.  
Bockhold, K. J., Rosenblatt, J. D., & Partridge, T. A. (1998). Aging normal and dystrophic 
mouse muscle: analysis of myogenicity in cultures of living single fibers. Muscle Nerve, 




Boontheekul, T., Hill, E. E., Kong, H. J., & Mooney, D. J. (2007). Regulating myoblast 
phenotype through controlled gel stiffness and degradation. Tissue Eng, 13(7), 1431-
1442. doi: 10.1089/ten.2006.0356 
Boontheekul, T., Kong, H. J., & Mooney, D. J. (2005). Controlling alginate gel degradation 
utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials, 
26(15), 2455-2465. doi: 10.1016/j.biomaterials.2004.06.044 
Borschel, G. H., Dennis, R. G., & Kuzon, W. M., Jr. (2004). Contractile skeletal muscle tissue-
engineered on an acellular scaffold. Plast Reconstr Surg, 113(2), 595-602; discussion 
603-594. doi: 10.1097/01.PRS.0000101064.62289.2F 
Borschel, G. H., Dow, D. E., Dennis, R. G., & Brown, D. L. (2006). Tissue-engineered axially 
vascularized contractile skeletal muscle. Plast Reconstr Surg, 117(7), 2235-2242. doi: 
10.1097/01.prs.0000224295.54073.49 
Borselli, C., Cezar, C. A., Shvartsman, D., Vandenburgh, H. H., & Mooney, D. J. (2011). The 
role of multifunctional delivery scaffold in the ability of cultured myoblasts to promote 
muscle regeneration. Biomaterials, 32(34), 8905-8914. doi: 
10.1016/j.biomaterials.2011.08.019 
Borselli, C., Storrie, H., Benesch-Lee, F., Shvartsman, D., Cezar, C., Lichtman, J. W., . . . 
Mooney, D. J. (2010). Functional muscle regeneration with combined delivery of 
angiogenesis and myogenesis factors. Proc Natl Acad Sci U S A, 107(8), 3287-3292. doi: 
10.1073/pnas.0903875106 
Brack, A. S., Conboy, M. J., Roy, S., Lee, M., Kuo, C. J., Keller, C., & Rando, T. A. (2007). 
Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. 
Science, 317(5839), 807-810. doi: 10.1126/science.1144090 
Brack, A. S., & Rando, T. A. (2007). Intrinsic changes and extrinsic influences of myogenic 
stem cell function during aging. Stem Cell Rev, 3(3), 226-237.  
Braga, M., Sinha Hikim, A. P., Datta, S., Ferrini, M. G., Brown, D., Kovacheva, E. L., . . . Sinha-
Hikim, I. (2008). Involvement of oxidative stress and caspase 2-mediated intrinsic 
pathway signaling in age-related increase in muscle cell apoptosis in mice. Apoptosis, 




Brickson, S., Hollander, J., Corr, D. T., Ji, L. L., & Best, T. M. (2001). Oxidant production and 
immune response after stretch injury in skeletal muscle. Med Sci Sports Exerc, 33(12), 
2010-2015.  
Brickson, S., Ji, L. L., Schell, K., Olabisi, R., St Pierre Schneider, B., & Best, T. M. (2003). 
M1/70 attenuates blood-borne neutrophil oxidants, activation, and myofiber damage 
following stretch injury. J Appl Physiol (1985), 95(3), 969-976. doi: 
10.1152/japplphysiol.00005.2003 
Brown, A. C., & Barker, T. H. (2014). Fibrin-based biomaterials: modulation of macroscopic 
properties through rational design at the molecular level. Acta Biomater, 10(4), 1502-
1514. doi: 10.1016/j.actbio.2013.09.008 
Brown, B. N., Valentin, J. E., Stewart-Akers, A. M., McCabe, G. P., & Badylak, S. F. (2009). 
Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with 
and without a cellular component. Biomaterials, 30(8), 1482-1491. doi: 
10.1016/j.biomaterials.2008.11.040 
Brunelli, G., Monini, L., & Brunelli, F. (1990). [Direct muscular neurotization]. Ann Chir Main 
Memb Super, 9(4), 290-295.  
Calderon, W., Chang, N., & Mathes, S. J. (1986). Comparison of the effect of bacterial 
inoculation in musculocutaneous and fasciocutaneous flaps. Plast Reconstr Surg, 77(5), 
785-794.  
Callaghan, T. M., & Wilhelm, K. P. (2008). A review of ageing and an examination of clinical 
methods in the assessment of ageing skin. Part 2: Clinical perspectives and clinical 
methods in the evaluation of ageing skin. Int J Cosmet Sci, 30(5), 323-332. doi: 
10.1111/j.1468-2494.2008.00455.x 
Carey, K. A., Farnfield, M. M., Tarquinio, S. D., & Cameron-Smith, D. (2007). Impaired 
expression of Notch signaling genes in aged human skeletal muscle. J Gerontol A Biol 
Sci Med Sci, 62(1), 9-17.  
Carlson, B. M. (1968). Regeneration fo the completely excised gastrocnemius muscle in the frog 





Carlson, B. M. (1995). Factors influencing the repair and adaptation of muscles in aged 
individuals: satellite cells and innervation. J Gerontol A Biol Sci Med Sci, 50 Spec No, 
96-100.  
Carlson, B. M., & Faulkner, J. A. (1989). Muscle transplantation between young and old rats: 
age of host determines recovery. Am J Physiol, 256(6 Pt 1), C1262-1266. doi: 
10.1152/ajpcell.1989.256.6.C1262 
Carlson, B. M., & Faulkner, J. A. (1996). The regeneration of noninnervated muscle grafts and 
marcaine-treated muscles in young and old rats. J Gerontol A Biol Sci Med Sci, 51(1), 
B43-49.  
Carlson, B. M., & Faulkner, J. A. (1998). Muscle regeneration in young and old rats: effects of 
motor nerve transection with and without marcaine treatment. J Gerontol A Biol Sci Med 
Sci, 53(1), B52-57.  
Carlson, M. E., Hsu, M., & Conboy, I. M. (2008). Imbalance between pSmad3 and Notch 
induces CDK inhibitors in old muscle stem cells. Nature, 454(7203), 528-532. doi: 
10.1038/nature07034 
Carnio, S., Serena, E., Rossi, C. A., De Coppi, P., Elvassore, N., & Vitiello, L. (2011). Three-
dimensional porous scaffold allows long-term wild-type cell delivery in dystrophic 
muscle. J Tissue Eng Regen Med, 5(1), 1-10. doi: 10.1002/term.282 
Carosio, S., Barberi, L., Rizzuto, E., Nicoletti, C., Del Prete, Z., & Musaro, A. (2013). 
Generation of eX vivo-vascularized Muscle Engineered Tissue (X-MET). Sci Rep, 3, 
1420. doi: 10.1038/srep01420 
Casar, J. C., Cabello-Verrugio, C., Olguin, H., Aldunate, R., Inestrosa, N. C., & Brandan, E. 
(2004). Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: 
requirement of syndecan-3 for successful fiber formation. J Cell Sci, 117(Pt 1), 73-84. 
doi: 10.1242/jcs.00828 
Chambers, J. B., Rimington, H. M., Rajani, R., Hodson, F., & Shabbo, F. (2007). A randomized 
comparison of the Cryolife O'Brien and Toronto stentless replacement aortic valves. J 
Thorac Cardiovasc Surg, 133(4), 1045-1050. doi: 10.1016/j.jtcvs.2006.10.071 
Chang, N., & Mathes, S. J. (1982). Comparison of the effect of bacterial inoculation in 




Charge, S. B., & Rudnicki, M. A. (2004). Cellular and molecular regulation of muscle 
regeneration. Physiol Rev, 84(1), 209-238. doi: 10.1152/physrev.00019.2003 
Chen, F., Yoo, J. J., & Atala, A. (1999). Acellular collagen matrix as a possible "off the shelf" 
biomaterial for urethral repair. Urology, 54(3), 407-410.  
Chen, M. C., Sun, Y. C., & Chen, Y. H. (2013). Electrically conductive nanofibers with highly 
oriented structures and their potential application in skeletal muscle tissue engineering. 
Acta Biomater, 9(3), 5562-5572. doi: 10.1016/j.actbio.2012.10.024 
Chevallay, B., & Herbage, D. (2000). Collagen-based biomaterials as 3D scaffold for cell 
cultures: applications for tissue engineering and gene therapy. Med Biol Eng Comput, 
38(2), 211-218.  
Chiron, S., Tomczak, C., Duperray, A., Laine, J., Bonne, G., Eder, A., . . . Coirault, C. (2012). 
Complex interactions between human myoblasts and the surrounding 3D fibrin-based 
matrix. PLoS One, 7(4), e36173. doi: 10.1371/journal.pone.0036173 
Chiu, D. T., Chen, L., Spielholtz, N., & Beasley, R. W. (1991). A comparative 
electrophysiological study on neurotisation in rats. J Hand Surg Br, 16(5), 505-510.  
Choi, J. S., Lee, S. J., Christ, G. J., Atala, A., & Yoo, J. J. (2008). The influence of electrospun 
aligned poly(epsilon-caprolactone)/collagen nanofiber meshes on the formation of self-
aligned skeletal muscle myotubes. Biomaterials, 29(19), 2899-2906. doi: 
10.1016/j.biomaterials.2008.03.031 
Cittadella Vigodarzere, G., & Mantero, S. (2014). Skeletal muscle tissue engineering: strategies 
for volumetric constructs. Front Physiol, 5, 362. doi: 10.3389/fphys.2014.00362 
Clark, R. A. (2001). Fibrin and wound healing. Ann N Y Acad Sci, 936, 355-367.  
Collins, C. A., Olsen, I., Zammit, P. S., Heslop, L., Petrie, A., Partridge, T. A., & Morgan, J. E. 
(2005). Stem cell function, self-renewal, and behavioral heterogeneity of cells from the 
adult muscle satellite cell niche. Cell, 122(2), 289-301. doi: 10.1016/j.cell.2005.05.010 
Conboy, I. M., Conboy, M. J., Smythe, G. M., & Rando, T. A. (2003). Notch-mediated 





Conboy, I. M., Conboy, M. J., Wagers, A. J., Girma, E. R., Weissman, I. L., & Rando, T. A. 
(2005). Rejuvenation of aged progenitor cells by exposure to a young systemic 
environment. Nature, 433(7027), 760-764. doi: 10.1038/nature03260 
Conboy, I. M., & Rando, T. A. (2002). The regulation of Notch signaling controls satellite cell 
activation and cell fate determination in postnatal myogenesis. Dev Cell, 3(3), 397-409.  
Conboy, I. M., & Rando, T. A. (2005). Aging, stem cells and tissue regeneration: lessons from 
muscle. Cell Cycle, 4(3), 407-410. doi: 10.4161/cc.4.3.1518 
Conconi, M. T., De Coppi, P., Bellini, S., Zara, G., Sabatti, M., Marzaro, M., . . . Nussdorfer, G. 
G. (2005). Homologous muscle acellular matrix seeded with autologous myoblasts as a 
tissue-engineering approach to abdominal wall-defect repair. Biomaterials, 26(15), 2567-
2574. doi: 10.1016/j.biomaterials.2004.07.035 
Cook, J. L., Tomlinson, J. L., Kreeger, J. M., & Cook, C. R. (1999). Induction of meniscal 
regeneration in dogs using a novel biomaterial. Am J Sports Med, 27(5), 658-665. doi: 
10.1177/03635465990270051901 
Coolican, S. A., Samuel, D. S., Ewton, D. Z., McWade, F. J., & Florini, J. R. (1997). The 
mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling 
pathways. J Biol Chem, 272(10), 6653-6662.  
Cooper, R. N., Tajbakhsh, S., Mouly, V., Cossu, G., Buckingham, M., & Butler-Browne, G. S. 
(1999). In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse 
skeletal muscle. J Cell Sci, 112 ( Pt 17), 2895-2901.  
Coppe, J. P., Desprez, P. Y., Krtolica, A., & Campisi, J. (2010). The senescence-associated 
secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol, 5, 99-118. 
doi: 10.1146/annurev-pathol-121808-102144 
Cornwell, K. G., & Pins, G. D. (2010). Enhanced proliferation and migration of fibroblasts on 
the surface of fibroblast growth factor-2-loaded fibrin microthreads. Tissue Eng Part A, 
16(12), 3669-3677. doi: 10.1089/ten.TEA.2009.0600 
Corona, B. T., Flanagan, K. E., Brininger, C. M., Goldman, S. M., Call, J. A., & Greising, S. M. 
(2018). Impact of volumetric muscle loss injury on persistent motoneuron axotomy. 




Corona, B. T., Garg, K., Ward, C. L., McDaniel, J. S., Walters, T. J., & Rathbone, C. R. (2013). 
Autologous minced muscle grafts: a tissue engineering therapy for the volumetric loss of 
skeletal muscle. Am J Physiol Cell Physiol, 305(7), C761-775. doi: 
10.1152/ajpcell.00189.2013 
Corona, B. T., Machingal, M. A., Criswell, T., Vadhavkar, M., Dannahower, A. C., Bergman, C., 
. . . Christ, G. J. (2012). Further development of a tissue engineered muscle repair 
construct in vitro for enhanced functional recovery following implantation in vivo in a 
murine model of volumetric muscle loss injury. Tissue Eng Part A, 18(11-12), 1213-
1228. doi: 10.1089/ten.TEA.2011.0614 
Corona, B. T., Rivera, J. C., Owens, J. G., Wenke, J. C., & Rathbone, C. R. (2015). Volumetric 
muscle loss leads to permanent disability following extremity trauma. J Rehabil Res Dev, 
52(7), 785-792. doi: 10.1682/JRRD.2014.07.0165 
Corona, B. T., Ward, C. L., Baker, H. B., Walters, T. J., & Christ, G. J. (2014). Implantation of 
in vitro tissue engineered muscle repair constructs and bladder acellular matrices partially 
restore in vivo skeletal muscle function in a rat model of volumetric muscle loss injury. 
Tissue Eng Part A, 20(3-4), 705-715. doi: 10.1089/ten.TEA.2012.0761 
Corona, B. T., Wu, X., Ward, C. L., McDaniel, J. S., Rathbone, C. R., & Walters, T. J. (2013). 
The promotion of a functional fibrosis in skeletal muscle with volumetric muscle loss 
injury following the transplantation of muscle-ECM. Biomaterials, 34(13), 3324-3335. 
doi: 10.1016/j.biomaterials.2013.01.061 
Cossu, G., & Biressi, S. (2005). Satellite cells, myoblasts and other occasional myogenic 
progenitors: possible origin, phenotypic features and role in muscle regeneration. Semin 
Cell Dev Biol, 16(4-5), 623-631. doi: 10.1016/j.semcdb.2005.07.003 
Cronin, E. M., Thurmond, F. A., Bassel-Duby, R., Williams, R. S., Wright, W. E., Nelson, K. D., 
& Garner, H. R. (2004). Protein-coated poly(L-lactic acid) fibers provide a substrate for 
differentiation of human skeletal muscle cells. J Biomed Mater Res A, 69(3), 373-381. 
doi: 10.1002/jbm.a.30009 
Dai, G., Kaazempur-Mofrad, M. R., Natarajan, S., Zhang, Y., Vaughn, S., Blackman, B. R., . . . 
Gimbrone, M. A., Jr. (2004). Distinct endothelial phenotypes evoked by arterial 
waveforms derived from atherosclerosis-susceptible and -resistant regions of human 





Dellgren, G., Eriksson, M., Brodin, L. A., & Radegran, K. (1999). The extended Biocor stentless 
aortic bioprosthesis. Early clinical experience. Scand Cardiovasc J, 33(5), 259-264.  
DeQuach, J. A., Lin, J. E., Cam, C., Hu, D., Salvatore, M. A., Sheikh, F., & Christman, K. L. 
(2012). Injectable skeletal muscle matrix hydrogel promotes neovascularization and 
muscle cell infiltration in a hindlimb ischemia model. Eur Cell Mater, 23, 400-412; 
discussion 412.  
Deschenes, M. R., Roby, M. A., Eason, M. K., & Harris, M. B. (2010). Remodeling of the 
neuromuscular junction precedes sarcopenia related alterations in myofibers. Exp 
Gerontol, 45(5), 389-393. doi: 10.1016/j.exger.2010.03.007 
DiMario, J. X., & Stockdale, F. E. (1995). Differences in the developmental fate of cultured and 
noncultured myoblasts when transplanted into embryonic limbs. Exp Cell Res, 216(2), 
431-442. doi: 10.1006/excr.1995.1054 
Donghui, C., Shicai, C., Wei, W., Fei, L., Jianjun, J., Gang, C., & Hongliang, Z. (2010). 
Functional modulation of satellite cells in long-term denervated human laryngeal muscle. 
Laryngoscope, 120(2), 353-358. doi: 10.1002/lary.20796 
Drewa, T., Adamowicz, J., & Sharma, A. (2012). Tissue engineering for the oncologic urinary 
bladder. Nat Rev Urol, 9(10), 561-572. doi: 10.1038/nrurol.2012.158 
Drury, J. L., Boontheekul, T., & Mooney, D. J. (2005). Cellular cross-linking of peptide 
modified hydrogels. J Biomech Eng, 127(2), 220-228.  
Dziki, J., Badylak, S., Yabroudi, M., Sicari, B., Ambrosio, F., Stearns, K., . . . Rubin, J. P. 
(2016). An acellular biologic scaffold treatment for volumetric muscle loss: results of a 
13-patient cohort study. NPJ Regen Med, 1, 16008. doi: 10.1038/npjregenmed.2016.8 
Edelberg, J. M., & Reed, M. J. (2003). Aging and angiogenesis. Front Biosci, 8, s1199-1209.  
Edelman, E. R., Mathiowitz, E., Langer, R., & Klagsbrun, M. (1991). Controlled and modulated 
release of basic fibroblast growth factor. Biomaterials, 12(7), 619-626.  
Falanga, V., & Sabolinski, M. (1999). A bilayered living skin construct (APLIGRAF) accelerates 




Fan, C., Jiang, P., Fu, L., Cai, P., Sun, L., & Zeng, B. (2008). Functional reconstruction of 
traumatic loss of flexors in forearm with gastrocnemius myocutaneous flap transfer. 
Microsurgery, 28(1), 71-75. doi: 10.1002/micr.20449 
Ferraro, F., Celso, C. L., & Scadden, D. (2010). Adult stem cels and their niches. Adv Exp Med 
Biol, 695, 155-168. doi: 10.1007/978-1-4419-7037-4_11 
Ferry, A., Noirez, P., Page, C. L., Salah, I. B., Daegelen, D., & Rieu, M. (1999). Effects of 
anabolic/androgenic steroids on regenerating skeletal muscles in the rat. Acta Physiol 
Scand, 166(2), 105-110. doi: 10.1046/j.1365-201x.1999.00549.x 
FORBES, A., & COBB, S. (1926). PHYSIOLOGY OF SYMPATHETIC NERVOUS SYSTEM 
IN RELATION TO CERTAIN SURGICAL PROBLEMS. Journal of the American 
Medical Association, 86(25), 1884-1886. doi: 10.1001/jama.1926.02670510006002 
Foster, A. H., & Carlson, B. M. (1980). Myotoxicity of local anesthetics and regeneration of the 
damaged muscle fibers. Anesth Analg, 59(10), 727-736.  
Franklin, R. J., Zhao, C., & Sim, F. J. (2002). Ageing and CNS remyelination. Neuroreport, 
13(7), 923-928.  
Frantz, C., Stewart, K. M., & Weaver, V. M. (2010). The extracellular matrix at a glance. J Cell 
Sci, 123(Pt 24), 4195-4200. doi: 10.1242/jcs.023820 
Fredsted, A., Gissel, H., Madsen, K., & Clausen, T. (2007). Causes of excitation-induced muscle 
cell damage in isometric contractions: mechanical stress or calcium overload? Am J 
Physiol Regul Integr Comp Physiol, 292(6), R2249-2258. doi: 
10.1152/ajpregu.00415.2006 
Freund, A., Orjalo, A. V., Desprez, P. Y., & Campisi, J. (2010). Inflammatory networks during 
cellular senescence: causes and consequences. Trends Mol Med, 16(5), 238-246. doi: 
10.1016/j.molmed.2010.03.003 
Frey, S. P., Jansen, H., Raschke, M. J., Meffert, R. H., & Ochman, S. (2012). VEGF improves 
skeletal muscle regeneration after acute trauma and reconstruction of the limb in a rabbit 
model. Clin Orthop Relat Res, 470(12), 3607-3614. doi: 10.1007/s11999-012-2456-7 
Frontera, W. R., & Ochala, J. (2015). Skeletal muscle: a brief review of structure and function. 




Gamba, P. G., Conconi, M. T., Lo Piccolo, R., Zara, G., Spinazzi, R., & Parnigotto, P. P. (2002). 
Experimental abdominal wall defect repaired with acellular matrix. Pediatr Surg Int, 
18(5-6), 327-331. doi: 10.1007/s00383-002-0849-5 
Gardner, S. E., Humphry, M., Bennett, M. R., & Clarke, M. C. (2015). Senescent Vascular 
Smooth Muscle Cells Drive Inflammation Through an Interleukin-1alpha-Dependent 
Senescence-Associated Secretory Phenotype. Arterioscler Thromb Vasc Biol, 35(9), 
1963-1974. doi: 10.1161/ATVBAHA.115.305896 
Garg, K., Corona, B. T., & Walters, T. J. (2015). Therapeutic strategies for preventing skeletal 
muscle fibrosis after injury. Front Pharmacol, 6, 87. doi: 10.3389/fphar.2015.00087 
Garg, K., Ward, C. L., Hurtgen, B. J., Wilken, J. M., Stinner, D. J., Wenke, J. C., . . . Corona, B. 
T. (2015). Volumetric muscle loss: persistent functional deficits beyond frank loss of 
tissue. J Orthop Res, 33(1), 40-46. doi: 10.1002/jor.22730 
Garg, K., Ward, C. L., Rathbone, C. R., & Corona, B. T. (2014). Transplantation of devitalized 
muscle scaffolds is insufficient for appreciable de novo muscle fiber regeneration after 
volumetric muscle loss injury. Cell Tissue Res, 358(3), 857-873. doi: 10.1007/s00441-
014-2006-6 
Garrett, W. E., Jr. (1996). Muscle strain injuries. Am J Sports Med, 24(6 Suppl), S2-8.  
Gentile, N. E., Stearns, K. M., Brown, E. H., Rubin, J. P., Boninger, M. L., Dearth, C. L., . . . 
Badylak, S. F. (2014). Targeted rehabilitation after extracellular matrix scaffold 
transplantation for the treatment of volumetric muscle loss. Am J Phys Med Rehabil, 
93(11 Suppl 3), S79-87. doi: 10.1097/PHM.0000000000000145 
Gerard, C., Forest, M. A., Beauregard, G., Skuk, D., & Tremblay, J. P. (2012). Fibrin gel 
improves the survival of transplanted myoblasts. Cell Transplant, 21(1), 127-137. doi: 
10.3727/096368911X576018 
Gibson, M. C., & Schultz, E. (1983). Age-related differences in absolute numbers of skeletal 
muscle satellite cells. Muscle Nerve, 6(8), 574-580. doi: 10.1002/mus.880060807 
Gilbert-Honick, J., Ginn, B., Zhang, Y., Salehi, S., Wagner, K. R., Mao, H. Q., & Grayson, W. 
L. (2018). Adipose-derived Stem/Stromal Cells on Electrospun Fibrin Microfiber 
Bundles Enable Moderate Muscle Reconstruction in a Volumetric Muscle Loss Model. 




Gilbert-Honick, J., Iyer, S. R., Somers, S. M., Lovering, R. M., Wagner, K., Mao, H. Q., & 
Grayson, W. L. (2018). Engineering functional and histological regeneration of 
vascularized skeletal muscle. Biomaterials, 164, 70-79. doi: 
10.1016/j.biomaterials.2018.02.006 
Gilbert, T. W., Sellaro, T. L., & Badylak, S. F. (2006). Decellularization of tissues and organs. 
Biomaterials, 27(19), 3675-3683. doi: 10.1016/j.biomaterials.2006.02.014 
Gilbert, T. W., Stewart-Akers, A. M., Sydeski, J., Nguyen, T. D., Badylak, S. F., & Woo, S. L. 
(2007). Gene expression by fibroblasts seeded on small intestinal submucosa and 
subjected to cyclic stretching. Tissue Eng, 13(6), 1313-1323. doi: 10.1089/ten.2006.0318 
Gillies, A. R., & Lieber, R. L. (2011). Structure and function of the skeletal muscle extracellular 
matrix. Muscle Nerve, 44(3), 318-331. doi: 10.1002/mus.22094 
Goldman, S. M., & Corona, B. T. (2017). Co-delivery of micronized urinary bladder matrix 
damps regenerative capacity of minced muscle grafts in the treatment of volumetric 
muscle loss injuries. PLoS One, 12(10), e0186593. doi: 10.1371/journal.pone.0186593 
Goldman, S. M., Henderson, B. E. P., & Corona, B. T. (2017). Evaluation of bone marrow 
mononuclear cells as an adjunct therapy to minced muscle graft for the treatment of 
volumetric muscle loss injuries. Stem Cell Res Ther, 8(1), 142. doi: 10.1186/s13287-017-
0589-z 
Goodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., . . 
. Newman, A. B. (2006). The loss of skeletal muscle strength, mass, and quality in older 
adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci, 
61(10), 1059-1064.  
Gopinath, S. D., & Rando, T. A. (2008). Stem cell review series: aging of the skeletal muscle 
stem cell niche. Aging Cell, 7(4), 590-598. doi: 10.1111/j.1474-9726.2008.00399.x 
Gosain, A., Chang, N., Mathes, S., Hunt, T. K., & Vasconez, L. (1990). A study of the 
relationship between blood flow and bacterial inoculation in musculocutaneous and 
fasciocutaneous flaps. Plast Reconstr Surg, 86(6), 1152-1162; discussion 1163.  
Grasman, J. M., Do, D. M., Page, R. L., & Pins, G. D. (2015). Rapid release of growth factors 





Grasman, J. M., Page, R. L., & Pins, G. D. (2017). (*) Design of an In Vitro Model of Cell 
Recruitment for Skeletal Muscle Regeneration Using Hepatocyte Growth Factor-Loaded 
Fibrin Microthreads. Tissue Eng Part A, 23(15-16), 773-783. doi: 
10.1089/ten.TEA.2016.0440 
Grasman, J. M., Pumphrey, L. M., Dunphy, M., Perez-Rogers, J., & Pins, G. D. (2014). Static 
axial stretching enhances the mechanical properties and cellular responses of fibrin 
microthreads. Acta Biomater, 10(10), 4367-4376. doi: 10.1016/j.actbio.2014.06.021 
Greene, T. L., & Beatty, M. E. (1988). Soft tissue coverage for lower-extremity trauma: current 
practice and techniques. A review. J Orthop Trauma, 2(2), 158-173.  
Grogan, B. F., Hsu, J. R., & Skeletal Trauma Research, C. (2011). Volumetric muscle loss. J Am 
Acad Orthop Surg, 19 Suppl 1, S35-37.  
Grounds, M. D. (1991). Towards understanding skeletal muscle regeneration. Pathol Res Pract, 
187(1), 1-22. doi: 10.1016/S0344-0338(11)81039-3 
Grounds, M. D., & Yablonka-Reuveni, Z. (1993). Molecular and cell biology of skeletal muscle 
regeneration. Mol Cell Biol Hum Dis Ser, 3, 210-256.  
Grubic, Z., Komel, R., Walker, W. F., & Miranda, A. F. (1995). Myoblast fusion and innervation 
with rat motor nerve alter distribution of acetylcholinesterase and its mRNA in cultures 
of human muscle. Neuron, 14(2), 317-327.  
Guex, A. G., Birrer, D. L., Fortunato, G., Tevaearai, H. T., & Giraud, M. N. (2013). 
Anisotropically oriented electrospun matrices with an imprinted periodic micropattern: a 
new scaffold for engineered muscle constructs. Biomed Mater, 8(2), 021001. doi: 
10.1088/1748-6041/8/2/021001 
Gutmann, E. (1945). The reinnervation of muscle by sensory nerve fibres. J Anat, 79(Pt 1), 1-8 
4.  
Gutmann, E., & Hanzlikova, V. (1966). Motor unit in old age. Nature, 209(5026), 921-922.  
Hall, J. K., Banks, G. B., Chamberlain, J. S., & Olwin, B. B. (2010). Prevention of muscle aging 





Harding, K., Sumner, M., & Cardinal, M. (2013). A prospective, multicentre, randomised 
controlled study of human fibroblast-derived dermal substitute (Dermagraft) in patients 
with venous leg ulcers. Int Wound J, 10(2), 132-137. doi: 10.1111/iwj.12053 
Harii, K., Ohmori, K., & Torii, S. (1976). Free gracilis muscle transplantation, with 
microneurovascular anastomoses for the treatment of facial paralysis. A preliminary 
report. Plast Reconstr Surg, 57(2), 133-143.  
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., Blackman, M. R., & Baltimore 
Longitudinal Study of, A. (2001). Longitudinal effects of aging on serum total and free 
testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin 
Endocrinol Metab, 86(2), 724-731. doi: 10.1210/jcem.86.2.7219 
Heher, P., Maleiner, B., Pruller, J., Teuschl, A. H., Kollmitzer, J., Monforte, X., . . . Fuchs, C. 
(2015). A novel bioreactor for the generation of highly aligned 3D skeletal muscle-like 
constructs through orientation of fibrin via application of static strain. Acta Biomater, 24, 
251-265. doi: 10.1016/j.actbio.2015.06.033 
Hepple, R. T., & Rice, C. L. (2016). Innervation and neuromuscular control in ageing skeletal 
muscle. J Physiol, 594(8), 1965-1978. doi: 10.1113/JP270561 
Hill, E., Boontheekul, T., & Mooney, D. J. (2006a). Designing scaffolds to enhance transplanted 
myoblast survival and migration. Tissue Eng, 12(5), 1295-1304. doi: 
10.1089/ten.2006.12.1295 
Hill, E., Boontheekul, T., & Mooney, D. J. (2006b). Regulating activation of transplanted cells 
controls tissue regeneration. Proc Natl Acad Sci U S A, 103(8), 2494-2499. doi: 
10.1073/pnas.0506004103 
Hoque, M. E., San, W. Y., Wei, F., Li, S., Huang, M. H., Vert, M., & Hutmacher, D. W. (2009). 
Processing of polycaprolactone and polycaprolactone-based copolymers into 3D 
scaffolds, and their cellular responses. Tissue Eng Part A, 15(10), 3013-3024. doi: 
10.1089/ten.TEA.2008.0355 
Hsieh, C. C., Rosenblatt, J. I., & Papaconstantinou, J. (2003). Age-associated changes in 
SAPK/JNK and p38 MAPK signaling in response to the generation of ROS by 3-




Hurd, S. A., Bhatti, N. M., Walker, A. M., Kasukonis, B. M., & Wolchok, J. C. (2015). 
Development of a biological scaffold engineered using the extracellular matrix secreted 
by skeletal muscle cells. Biomaterials, 49, 9-17. doi: 10.1016/j.biomaterials.2015.01.027 
Hurme, T., Kalimo, H., Lehto, M., & Jarvinen, M. (1991). Healing of skeletal muscle injury: an 
ultrastructural and immunohistochemical study. Med Sci Sports Exerc, 23(7), 801-810.  
Hurtgen, B. J., Ward, C. L., Leopold Wager, C. M., Garg, K., Goldman, S. M., Henderson, B. E. 
P., . . . Corona, B. T. (2017). Autologous minced muscle grafts improve endogenous 
fracture healing and muscle strength after musculoskeletal trauma. Physiol Rep, 5(14). 
doi: 10.14814/phy2.13362 
Huxley, A. F., & Niedergerke, R. (1954). Structural changes in muscle during contraction; 
interference microscopy of living muscle fibres. Nature, 173(4412), 971-973.  
Huxley, H., & Hanson, J. (1954). Changes in the cross-striations of muscle during contraction 
and stretch and their structural interpretation. Nature, 173(4412), 973-976.  
Iwasa, J., Engebretsen, L., Shima, Y., & Ochi, M. (2009). Clinical application of scaffolds for 
cartilage tissue engineering. Knee Surg Sports Traumatol Arthrosc, 17(6), 561-577. doi: 
10.1007/s00167-008-0663-2 
Jacquemin, V., Butler-Browne, G. S., Furling, D., & Mouly, V. (2007). IL-13 mediates the 
recruitment of reserve cells for fusion during IGF-1-induced hypertrophy of human 
myotubes. J Cell Sci, 120(Pt 4), 670-681. doi: 10.1242/jcs.03371 
Jang, Y. C., & Van Remmen, H. (2011). Age-associated alterations of the neuromuscular 
junction. Exp Gerontol, 46(2-3), 193-198. doi: 10.1016/j.exger.2010.08.029 
Jarvinen, M. J., & Lehto, M. U. (1993). The effects of early mobilisation and immobilisation on 
the healing process following muscle injuries. Sports Med, 15(2), 78-89.  
Jarvinen, T. A., Jarvinen, T. L., Kaariainen, M., Aarimaa, V., Vaittinen, S., Kalimo, H., & 
Jarvinen, M. (2007). Muscle injuries: optimising recovery. Best Pract Res Clin 
Rheumatol, 21(2), 317-331. doi: 10.1016/j.berh.2006.12.004 
Jarvinen, T. A., Jarvinen, T. L., Kaariainen, M., Kalimo, H., & Jarvinen, M. (2005). Muscle 





Jiang, C., Wen, Y., Kuroda, K., Hannon, K., Rudnicki, M. A., & Kuang, S. (2014). Notch 
signaling deficiency underlies age-dependent depletion of satellite cells in muscular 
dystrophy. Dis Model Mech, 7(8), 997-1004. doi: 10.1242/dmm.015917 
Jiang, Y. Z., Jimenez, J. M., Ou, K., McCormick, M. E., Zhang, L. D., & Davies, P. F. (2014). 
Hemodynamic disturbed flow induces differential DNA methylation of endothelial 
Kruppel-Like Factor 4 promoter in vitro and in vivo. Circ Res, 115(1), 32-43. doi: 
10.1161/CIRCRESAHA.115.303883 
Jirmanova, I., & Thesleff, S. (1972). Ultrastructural study of experimental muscle degeneration 
and regeneration in the adult rat. Z Zellforsch Mikrosk Anat, 131(1), 77-97.  
Ju, Y. M., Atala, A., Yoo, J. J., & Lee, S. J. (2014). In situ regeneration of skeletal muscle tissue 
through host cell recruitment. Acta Biomater, 10(10), 4332-4339. doi: 
10.1016/j.actbio.2014.06.022 
Jun, I., Jeong, S., & Shin, H. (2009). The stimulation of myoblast differentiation by electrically 
conductive sub-micron fibers. Biomaterials, 30(11), 2038-2047. doi: 
10.1016/j.biomaterials.2008.12.063 
Karalaki, M., Fili, S., Philippou, A., & Koutsilieris, M. (2009). Muscle regeneration: cellular and 
molecular events. In Vivo, 23(5), 779-796.  
Kasukonis, B., Kim, J., Brown, L., Jones, J., Ahmadi, S., Washington, T., & Wolchok, J. (2016). 
Codelivery of Infusion Decellularized Skeletal Muscle with Minced Muscle Autografts 
Improved Recovery from Volumetric Muscle Loss Injury in a Rat Model. Tissue Eng 
Part A, 22(19-20), 1151-1163. doi: 10.1089/ten.TEA.2016.0134 
Kasukonis, B. M., Kim, J. T., Washington, T. A., & Wolchok, J. C. (2016). Development of an 
infusion bioreactor for the accelerated preparation of decellularized skeletal muscle 
scaffolds. Biotechnol Prog, 32(3), 745-755. doi: 10.1002/btpr.2257 
Kherif, S., Lafuma, C., Dehaupas, M., Lachkar, S., Fournier, J. G., Verdiere-Sahuque, M., . . . 
Alameddine, H. S. (1999). Expression of matrix metalloproteinases 2 and 9 in 
regenerating skeletal muscle: a study in experimentally injured and mdx muscles. Dev 
Biol, 205(1), 158-170. doi: 10.1006/dbio.1998.9107 





Kim, J. T., Kasukonis, B. M., Brown, L. A., Washington, T. A., & Wolchok, J. C. (2016). 
Recovery from volumetric muscle loss injury: A comparison between young and aged 
rats. Exp Gerontol, 83, 37-46. doi: 10.1016/j.exger.2016.07.008 
Klebuc, M., & Menn, Z. (2013). Muscle flaps and their role in limb salvage. Methodist Debakey 
Cardiovasc J, 9(2), 95-99.  
Kolker, A. R., Brown, D. J., Redstone, J. S., Scarpinato, V. M., & Wallack, M. K. (2005). 
Multilayer reconstruction of abdominal wall defects with acellular dermal allograft 
(AlloDerm) and component separation. Ann Plast Surg, 55(1), 36-41; discussion 41-32.  
Kovacheva, E. L., Hikim, A. P., Shen, R., Sinha, I., & Sinha-Hikim, I. (2010). Testosterone 
supplementation reverses sarcopenia in aging through regulation of myostatin, c-Jun 
NH2-terminal kinase, Notch, and Akt signaling pathways. Endocrinology, 151(2), 628-
638. doi: 10.1210/en.2009-1177 
Krippendorf, B. B., & Riley, D. A. (1993). Distinguishing unloading- versus reloading-induced 
changes in rat soleus muscle. Muscle Nerve, 16(1), 99-108. doi: 10.1002/mus.880160116 
Kroehne, V., Heschel, I., Schugner, F., Lasrich, D., Bartsch, J. W., & Jockusch, H. (2008). Use 
of a novel collagen matrix with oriented pore structure for muscle cell differentiation in 
cell culture and in grafts. J Cell Mol Med, 12(5A), 1640-1648. doi: 10.1111/j.1582-
4934.2008.00238.x 
Kuang, S., Gillespie, M. A., & Rudnicki, M. A. (2008). Niche regulation of muscle satellite cell 
self-renewal and differentiation. Cell Stem Cell, 2(1), 22-31. doi: 
10.1016/j.stem.2007.12.012 
Kuhl, U., Ocalan, M., Timpl, R., Mayne, R., Hay, E., & von der Mark, K. (1984). Role of muscle 
fibroblasts in the deposition of type-IV collagen in the basal lamina of myotubes. 
Differentiation, 28(2), 164-172.  
Kung, T. A., Cederna, P. S., van der Meulen, J. H., Urbanchek, M. G., Kuzon, W. M., Jr., & 
Faulkner, J. A. (2014). Motor unit changes seen with skeletal muscle sarcopenia in oldest 
old rats. J Gerontol A Biol Sci Med Sci, 69(6), 657-665. doi: 10.1093/gerona/glt135 
Lahteenvuo, J., & Rosenzweig, A. (2012). Effects of aging on angiogenesis. Circ Res, 110(9), 




Lalegul-Ulker, O., Seker, S., Elcin, A. E., & Elcin, Y. M. (2019). Encapsulation of bone marrow-
MSCs in PRP-derived fibrin microbeads and preliminary evaluation in a volumetric 
muscle loss injury rat model: modular muscle tissue engineering. Artif Cells Nanomed 
Biotechnol, 47(1), 10-21. doi: 10.1080/21691401.2018.1540426 
Lantz, G. C., Badylak, S. F., Coffey, A. C., Geddes, L. A., & Blevins, W. E. (1990). Small 
intestinal submucosa as a small-diameter arterial graft in the dog. J Invest Surg, 3(3), 
217-227.  
Larsson, L. (1995). Motor units: remodeling in aged animals. J Gerontol A Biol Sci Med Sci, 50 
Spec No, 91-95.  
Launay, T., Armand, A. S., Charbonnier, F., Mira, J. C., Donsez, E., Gallien, C. L., & Chanoine, 
C. (2001). Expression and neural control of myogenic regulatory factor genes during 
regeneration of mouse soleus. J Histochem Cytochem, 49(7), 887-899. doi: 
10.1177/002215540104900709 
Lefeuvre, B., Crossin, F., Fontaine-Perus, J., Bandman, E., & Gardahaut, M. F. (1996). 
Innervation regulates myosin heavy chain isoform expression in developing skeletal 
muscle fibers. Mech Dev, 58(1-2), 115-127.  
Lesman, A., Koffler, J., Atlas, R., Blinder, Y. J., Kam, Z., & Levenberg, S. (2011). Engineering 
vessel-like networks within multicellular fibrin-based constructs. Biomaterials, 32(31), 
7856-7869. doi: 10.1016/j.biomaterials.2011.07.003 
Lieber, R. L., & Friden, J. (2000). Functional and clinical significance of skeletal muscle 
architecture. Muscle Nerve, 23(11), 1647-1666.  
Lin, A., & Dibling, B. (2002). The true face of JNK activation in apoptosis. Aging Cell, 1(2), 
112-116.  
Lin, C. H., Lin, Y. T., Yeh, J. T., & Chen, C. T. (2007). Free functioning muscle transfer for 
lower extremity posttraumatic composite structure and functional defect. Plast Reconstr 
Surg, 119(7), 2118-2126. doi: 10.1097/01.prs.0000260595.85557.41 
Liu, G., Pareta, R. A., Wu, R., Shi, Y., Zhou, X., Liu, H., . . . Zhang, Y. (2013). Skeletal 
myogenic differentiation of urine-derived stem cells and angiogenesis using microbeads 





Macchiarini, P., Jungebluth, P., Go, T., Asnaghi, M. A., Rees, L. E., Cogan, T. A., . . . Birchall, 
M. A. (2008). Clinical transplantation of a tissue-engineered airway. Lancet, 372(9655), 
2023-2030. doi: 10.1016/S0140-6736(08)61598-6 
Machingal, M. A., Corona, B. T., Walters, T. J., Kesireddy, V., Koval, C. N., Dannahower, A., . . 
. Christ, G. J. (2011). A tissue-engineered muscle repair construct for functional 
restoration of an irrecoverable muscle injury in a murine model. Tissue Eng Part A, 
17(17-18), 2291-2303. doi: 10.1089/ten.TEA.2010.0682 
MacKenzie, E. J., Bosse, M. J., Kellam, J. F., Burgess, A. R., Webb, L. X., Swiontkowski, M. F., 
. . . McCarthy, M. L. (2000). Characterization of patients with high-energy lower 
extremity trauma. J Orthop Trauma, 14(7), 455-466.  
Maley, M. A., Davies, M. J., & Grounds, M. D. (1995). Extracellular matrix, growth factors, 
genetics: their influence on cell proliferation and myotube formation in primary cultures 
of adult mouse skeletal muscle. Exp Cell Res, 219(1), 169-179. doi: 
10.1006/excr.1995.1217 
Marcinczyk, M., Dunn, A., Haas, G., Madsen, J., Scheidt, R., Patel, K., . . . Garg, K. (2018). The 
Effect of Laminin-111 Hydrogels on Muscle Regeneration in a Murine Model of Injury. 
Tissue Eng Part A. doi: 10.1089/ten.TEA.2018.0200 
Marshall, P. A., Williams, P. E., & Goldspink, G. (1989). Accumulation of collagen and altered 
fiber-type ratios as indicators of abnormal muscle gene expression in the mdx dystrophic 
mouse. Muscle Nerve, 12(7), 528-537. doi: 10.1002/mus.880120703 
Mase, V. J., Jr., Hsu, J. R., Wolf, S. E., Wenke, J. C., Baer, D. G., Owens, J., . . . Walters, T. J. 
(2010). Clinical application of an acellular biologic scaffold for surgical repair of a large, 
traumatic quadriceps femoris muscle defect. Orthopedics, 33(7), 511. doi: 
10.3928/01477447-20100526-24 
Matsumoto, T., Sasaki, J., Alsberg, E., Egusa, H., Yatani, H., & Sohmura, T. (2007). Three-
dimensional cell and tissue patterning in a strained fibrin gel system. PLoS One, 2(11), 
e1211. doi: 10.1371/journal.pone.0001211 
McGeachie, J. K., & Grounds, M. D. (1989). The onset of myogenesis in denervated mouse 




McNamara, M. J., Garrett, W. E., Jr., Seaber, A. V., & Goldner, J. L. (1987). Neurorrhaphy, 
nerve grafting, and neurotization: a functional comparison of nerve reconstruction 
techniques. J Hand Surg Am, 12(3), 354-360.  
McNeil, C. J., Doherty, T. J., Stashuk, D. W., & Rice, C. L. (2005). Motor unit number estimates 
in the tibialis anterior muscle of young, old, and very old men. Muscle Nerve, 31(4), 461-
467. doi: 10.1002/mus.20276 
Merritt, E. K., Cannon, M. V., Hammers, D. W., Le, L. N., Gokhale, R., Sarathy, A., . . . Farrar, 
R. P. (2010). Repair of traumatic skeletal muscle injury with bone-marrow-derived 
mesenchymal stem cells seeded on extracellular matrix. Tissue Eng Part A, 16(9), 2871-
2881. doi: 10.1089/ten.TEA.2009.0826 
Mertens, J. P., Sugg, K. B., Lee, J. D., & Larkin, L. M. (2014). Engineering muscle constructs 
for the creation of functional engineered musculoskeletal tissue. Regen Med, 9(1), 89-
100. doi: 10.2217/rme.13.81 
Monroy, J. A., Powers, K. L., Gilmore, L. A., Uyeno, T. A., Lindstedt, S. L., & Nishikawa, K. C. 
(2012). What is the role of titin in active muscle? Exerc Sport Sci Rev, 40(2), 73-78. doi: 
10.1097/JES.0b013e31824580c6 
Morissette, M. R., Cook, S. A., Foo, S., McKoy, G., Ashida, N., Novikov, M., . . . Rosenzweig, 
A. (2006). Myostatin regulates cardiomyocyte growth through modulation of Akt 
signaling. Circ Res, 99(1), 15-24. doi: 10.1161/01.RES.0000231290.45676.d4 
Muramatsu, T., Muramatsu, H., & Kojima, T. (2006). Identification of proteoglycan-binding 
proteins. Methods Enzymol, 416, 263-278. doi: 10.1016/S0076-6879(06)16017-6 
Nagata, S., Kurosawa, M., Mima, K., Nambo, Y., Fujii, Y., Watanabe, G., & Taya, K. (1999). 
Effects of anabolic steroid (19-nortestosterone) on the secretion of testicular hormones in 
the stallion. J Reprod Fertil, 115(2), 373-379.  
Nguyen, H. X., & Tidball, J. G. (2003). Interactions between neutrophils and macrophages 
promote macrophage killing of rat muscle cells in vitro. J Physiol, 547(Pt 1), 125-132. 
doi: 10.1113/jphysiol.2002.031450 
Niu, X., Feng, Q., Wang, M., Guo, X., & Zheng, Q. (2009). Porous nano-HA/collagen/PLLA 
scaffold containing chitosan microspheres for controlled delivery of synthetic peptide 





Nomura, Y. (2006). Structural change in decorin with skin aging. Connect Tissue Res, 47(5), 
249-255. doi: 10.1080/03008200600846606 
Ochoa, O., Sun, D., Reyes-Reyna, S. M., Waite, L. L., Michalek, J. E., McManus, L. M., & 
Shireman, P. K. (2007). Delayed angiogenesis and VEGF production in CCR2-/- mice 
during impaired skeletal muscle regeneration. Am J Physiol Regul Integr Comp Physiol, 
293(2), R651-661. doi: 10.1152/ajpregu.00069.2007 
Oda, K. (1984). Age changes of motor innervation and acetylcholine receptor distribution on 
human skeletal muscle fibres. J Neurol Sci, 66(2-3), 327-338.  
Olfert, I. M., Baum, O., Hellsten, Y., & Egginton, S. (2016). Advances and challenges in skeletal 
muscle angiogenesis. Am J Physiol Heart Circ Physiol, 310(3), H326-336. doi: 
10.1152/ajpheart.00635.2015 
Opara, E. C., Mirmalek-Sani, S. H., Khanna, O., Moya, M. L., & Brey, E. M. (2010). Design of a 
bioartificial pancreas(+). J Investig Med, 58(7), 831-837. doi: 
10.231/JIM.0b013e3181ed3807 
Oryan, A., Alidadi, S., Moshiri, A., & Maffulli, N. (2014). Bone regenerative medicine: classic 
options, novel strategies, and future directions. J Orthop Surg Res, 9(1), 18. doi: 
10.1186/1749-799X-9-18 
Ott, H. C., Matthiesen, T. S., Goh, S. K., Black, L. D., Kren, S. M., Netoff, T. I., & Taylor, D. A. 
(2008). Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial 
heart. Nat Med, 14(2), 213-221. doi: 10.1038/nm1684 
Ottenheijm, C. A., & Granzier, H. (2010). Lifting the nebula: novel insights into skeletal muscle 
contractility. Physiology (Bethesda), 25(5), 304-310. doi: 10.1152/physiol.00016.2010 
Owens, B. D., Kragh, J. F., Jr., Wenke, J. C., Macaitis, J., Wade, C. E., & Holcomb, J. B. (2008). 
Combat wounds in operation Iraqi Freedom and operation Enduring Freedom. J Trauma, 
64(2), 295-299. doi: 10.1097/TA.0b013e318163b875 
Owens, J. G., Blair, J. A., Patzkowski, J. C., Blanck, R. V., Hsu, J. R., & Skeletal Trauma 
Research, C. (2011). Return to running and sports participation after limb salvage. J 




Page, R. L., Malcuit, C., Vilner, L., Vojtic, I., Shaw, S., Hedblom, E., . . . Dominko, T. (2011). 
Restoration of skeletal muscle defects with adult human cells delivered on fibrin 
microthreads. Tissue Eng Part A, 17(21-22), 2629-2640. doi: 
10.1089/ten.TEA.2011.0024 
Patel, V. A., Zhang, Q. J., Siddle, K., Soos, M. A., Goddard, M., Weissberg, P. L., & Bennett, M. 
R. (2001). Defect in insulin-like growth factor-1 survival mechanism in atherosclerotic 
plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and 
signaling. Circ Res, 88(9), 895-902.  
Pavlath, G. K., Dominov, J. A., Kegley, K. M., & Miller, J. B. (2003). Regeneration of 
transgenic skeletal muscles with altered timing of expression of the basic helix-loop-helix 
muscle regulatory factor MRF4. Am J Pathol, 162(5), 1685-1691. doi: 10.1016/S0002-
9440(10)64303-9 
Pelosi, L., Giacinti, C., Nardis, C., Borsellino, G., Rizzuto, E., Nicoletti, C., . . . Musaro, A. 
(2007). Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating 
inflammatory cytokines and chemokines. FASEB J, 21(7), 1393-1402. doi: 10.1096/fj.06-
7690com 
Perniconi, B., Costa, A., Aulino, P., Teodori, L., Adamo, S., & Coletti, D. (2011). The pro-
myogenic environment provided by whole organ scale acellular scaffolds from skeletal 
muscle. Biomaterials, 32(31), 7870-7882. doi: 10.1016/j.biomaterials.2011.07.016 
Pomara, C., Barone, R., Marino Gammazza, A., Sangiorgi, C., Barone, F., Pitruzzella, A., . . . 
Turillazzi, E. (2016). Effects of Nandrolone Stimulation on Testosterone Biosynthesis in 
Leydig Cells. J Cell Physiol, 231(6), 1385-1391. doi: 10.1002/jcp.25272 
Porzionato, A., Sfriso, M. M., Pontini, A., Macchi, V., Petrelli, L., Pavan, P. G., . . . De Caro, R. 
(2015). Decellularized Human Skeletal Muscle as Biologic Scaffold for Reconstructive 
Surgery. Int J Mol Sci, 16(7), 14808-14831. doi: 10.3390/ijms160714808 
Prabaharan, M., & Jayakumar, R. (2009). Chitosan-graft-beta-cyclodextrin scaffolds with 
controlled drug release capability for tissue engineering applications. Int J Biol 
Macromol, 44(4), 320-325. doi: 10.1016/j.ijbiomac.2009.01.005 
Prevel, C. D., Eppley, B. L., Summerlin, D. J., Jackson, J. R., McCarty, M., & Badylak, S. F. 
(1995). Small intestinal submucosa: utilization for repair of rodent abdominal wall 




Ramasamy, A., Harrisson, S. E., Clasper, J. C., & Stewart, M. P. (2008). Injuries from roadside 
improvised explosive devices. J Trauma, 65(4), 910-914. doi: 
10.1097/TA.0b013e3181848cf6 
Renault, V., Thornell, L. E., Butler-Browne, G., & Mouly, V. (2002). Human skeletal muscle 
satellite cells: aging, oxidative stress and the mitotic clock. Exp Gerontol, 37(10-11), 
1229-1236.  
Rhim, C., Lowell, D. A., Reedy, M. C., Slentz, D. H., Zhang, S. J., Kraus, W. E., & Truskey, G. 
A. (2007). Morphology and ultrastructure of differentiating three-dimensional 
mammalian skeletal muscle in a collagen gel. Muscle Nerve, 36(1), 71-80. doi: 
10.1002/mus.20788 
Romijn, J. A., Coyle, E. F., Sidossis, L. S., Gastaldelli, A., Horowitz, J. F., Endert, E., & Wolfe, 
R. R. (1993). Regulation of endogenous fat and carbohydrate metabolism in relation to 
exercise intensity and duration. Am J Physiol, 265(3 Pt 1), E380-391. doi: 
10.1152/ajpendo.1993.265.3.E380 
Rossi, C. A., Flaibani, M., Blaauw, B., Pozzobon, M., Figallo, E., Reggiani, C., . . . De Coppi, P. 
(2011). In vivo tissue engineering of functional skeletal muscle by freshly isolated 
satellite cells embedded in a photopolymerizable hydrogel. FASEB J, 25(7), 2296-2304. 
doi: 10.1096/fj.10-174755 
Samuel, M. A., Valdez, G., Tapia, J. C., Lichtman, J. W., & Sanes, J. R. (2012). Agrin and 
synaptic laminin are required to maintain adult neuromuscular junctions. PLoS One, 
7(10), e46663. doi: 10.1371/journal.pone.0046663 
Sandusky, G. E., Jr., Badylak, S. F., Morff, R. J., Johnson, W. D., & Lantz, G. (1992). Histologic 
findings after in vivo placement of small intestine submucosal vascular grafts and 
saphenous vein grafts in the carotid artery in dogs. Am J Pathol, 140(2), 317-324.  
Saxena, A. K., Marler, J., Benvenuto, M., Willital, G. H., & Vacanti, J. P. (1999). Skeletal 
muscle tissue engineering using isolated myoblasts on synthetic biodegradable polymers: 
preliminary studies. Tissue Eng, 5(6), 525-532. doi: 10.1089/ten.1999.5.525 
Saxena, A. K., Willital, G. H., & Vacanti, J. P. (2001). Vascularized three-dimensional skeletal 




Schultz, G. S., & Wysocki, A. (2009). Interactions between extracellular matrix and growth 
factors in wound healing. Wound Repair Regen, 17(2), 153-162. doi: 10.1111/j.1524-
475X.2009.00466.x 
Seene, T., & Kaasik, P. (2012). Role of exercise therapy in prevention of decline in aging muscle 
function: glucocorticoid myopathy and unloading. J Aging Res, 2012, 172492. doi: 
10.1155/2012/172492 
Serra, C., Tangherlini, F., Rudy, S., Lee, D., Toraldo, G., Sandor, N. L., . . . Bhasin, S. (2013). 
Testosterone improves the regeneration of old and young mouse skeletal muscle. J 
Gerontol A Biol Sci Med Sci, 68(1), 17-26. doi: 10.1093/gerona/gls083 
Shalhav, A. L., Elbahnasy, A. M., Bercowsky, E., Kovacs, G., Brewer, A., Maxwell, K. L., . . . 
Clayman, R. V. (1999). Laparoscopic replacement of urinary tract segments using 
biodegradable materials in a large-animal model. J Endourol, 13(4), 241-244. doi: 
10.1089/end.1999.13.241 
Shao, S., Zhou, S., Li, L., Li, J., Luo, C., Wang, J., . . . Weng, J. (2011). Osteoblast function on 
electrically conductive electrospun PLA/MWCNTs nanofibers. Biomaterials, 32(11), 
2821-2833. doi: 10.1016/j.biomaterials.2011.01.051 
Shvartsman, D., Storrie-White, H., Lee, K., Kearney, C., Brudno, Y., Ho, N., . . . Mooney, D. J. 
(2014). Sustained delivery of VEGF maintains innervation and promotes reperfusion in 
ischemic skeletal muscles via NGF/GDNF signaling. Mol Ther, 22(7), 1243-1253. doi: 
10.1038/mt.2014.76 
Sicari, B. M., Agrawal, V., Siu, B. F., Medberry, C. J., Dearth, C. L., Turner, N. J., & Badylak, 
S. F. (2012). A murine model of volumetric muscle loss and a regenerative medicine 
approach for tissue replacement. Tissue Eng Part A, 18(19-20), 1941-1948. doi: 
10.1089/ten.TEA.2012.0475 
Sicari, B. M., Rubin, J. P., Dearth, C. L., Wolf, M. T., Ambrosio, F., Boninger, M., . . . Badylak, 
S. F. (2014). An acellular biologic scaffold promotes skeletal muscle formation in mice 
and humans with volumetric muscle loss. Sci Transl Med, 6(234), 234ra258. doi: 
10.1126/scitranslmed.3008085 
Sim, F. J., Zhao, C., Penderis, J., & Franklin, R. J. (2002). The age-related decrease in CNS 
remyelination efficiency is attributable to an impairment of both oligodendrocyte 




Sinha-Hikim, I., Braga, M., Shen, R., & Sinha Hikim, A. P. (2007). Involvement of c-Jun NH2-
terminal kinase and nitric oxide-mediated mitochondria-dependent intrinsic pathway 
signaling in cardiotoxin-induced muscle cell death: role of testosterone. Apoptosis, 
12(11), 1965-1978. doi: 10.1007/s10495-007-0120-6 
Smith, C. K., 2nd, Janney, M. J., & Allen, R. E. (1994). Temporal expression of myogenic 
regulatory genes during activation, proliferation, and differentiation of rat skeletal muscle 
satellite cells. J Cell Physiol, 159(2), 379-385. doi: 10.1002/jcp.1041590222 
Snow, M. H. (1977). The effects of aging on satellite cells in skeletal muscles of mice and rats. 
Cell Tissue Res, 185(3), 399-408.  
Socha, M. J., & Segal, S. S. (2018). Microvascular mechanisms limiting skeletal muscle blood 
flow with advancing age. J Appl Physiol (1985), 125(6), 1851-1859. doi: 
10.1152/japplphysiol.00113.2018 
Song, J. J., & Ott, H. C. (2011). Organ engineering based on decellularized matrix scaffolds. 
Trends Mol Med, 17(8), 424-432. doi: 10.1016/j.molmed.2011.03.005 
Sprenger, C. C., Plymate, S. R., & Reed, M. J. (2008). Extracellular influences on tumour 
angiogenesis in the aged host. Br J Cancer, 98(2), 250-255. doi: 10.1038/sj.bjc.6604144 
St Pierre, B. A., & Tidball, J. G. (1994). Differential response of macrophage subpopulations to 
soleus muscle reloading after rat hindlimb suspension. J Appl Physiol (1985), 77(1), 290-
297. doi: 10.1152/jappl.1994.77.1.290 
Striganova, A. R. (1958). [Reactive changes of the intact muscle in atrophy and restoration of 
opposite denervated muscle in rats]. Arkh Patol, 20(9), 11-17.  
Studitsky, A. N. (1964). Free Auto- and Homografts of Muscle Tissue in Experiments on 
Animals. Ann N Y Acad Sci, 120, 789-801.  
Suckow, M. A., Voytik-Harbin, S. L., Terril, L. A., & Badylak, S. F. (1999). Enhanced bone 
regeneration using porcine small intestinal submucosa. J Invest Surg, 12(5), 277-287.  
Suelves, M., Lluis, F., Ruiz, V., Nebreda, A. R., & Munoz-Canoves, P. (2004). Phosphorylation 
of MRF4 transactivation domain by p38 mediates repression of specific myogenic genes. 




Suga, T., Kinugawa, S., Takada, S., Kadoguchi, T., Fukushima, A., Homma, T., . . . Tsutsui, H. 
(2014). Combination of exercise training and diet restriction normalizes limited exercise 
capacity and impaired skeletal muscle function in diet-induced diabetic mice. 
Endocrinology, 155(1), 68-80. doi: 10.1210/en.2013-1382 
Sugamori, M. E., & Sefton, M. V. (1989). Microencapsulation of pancreatic islets in a water 
insoluble polyacrylate. ASAIO Trans, 35(4), 791-799.  
Sulaiman, O. A., Midha, R., Munro, C. A., Matsuyama, T., Al-Majed, A., & Gordon, T. (2002). 
Chronic Schwann cell denervation and the presence of a sensory nerve reduce motor 
axonal regeneration. Exp Neurol, 176(2), 342-354.  
Takahashi, M., Tatsugi, Y., & Kohno, T. (2004). Endocrinological and pathological effects of 
anabolic-androgenic steroid in male rats. Endocr J, 51(4), 425-434.  
Tamai, S., Komatsu, S., Sakamoto, H., Sano, S., & Sasauchi, N. (1970). Free muscle transplants 
in dogs, with microsurgical neurovascular anastomoses. Plast Reconstr Surg, 46(3), 219-
225.  
Tateyama, M., Fujihara, K., Misu, T., & Itoyama, Y. (2009). CCR7+ myeloid dendritic cells 
together with CCR7+ T cells and CCR7+ macrophages invade CCL19+ nonnecrotic 
muscle fibers in inclusion body myositis. J Neurol Sci, 279(1-2), 47-52. doi: 
10.1016/j.jns.2008.12.024 
Tedesco, F. S., & Cossu, G. (2012). Stem cell therapies for muscle disorders. Curr Opin Neurol, 
25(5), 597-603. doi: 10.1097/WCO.0b013e328357f288 
Terada, N., Takayama, S., Yamada, H., & Seki, T. (2001). Muscle repair after a transsection 
injury with development of a gap: an experimental study in rats. Scand J Plast Reconstr 
Surg Hand Surg, 35(3), 233-238.  
Thomas, D. R. (2001). Age-related changes in wound healing. Drugs Aging, 18(8), 607-620. doi: 
10.2165/00002512-200118080-00005 
Thomas, G. D. (2013). Functional muscle ischemia in Duchenne and Becker muscular 
dystrophy. Front Physiol, 4, 381. doi: 10.3389/fphys.2013.00381 
Thomas, K., Engler, A. J., & Meyer, G. A. (2015). Extracellular matrix regulation in the muscle 




Thompson, N. (1971a). Autogenous free grafts of skeletal muscle. A preliminary experimental 
and clinical study. Plast Reconstr Surg, 48(1), 11-27.  
Thompson, N. (1971b). Investigation of autogenous skeletal muscle free grafts in the dog with a 
report on a successful free graft of skeletal muscle in man. Transplantation, 12(5), 353-
363.  
Tidball, J. G. (1995). Inflammatory cell response to acute muscle injury. Med Sci Sports Exerc, 
27(7), 1022-1032.  
Tidball, J. G. (2011). Mechanisms of muscle injury, repair, and regeneration. Compr Physiol, 
1(4), 2029-2062. doi: 10.1002/cphy.c100092 
Tidball, J. G., & Wehling-Henricks, M. (2007). Macrophages promote muscle membrane repair 
and muscle fibre growth and regeneration during modified muscle loading in mice in 
vivo. J Physiol, 578(Pt 1), 327-336. doi: 10.1113/jphysiol.2006.118265 
Toumi, H., & Best, T. M. (2003). The inflammatory response: friend or enemy for muscle 
injury? Br J Sports Med, 37(4), 284-286.  
TOWER, S. S. (1931). A SEARCH FOR TROPHIC INFLUENCE OF POSTERIOR SPINAL 
ROOTS ON SKELETAL MUSCLE, WITH A NOTE ON THE NERVE FIBRES 
FOUND IN THE PROXIMAL STUMPS OF THE ROOTS AFTER EXCISION OF THE 
ROOT GANGLIA. Brain, 54(1), 99-110. doi: 10.1093/brain/54.1.99 
TOWER, S. S. (1939). PERSISTENCE OF FIBRILLATION IN DENERVATED SKELETAL 
MUSCLE AND ITS NONOCCURRENCE IN MUSCLE AFTER TENOTOMY. 
Archives of Neurology & Psychiatry, 42(2), 219-223. doi: 
10.1001/archneurpsyc.1939.02270200039003 
Turner, N. J., Badylak, J. S., Weber, D. J., & Badylak, S. F. (2012). Biologic scaffold remodeling 
in a dog model of complex musculoskeletal injury. J Surg Res, 176(2), 490-502. doi: 
10.1016/j.jss.2011.11.1029 
Turner, N. J., & Badylak, S. F. (2012). Regeneration of skeletal muscle. Cell Tissue Res, 347(3), 
759-774. doi: 10.1007/s00441-011-1185-7 
Turner, N. J., Yates, A. J., Jr., Weber, D. J., Qureshi, I. R., Stolz, D. B., Gilbert, T. W., & 




regeneration of a functioning musculotendinous junction. Tissue Eng Part A, 16(11), 
3309-3317. doi: 10.1089/ten.TEA.2010.0169 
Ullman, M., Ullman, A., Sommerland, H., Skottner, A., & Oldfors, A. (1990). Effects of growth 
hormone on muscle regeneration and IGF-I concentration in old rats. Acta Physiol Scand, 
140(4), 521-525. doi: 10.1111/j.1748-1716.1990.tb09029.x 
Untergasser, G., Madersbacher, S., & Berger, P. (2005). Benign prostatic hyperplasia: age-
related tissue-remodeling. Exp Gerontol, 40(3), 121-128. doi: 
10.1016/j.exger.2004.12.008 
Valentin, J. E., Turner, N. J., Gilbert, T. W., & Badylak, S. F. (2010). Functional skeletal muscle 
formation with a biologic scaffold. Biomaterials, 31(29), 7475-7484. doi: 
10.1016/j.biomaterials.2010.06.039 
van Wachem, P. B., Brouwer, L. A., & van Luyn, M. J. (1999). Absence of muscle regeneration 
after implantation of a collagen matrix seeded with myoblasts. Biomaterials, 20(5), 419-
426.  
Vekris, M. D., Beris, A. E., Lykissas, M. G., Korompilias, A. V., Vekris, A. D., & Soucacos, P. 
N. (2008). Restoration of elbow function in severe brachial plexus paralysis via muscle 
transfers. Injury, 39 Suppl 3, S15-22. doi: 10.1016/j.injury.2008.06.008 
Velleman, S. G. (1999). The role of the extracellular matrix in skeletal muscle development. 
Poult Sci, 78(5), 778-784. doi: 10.1093/ps/78.5.778 
Villalta, S. A., Nguyen, H. X., Deng, B., Gotoh, T., & Tidball, J. G. (2009). Shifts in 
macrophage phenotypes and macrophage competition for arginine metabolism affect the 
severity of muscle pathology in muscular dystrophy. Hum Mol Genet, 18(3), 482-496. 
doi: 10.1093/hmg/ddn376 
Vindigni, V., Mazzoleni, F., Rossini, K., Fabbian, M., Zanin, M. E., Bassetto, F., & Carraro, U. 
(2004). Reconstruction of ablated rat rectus abdominis by muscle regeneration. Plast 
Reconstr Surg, 114(6), 1509-1515; discussion 1516-1508.  
Wainwright, D. J. (1995). Use of an acellular allograft dermal matrix (AlloDerm) in the 




Walters, B. D., & Stegemann, J. P. (2014). Strategies for directing the structure and function of 
three-dimensional collagen biomaterials across length scales. Acta Biomater, 10(4), 1488-
1501. doi: 10.1016/j.actbio.2013.08.038 
Wang, L., Cao, L., Shansky, J., Wang, Z., Mooney, D., & Vandenburgh, H. (2014). Minimally 
invasive approach to the repair of injured skeletal muscle with a shape-memory scaffold. 
Mol Ther, 22(8), 1441-1449. doi: 10.1038/mt.2014.78 
Ward, C. L., Ji, L., & Corona, B. T. (2015). An Autologous Muscle Tissue Expansion Approach 
for the Treatment of Volumetric Muscle Loss. Biores Open Access, 4(1), 198-208. doi: 
10.1089/biores.2015.0009 
White, J. P., Baltgalvis, K. A., Sato, S., Wilson, L. B., & Carson, J. A. (2009). Effect of 
nandrolone decanoate administration on recovery from bupivacaine-induced muscle 
injury. J Appl Physiol (1985), 107(5), 1420-1430. doi: 10.1152/japplphysiol.00668.2009 
Winkler, J. T., Swaim, S. F., Sartin, E. A., Henderson, R. A., & Welch, J. A. (2002). The effect 
of a porcine-derived small intestinal submucosa product on wounds with exposed bone in 
dogs. Vet Surg, 31(6), 541-551.  
Wolf, M. T., Carruthers, C. A., Dearth, C. L., Crapo, P. M., Huber, A., Burnsed, O. A., . . . 
Badylak, S. F. (2014). Polypropylene surgical mesh coated with extracellular matrix 
mitigates the host foreign body response. J Biomed Mater Res A, 102(1), 234-246. doi: 
10.1002/jbm.a.34671 
Wu, X., Corona, B. T., Chen, X., & Walters, T. J. (2012). A standardized rat model of 
volumetric muscle loss injury for the development of tissue engineering therapies. Biores 
Open Access, 1(6), 280-290. doi: 10.1089/biores.2012.0271 
Yablonka-Reuveni, Z., & Rivera, A. J. (1994). Temporal expression of regulatory and structural 
muscle proteins during myogenesis of satellite cells on isolated adult rat fibers. Dev Biol, 
164(2), 588-603. doi: 10.1006/dbio.1994.1226 
Yang, J., Jao, B., McNally, A. K., & Anderson, J. M. (2014). In vivo quantitative and qualitative 
assessment of foreign body giant cell formation on biomaterials in mice deficient in 
natural killer lymphocyte subsets, mast cells, or the interleukin-4 receptoralpha and in 





Zacks, S. I., & Sheff, M. F. (1982). Age-related impeded regeneration of mouse minced anterior 
tibial muscle. Muscle Nerve, 5(2), 152-161. doi: 10.1002/mus.880050213 
Zalewski, A. A. (1970). Effects of reinnervation on denervated skeletal muscle by axons of 
motor, sensory, and sympathetic neurons. Am J Physiol, 219(6), 1675-1679. doi: 
10.1152/ajplegacy.1970.219.6.1675 
Zammit, P. S., Heslop, L., Hudon, V., Rosenblatt, J. D., Tajbakhsh, S., Buckingham, M. E., . . . 
Partridge, T. A. (2002). Kinetics of myoblast proliferation show that resident satellite 
cells are competent to fully regenerate skeletal muscle fibers. Exp Cell Res, 281(1), 39-
49.  
Zatti, S., Zoso, A., Serena, E., Luni, C., Cimetta, E., & Elvassore, N. (2012). Micropatterning 
topology on soft substrates affects myoblast proliferation and differentiation. Langmuir, 
28(5), 2718-2726. doi: 10.1021/la204776e 
Zhang, F., Lineaweaver, W. C., Ustuner, T., Kao, S. D., Tonken, H. P., Campagna-Pinto, D., & 
Buncke, H. J. (1997). Comparison of muscle mass preservation in denervated muscle and 
transplanted muscle flaps after motor and sensory reinnervation and neurotization. Plast 
Reconstr Surg, 99(3), 803-814.  
Zhenevskaya, R. P. (1962). Experimental histologic investigation of striated muscle tissue. Rev 
Can Biol, 21, 457-470.  
Zhou, H., & Xu, H. H. (2011). The fast release of stem cells from alginate-fibrin microbeads in 
injectable scaffolds for bone tissue engineering. Biomaterials, 32(30), 7503-7513. doi: 
10.1016/j.biomaterials.2011.06.045 
Zou, Y., Zhang, R. Z., Sabatelli, P., Chu, M. L., & Bonnemann, C. G. (2008). Muscle interstitial 
fibroblasts are the main source of collagen VI synthesis in skeletal muscle: implications 
for congenital muscular dystrophy types Ullrich and Bethlem. J Neuropathol Exp Neurol, 








Recovery from Volumetric Muscle Loss Injury: A Comparison 
between Young and Aged Rats 
 
Submitted as an original article by: 
 
John T. Kim1, Benjamin Kasukonis1, Lemuel Brown2, Tyrone Washington2, and Jeffrey C.  
Wolchok PhD1 
 
1 Department of Biomedical Engineering, University of Arkansas, Fayetteville, Arkansas, 72701 
2 Department of Health, Human Performance, and Recreation, College of Education and Health 
Professions, University of Arkansas, Fayetteville, AR, Fayetteville, Arkansas 72701 
 
Corresponding Author: 
Jeffrey C. Wolchok, PhD 
Department of Biomedical Engineering 
University of Arkansas 







 Comparison between young and aged rats to volumetric muscle loss injury (VML). 
 Age does not exacerbate the post-VML functional response. 
 Age affects ECM composition and results in a more fibrotic post-VML environment. 
 
Abstract 
Termed volumetric muscle loss (VML), the bulk loss of skeletal muscle tissue either through 
trauma or surgery overwhelms the capacity for repair, leading to the formation of non-contractile 
scar tissue. The myogenic potential, along with other factors that influence wound repair are 
known to decline with age.  In order to develop effective treatment strategies for VML injuries 
that are effective across a broad range of patient populations, it is necessary to understand how 
the response to VML injury is affected by aging.  Towards this end, this study was conducted to 
compare the response of young and aged animal groups to a lower extremity VML injury.  
Young (3 months, n=12) and aged (18 months, n=8) male Fischer 344 rats underwent surgical 
VML injury of the tibialis anterior muscle. Three months after VML injury it was found that 
young TA muscle was on average 16% heavier than aged muscle when no VML injury was 
performed and 25% heavier when comparing VML treated young and aged animals (p<0.0001, 
p<0.0001).  Peak contractile force for both the young and aged groups was found to decrease 
significantly following VML injury, producing 65% and 59% of the contralateral limbs’ peak 
force, respectively (p<0.0001).  However, there were no differences found for peak contractile 
force based on age, suggesting that VML affects muscle’s ability to repair, regardless of age. In 
this study, we used the ratio of collagen I to MyoD expression as a metric for fibrosis vs. 
myogenesis. Decreasing fiber cross-sectional area with advancing age (p<0.005) coupled with 
the ratio of collagen I to MyoD expression, which increased with age, supports the thought that 




is also exacerbated by the contribution of VML injury, where a 77-fold increase in the ratio of 
collagen I to MyoD was observed in the aged group (p<0.0002). The aged animal model 
described in this study provides a tool for investigators exploring not only the development of 
VML injury strategies but also the effect of aging on muscle regeneration.    
 






Our multidisciplinary team is exploring the development of implantable biomaterials 
targeting the repair of damaged skeletal muscle (Hurd et al., 2015; B. Kasukonis, J. Kim, T. 
Washington, & J. Wolchok, 2016). Towards that end we are particularly interested in 
understanding the response of muscle to volumetric muscle loss injury (Corona et al., 2015; 
Grogan, Hsu, & Skeletal Trauma Research, 2011b). In response to mild injuries like strains and 
contusions, in which the myocytes are damaged but the underlying muscle structure and satellite 
cell population is preserved, muscle has a strong capacity for regeneration (M. Hill et al., 2003; 
Mauro, 1961). Muscle regeneration is characterized by progressive and coordinated 
inflammation, repair, and remodeling phases (Charge & Rudnicki, 2004b; Mann et al., 2011b; 
Turner & Badylak, 2012b).  During the first hours and days after injury, phagocytic neutrophils 
and macrophages are recruited to the wound site to clear the injury of dead cells and necrotic 
tissue during what is termed the inflammatory phase.  Transition from the inflammatory phase to 
the repair phase, is characterized by a shift in the phenotype of the macrophages from the 
inflammatory M1 phenotype, responsible for the digestion of necrotic tissues and promotion of 
satellite cell proliferation, to tissue remodeling M2 macrophages responsible for myoblast 
proliferation, growth and differentiation (Tidball, 2005a; Tidball & Villalta, 2010).  During the 
repair phase, satellite cells proliferate and differentiate into myoblasts that fuse with other 
myoblasts or with existing fibers to form new skeletal muscle (Turner & Badylak, 2012b).  The 
remodeling phase is a continuation of the repair phase where myofibers mature and start to 
adhere to both native and newly remodeled extracellular matrix (ECM). In muscle, the 




the injury (Benoit & Belt, 1970; Nikolaou, Macdonald, Glisson, Seaber, & Garrett, 1987; Warren 
et al., 2007). 
Alternatively, when significant skeletal muscle volume is lost (trauma or surgical 
resection) the regenerative cues provided by the underlying ECM and satellite cell pool is 
missing, and regeneration is poor. Termed volumetric muscle loss (VML), the bulk loss of 
muscle tissue (>20% by mass) overwhelms the capacity for regeneration, leading to the 
formation of non-contractile scar tissue at the defect site and functional impairment for the 
patient (Grogan et al., 2011b; Terada et al., 2001). The poor clinical outcome following VML 
injury combined with a lack of effective treatment options motivates our exploration of VML 
regeneration.  To better understand the sequence of events that follow VML injury and aid in the 
development of effective treatment strategies, various pre-clinical animal models have been 
developed (X. K. Chen & Walters, 2013; Hou, Gong, & Zhu, 2016; Turner et al., 2012; Wu, 
Corona, Chen, & Walters, 2012b; J. Zhang et al., 2016). Among these, the hind limb muscles of 
the rat are a reliable pre-clinical model that recapitulates healing with non-contractile scar tissue 
observed in humans following VML injury (Wu et al., 2012b). In particular, the rat hind limb has 
become a standard model for military research (Aurora et al., 2014; Aurora et al., 2015; Corona, 
Garg, et al., 2013; Corona, Ward, Baker, Walters, & Christ, 2014a). This group of investigators 
is seeking treatments for VML injuries caused by devastating battlefield trauma. With the active 
military population in mind, the response to VML injury has typically been explored in young  
(<50% of the median lifespan = 24 months) rat models. However, in addition to traumatic 
injuries, the surgical removal of muscle as a treatment for soft tissue sarcoma is another 




typically older, and therefore an improved understanding of the response to VML injury in aged 
muscle may provide unique insights that could guide future treatment strategies.  
With increasing age, both animals and humans develop pathological changes to muscle 
tissue which includes decreased muscle volume and increased adipose infiltration which reduces 
muscle strength and can increase the risk of injury (Freemont & Hoyland, 2007). These aged-
associated changes in muscle physiology can act as obstacles to muscle regeneration (Grounds, 
1998a). We suspect that age related changes in muscle physiology might significantly influence 
the response to VML injury. It is well established that muscle resident satellite cells account for 
the majority of skeletal muscle’s regenerative capacity following injury (Conboy & Rando, 
2005).  However, aging leads to an overall decrease in myogenic capacity mostly in part due to 
reduced satellite cell activity (Brack & Rando, 2007b; Conboy & Rando, 2005; Snow, 1977). 
Specifically, it appears there is an age-related loss in satellite cell functionality, possibly 
indicating that the “aging” of the satellite cells renders them less responsive to regenerative cues 
(Brack & Rando, 2007a; Charge & Rudnicki, 2004b; Gopinath & Rando, 2008b).  In addition, a 
decreased responsiveness to the stimuli needed to induce activation and proliferation of satellite 
cells has been observed with aging (Brack et al., 2007a; Gopinath & Rando, 2008b; Kuang et al., 
2008; Vinciguerra, Musaro, & and Rosenthal, 2010).  When taken as a whole, the literature 
supports the conclusion that aging diminishes the regenerative capacity of muscle. 
While aging associated changes in muscle regeneration are known to exist, the effects of 
aging on VML recovery has yet to be explored to our knowledge.  With that gap in mind, an 
aged animal model of VML injury was developed to investigate and compare the regenerative 
response following VML injury of the hind limb tibialis anterior (TA) muscle. Two populations 




representative of adolescent (25% of mean lifespan) and early elderly (75% of mean lifespan) rat 
lifespans. In order to assess the response to injury; muscle strength, mass, histology, and gene 
expression profiles were measured for both aged and young animals three-months post VML 
injury, a commonly explored VML recovery time point (Aurora et al., 2015; Corona, Garg, et al., 
2013; Corona et al., 2014b; Merritt, Cannon, et al., 2010b; Wu et al., 2012b).  Overall, the study 
was designed to compare the response between the two age groups and test the hypothesis that 
aged animals recover differently from VML injury when compared to young animals as might be 
evidenced by differences in myogenesis, contractile force, muscle atrophy, and tissue fibrosis.  
Somewhat similar to VML in terms of functional outcomes, crush injuries result in similar 
functional deficits in the muscle or in severe cases, complete amputation of the limb due to 
inflammation, tissue swelling and necrosis, a condition known as acute compartment syndrome 
(ACS) (Via, Oliva, Spoliti, & Maffulli, 2015).  Although this may seem a worthwhile issue to 
address, the effects of surgical VML don’t lead to other myopathies and conditions as ACS does.  
Additionally, due to high mortality rates associated with ACS (Schwartz et al., 1989), it would 
not be guaranteed that all animals used in the study would survive to the end of the study.   
  The results generated by this study not only provide some of the first insights into 
recovery from VML injury in aged muscle, but also provide baseline recovery measures from 






Volumetric Muscle Loss Injury 
 In vivo VML injury studies were performed with young (3 month) and aged (18 months) 
male Fisher 3 44 rats.  All contralateral limbs to the VML injured limb served as internal controls 
for comparison and are denoted as the normal groups in the study. The young rats (n=12) were 
purchased commercially from Harlan Laboratories (Indianapolis, IN) and the aged rats (n=8) 
were obtained through the National Institute on Aging (Bethesda, MD). Surgical procedures and 
implant preparation methods were performed in accordance with protocols approved by the 
University of Arkansas IACUC (Protocol #14044) and guided by published methods (Wu et al., 
2012b).  Anesthesia was induced using isoflurane (1-3%) in oxygen. The implant site was 
surgically exposed through a 1-2 cm incision running parallel to the tibia. The TA was identified 
and a partial thickness VML defect (8mm diameter x 3mm deep) was created using a sterile 
biopsy punch (Figure 1). Data that was previously collected correlated animal body weight to 
TA mass for each animal group (Figure 2).  From this relationship, the percentage of total TA 
mass excised during surgery was calculated for each animal, to help insure consistent defect 
creation across all animals.  The average size of the VML defect was 18.7±0.6% and 19.5±0.6% 
for the young and aged animal groups respectively (Corona et al., 2014a). The difference in 
defect size between groups was not statistically significant (p=0.36). The contralateral limb was 
left untreated to serve as an internal comparative control. The deeper periosteum and surface skin 
layers were separately closed using an interrupted stich with a 5-0 absorbable suture (Vicryl, 
Ethicon, Summerville, MA). Postoperative analgesia consisted of 0.1mg/kg buprenorphine 
administered subcutaneously via injection (neck scruff) twice daily for two days. Animals also 




ClearH2O, Westbrook, ME) added as needed to each cage out to 7 days. Following surgery, 
animals were housed in standard-sized rat cages with unrestricted movement. The animals were 
allowed to bear weight on the operative extremity as tolerated. All animals were housed for a 12-
week recovery period. 
 
In-situ Contractile Force Measurement 
Peak tetanic contraction produced by the TA muscle of both young (n=12) and aged (n=8) 
rats were measured isometrically in vivo using similar procedures previously described18.  After 
rats were anesthetized (2-2.5% isoflurane), the left hindlimb was prepared for measurement. To 
eliminate force contributions from the synergist muscle, distal tenotomies were performed on the 
extensor digitorum longus (EDL) and extensor halluces longus (EHL). The knee was stabilized 
in place using a custom mounting system and the knee and ankle were positioned at a right angle. 
The foot was attached to a foot-plate with surgical tape, which was attached to the shaft of a 
servomotor (Aurora Scientific, Inc., Mod. 305b) and was in turn controlled by a computer.  
Percutaneous needle electrodes were inserted into the anterior compartment of the TA to 
stimulate the peroneal nerve.  Optimal voltage (2 – 5 V) was determined using a series of tetanic 
contractions (150Hz, 0.1 ms pulse width, 400 ms train). Average peak tetanic force for each 
animal was calculated from the average of 5 contractions. To minimize muscle fatigue, 1-minute 
rest periods were taken between contraction cycles. Commercial muscle physiology software 
(Aurora Scientific, Inc., Ontario, Canada) was used to collect contractile force versus time data. 
At the conclusion of electrophysiological testing, all animals were euthanized through carbon 
dioxide inhalation in accordance with guidelines provided by the 2013 AVMA Panel on 




Tissue Histology and Image Analysis 
VML treated TA muscles along with contralateral untreated TA muscles were harvested 
from young (n=12) and aged (n=8) and trimmed to remove fascia and tendon, then weighed. 
EDL muscles were also collected and weighed for comparison between groups. Muscles were 
rinsed in sterile PBS, dabbed dry, and then weighed. Harvested muscles were flash frozen in 
liquid nitrogen, and stored at -80°C for histological analysis. Tissue cross-sections were obtained 
with the aid of a cryostat (Leica BioSystems) and maintained at a temperature between -25 to -
20°C and thickness of 7 µm. Cross-sectional slices were taken from the top third of the TA 
muscle, the region where the surgical VML injury was created. Prior to immunostaining, slides 
were permeabilized in 0.1% 10X Triton then rinsed in phosphate-buffered solution (PBS, pH 
7.4). Slides were then blocked in PBS containing 4% goat serum and 0.05% sodium azide for 1h 
at room temperature prior to incubation in primary antibodies including mouse-anti-collagen I 
IgG (1:500, Sigma Aldrich), rabbit polyclonal anti-collagen III (1:1000, Abcam), and mouse-
anti-myosin IgG2B (MF-20, 1:10, Developmental Studies Hybridoma Bank, Iowa City, IA) for 4h 
at 4°C. Following PBS washes, slides were incubated in the appropriate corresponding Alexa 
Fluor 488 and 596 (1:500, Life Technologies) labeled secondary antibodies for 30 minutes at 
room temperature. Additional tissue sections were stained using commercially available 
Hematoxylin and Eosin (H&E) and Masson’s Trichrome staining kits following manufacturers’ 
guidelines (Sigma). All sections were mounted onto microscope slides and digitally imaged. 
Treated sections were evaluated for myofiber average cross-sectional area, formation, and 
organization as well as the formation and extent of VML site repair tissue for comparison to 




Collagen type I and III accumulation, a potential indicator of diffuse muscle fibrosis, in 
tissue regions away from the VML defect area was estimated using measures of collagen I 
(Sigma Aldrich, St. Louis, MO) and collagen III (Abcam, Cambridge, MA) immunoreactivity 
and guided by published methods (Bedair et al., 2007). Tissue immunoreactivity to collagen I 
was calculated from fluorescent microscopic images (200X) using image analysis software 
(Image J, NIH). All images were converted to 8-bit, gray scale, and uniformly thresholded across 
all samples to isolate collagen type I and III positive tissue regions. From these images the 
percent collagen type I and III positive tissue area was calculated for all tissue sections. Similar 
image analysis methods were used to compute muscle fiber cross-sectional area from magnified 
(200X) images. Images were converted to gray scale and thresholded to isolate individual muscle 
fibers. Fiber cross sectional area (um2) for all fibers within an individual image (typically 50+ 
fibers) were calculated. Representative tissue sections collected from four animals per group 
were used for all calculations. Within each section, three separate regions were imaged and 
analyzed to calculate the average collagen type I and III percent area as well as average fiber 
cross-sectional area for each sample. A total of twelve images were analyzed for each treatment 
group.  All image analysis was performed using a protocol with set parameters to process each 






Real-time PCR was performed using the protocol reported by Washington et al 
(Washington et al., 2013).  In preparation for RT-PCR, samples of muscle from the defect site of 
the right and left TA (n=4 animals/experimental group) were homogenized with Trizol (Ambion, 
Carlsbad, CA)/choloroform (Sigma Aldrich, St. Louis, MO). Samples were treated with DNase 
(Invitrogen, Carlsbad, CA) and then RNA was extracted using an RNAeasy kit (Invitrogen, 
Carlsbad, CA). After quantification of RNA with a plate reader (BioTek, Winooski, VT), RNA 
was converted to cDNA with a kit (Invitrogen, Carlsbad, CA). TAQMAN primers (Invitrogen, 
Carlsbad, CA) for MyoD, Collagen I, Collagen III, ratios of Collagen I to MyoD and Collaen I to 
Collagen III, and 18S rRNA housekeeping were used to quantify the expression of desired genes. 
Experimental sample group expressions were normalized to 18S rRNA and then referenced to 
the contralateral normal limb. Gene expression levels are reported as fold change using the 2-
(ΔΔCt) method. 
Data Analysis 
 All data is presented as the mean ± standard error and was tested for normality using the 
Shapiro-Wilks Test.  In addition, the data is also presented as mean ± standard deviation for 
reference in Table 1. The key outcome measures, muscle mass, peak tetanic force, percent 
collagen I / III areas, fiber cross-sectional area, and gene expression fold changes were analyzed 
with two-way ANOVA. Post hoc comparison testing was performed using Tukey’s HSD test. 
All statistical analyses were performed using commercial statistical analysis software (JMP 11 
Pro). Animal growth and defect size comparisons were made using a two-sided Students t-test. A 





C. Results  
Animal Body Weight 
 Both aged and young animals tolerated the surgery well and there were no signs of post-
surgical infection. At one week post-implantation, all animals were fully ambulatory with no 
noticeable gait differences between groups. At the end of the study period, the young animals 
increased in mass by an average of 36% (312±3 vs. 424±7 g, p<0.0001) whereas the aged 
animals showed no significant change in body weight (Figure 3).  Also, by the end of the 12-
week study period the difference in average mass between the aged and young groups had 
narrowed to 3%. The difference in mass between young and aged animals at the end of the study 
period was not statistically significant (p=0.38). Over the study period, the young animals put on 
mass at a growth rate of 9.3±0.4 g/week while the aged animals lost mass at a negative growth 
rate of 2.3±0.9 g/week. Age (young vs. old) was shown to have a statistically significant effect 
on animal growth rate (p<0.05).  
 
TA Peak Tetanic Contractile Force 
 Tetanic contraction plots for all muscles were characterized by a sharp rise in force, 
followed by a plateau at the peak force, and then a return to a no force resting state (Figure 4). 
There was a main effect of treatment with VML injury to decrease peak contractile force, 
regardless of age (p<0.0001).  Based on age, peak contractile force showed a decreasing trend 
moving from the young to the aged group (p=0.08).  The young and aged VML groups produced 
65% (2.16±0.07 N/kg vs. 1.39±0.11 N/kg, p<0.0001) and 59% (2.02±0.05 N/kg vs 1.19±0.12 
N/kg, p<0.0001) of their respective contralateral normal muscles in response to VML injury 




TA and EDL Muscle Mass 
Upon gross examination the defect site was visible on TA muscle samples collected from 
both young and aged VML treated animals. Morphologically, there is a drastic difference in 
overall muscle appearance and size following VML injury (Figure 5). EDL muscles were not 
surgically disrupted during the TA VML defect treatment. Superficially, the EDL muscles 
associated with both the normal and VML treated TA muscles appeared normal, with the VML 
side EDL appearing slightly larger in size than the normal EDL. However, treated muscles were 
noticeably larger in size.  There was a main effect of age and treatment to decrease TA muscle 
mass normalized to body weight, but no interaction effect was observed (p<0.0001, p<0.0001, 
Figure 5). Based on age, the young normal group compared to the aged normal group exhibited 
a 16% increase in normalized TA weight (1.61±0.04 mg/g vs. 1.37±0.05 mg/g, p<0.0001).  A 
similar response to age was exhibited by the young VML group compared to the aged VML 
group with a 25% increase in normalized TA weight (1.27±0.02 mg/g vs. 0.99±0.02 mg/g, 
p<0.0001). In response to treatment within the young group, young normal TA mass was on 
average 24% heavier than young VML TA muscle (1.61±0.04 mg/g vs. 1.27±0.04 mg/g, 
p<0.0001, Figure 5). Similarly, within the aged group, aged normal TA mass on average was 
32% heavier than aged VML TA muscle (1.37±0.05 mg/g vs 0.99±0.02 mg/g, p<0.0001, Figure 
5).  
Interestingly for the normalized EDL weights, the main effect of age decreased EDL 
mass whereas treatment was found to have an effect to increase EDL mass (p<0.0001 and 
p<0.008, respectively). However, an interaction effect was not observed. Based on age, the aged 
normal group compared to the young normal group exhibited a 25% decrease in normalized EDL 




compared to the young VML group exhibited a 20% decrease in normalized EDL weight 
(0.43±0.01 mg/g vs. 0.35±0.02 mg/g, p<0.0001). Within the young group, there was an increase 
of 7% in EDL mass in response to VML injury (0.4±0.01 mg/g vs. 0.43±0.01 mg/g, p<0.008).  
Similarly, within the aged group in response to VML injury, there was an increase of 12% in 
EDL weight (0.31±0.02 mg/g vs. 0.35±0.02 mg/g, p<0.008).  
 
VML Site Histology 
 Normal TA muscle histology for both young and aged groups (Figure 6A/B, E/F) was 
characterized by ordered circular bundles of MHC positive myofibers surrounded by collagen 
positive perimysium extending completely out to the anterior surface of the muscle.  Twelve-
weeks following VML injury, tissue sections prepared from young animals were characterized 
by collagen-dense repair layer located at the muscle surface. For the young VML muscles, MHC 
positive muscle fibers were observed up to the border of the repair layer, but did not extend into 
the repair tissue itself (Figure 6C,D). A similar distinct layer of collagen enriched repair tissue 
was not typically observed within the aged animal groups. Aged animal sections prepared from 
VML site tissue samples were frequently characterized by a region of diffuse collagen I 
deposition, as well as an overall appearance indicating increased MHC positive myofibers 
disorganization in the repair region (Figure 6G,H). While MHC positive muscle fibers were 
present they were generally less closely packed than in normal TA muscle sections. 
 
Collagen Percent Area and Fiber Cross-sectional Area  
 Percent area positively stained for collagen I and III provided a quantitative measure of 




changes in percent area stained for collagen I between young normal and VML muscles 
(7.6±1.6% vs. 8.3±1.0%, Figure 7C).  Similarly, aged normal and VML treated muscles showed 
no changes in percent collagen I area (6.0±1.3% vs. 8.3±0.9%).  
There was a main effect of VML injury to decrease collagen III percent area in the young 
group and increase in the aged group (p=0.011, Figure 7D). Collagen III area decreased by 13% 
(19.2%±0.2% and 16.8%±1.6%) for the young normal group compared to the young VML 
group. Collagen III percent area increased by 10% (20.8%±1.6% and 23%±3.0%) in the aged 
VML group compared to the aged normal group. 
Similarly, age had a significant effect to decrease average TA fiber cross-sectional area 
(p=0.0365, Figure 8C). Average cross-sectional area decreased by 17% (2299±154 µm2 and 
1926±122 µm2) for the aged normal group compared to the young normal group. For the aged 
VML group compared to the young VML group, fiber cross-sectional area decreased by 28% 
(2123±100 µm2 and 1585±318 µm2).   
 
Gene Expression 
 There was a main effect of VML injury to decrease MyoD gene expression regardless of 
age in rat TA muscle (p=0.0231, Figure 9A). There was approximately a 13-fold decrease 
(1±0.58 and 0.08±0.04) in MyoD expression for the young VML group compared to the young 
normal group (Figure 9A).  Comparing the aged VML group to the aged normal group, there 
was a 10-fold decrease in MyoD expression (1±0.21 vs. 0.1±0.03).  For collagen I an interaction 
effect of age and VML injury was found to increase collagen I expression (p<0.003, Figure 9B).  
There were no differences found in collagen I expression within the young group, however, 




expression was found (p<0.0009) exhibiting a treatment effect. Between the young VML  
(1.55±0.14) and aged VML (14±4) groups, a 9-fold increase in collagen I expression in the aged 
VML group compared to the young VML group was observed (p<0.0014, Figure 9B). 
Regarding collagen III gene expression, there was an interaction effect of age and VML injury 
on expression levels (p=0.0164, Figure 9C). Post-hoc comparison revealed that the young VML 
group responded with a 2-fold increase in collagen III expression over the young normal group 
to VML injury (1±0.14 vs. 2.14±0.25, p=0.034). While not exhibiting significance for VML 
injury within the aged group, the aged VML group exhibited a significantly lower response 
compared to the young VML group with a 3.5-fold decrease in collagen III expression 
(2.14±0.25 vs. 0.61±0. 26, p=0.013, Figure 9C).  
 There was an interaction effect of age and treatment on the ratio of collagen I to MyoD 
(p<0.011). Post-hoc comparison revealed that the aged VML group responded with a 77-fold 
increase in the collagen I to MyoD ratio over the aged normal group to VML injury (0.95±0.25 
vs 74.5±18.8, p<0.0002, Figure 9D).  While not exhibiting significant differences for VML 
injury, the young group did exhibit significantly lower ratios of collagen I to MyoD compared to 
the aged VML group. Compared to the young VML group, the aged VML group exhibited a 2-
fold increase in collagen I to MyoD ratio over the young VML group exhibiting an age effect 
(32.9±10.5 vs. 74.5±18.8, p=0.0241, Figure 9D).   
Similarly, there was an interaction effect of age and VML injury on the ratio of collagen I 
to collagen III gene expression. Post-hoc comparison revealed that the aged VML group 
responded with an 8-fold increase in the collagen I to collagen III ratio over the aged normal 
group to VML injury (3.33±2.18 vs 27.8±5.21, p<0.0001, Figure 9E).  While not exhibiting 




collagen I to collagen III compared to the aged VML group. Compared to the young VML group, 
the aged VML group exhibited a 38-fold increase in collagen I to collagen III ratio over the 
young VML group exhibiting an age effect (0.736±0.044 vs. 27.8±5.2, p<0.0001, Figure 9D). 
 
D. Discussion 
Extracellular matrix (ECM) remodeling is a critical aspect of successful resolution of the 
regenerative response in skeletal muscle. Skeletal muscle has a robust capacity to recover from 
injury in which there is not a significant loss of muscle mass. However, when there is traumatic 
muscle injury and more than 20% of the muscle is lost (VML), the regenerative process will not 
resolve and there will be a functional deficit (Corona et al., 2015; Garg, Corona, & Walters, 
2014; Grasman, Zayas, Page, & Pins, 2015; Grogan et al., 2011b).  Indicative of such injuries, it 
is expected for there to be nerve damage or even complete denervation of the muscle.  
Interestingly, even with temporary denervation of the muscle, it has been reported that muscle 
virtually recovers completely given that reinnervation is allowed to proceed unhindered (Lowrie, 
Krishnan, & Vrbova, 1982).  However, even if innervation is preserved, unless there is 
transmission from the nerve to the muscle, degenerative changes have been observed in the 
muscle (Drachman, 1974; Gordon, Perry, Tuffery, & Vrbova, 1974).  Though VML itself has 
been investigated, the response to VML in the aged population has yet to be explored. To our 
knowledge this is the first study to investigate how aging modulates the response to VML. The 
current study reports that aging muscle modifies the ECM response post-VML.  The current 
study reports that the ECM response post-VML is modified in muscle from aged rats. It is of 
vital importance to understand how aged muscle response to VML so effective tissue 
engineering treatment strategies can be developed for this population to aid in skeletal muscle 




  Sarcopenia is associated with decreased muscle mass and force deficits (Blough & 
Linderman, 2000; Carson, Lee, McClung, & Hand, 2002; Washington, Healey, Thompson, 
Lowe, & Carson, 2014). Our data is consistent with the literature in that we demonstrate an aged-
dependent decrease in muscle mass in both the TA and the EDL. Additionally we demonstrate a 
trend for an age-dependent decrease in peak tetanic force. VML is associated with incomplete 
skeletal muscle regeneration. We are the first to demonstrate how aging affects skeletal muscle 
post-VML. 3 months post-VML skeletal muscle mass had only returned to 75% of the 
contralateral control limb regardless of age.  Additionally, muscle force only returned to 
approximately 60% of the contralateral control limb 3 months post-VML in young and aged rats.  
Taken together, the similar muscle mass loss and force deficit between young and aged rats, 
suggests age does not exacerbate the post-VML functional response.   
Skeletal muscle regeneration is a complex process that is characterized by inflammation, 
ECM remodeling, and myofiber growth (L. A. Brown et al., 2015; Washington et al., 2011). 
Impairments to any one of these processes can lead to incomplete skeletal muscle regeneration 
(Washington et al., 2011). The ECM plays an important role during skeletal muscle regeneration 
and acts as a functional link between skeletal muscle and bone. In skeletal muscle, the ECM is 
composed primarily of collagen I and collagen III (Kovanen, 2002). Previous research has 
demonstrated that 28 days post-VML there is a larger induction of collagen III compared to 
collagen I gene expression in young rats (Garg, Corona, et al., 2014). Our data is in agreement 
with this observation. We demonstrate an increase in collagen III gene expression with no 
change in collagen I gene expression 3 months post-VML. However, muscle from aged rats had 
a different response to VML. In muscle from aged rats, there was an increase in collagen I gene 




expression of collagen I gene expression may contribute to the impaired regenerative response 
associated with aged muscle. The mdx mouse is a model for Duchenne muscular dystrophy 
(DMD). DMD is a degenerative muscular disease associated with accumulation of ECM material 
(Fadic, 2005). It has been demonstrated that collagen I is elevated during the lifespan in this 
animal (McDonald, Hebert, Kunz, Ralles, & McLoon, 2015). Collagen I inhibits muscular 
regeneration and supports the production of more collagen (Alexakis, Partridge, & Bou-Gharios, 
2007). It has been demonstrated that type I collagen inhibits differentiation of C2C12 myoblasts 
(Alexakis et al., 2007). Differentiation of C2C12 myoblasts and myotubes is associated with a 
reduction in transcription of collagen I mRNA (Alexakis et al., 2007). The increased collagen I 
gene expression in aged muscle post-VML could negatively affect the ability of myoblasts to 
proliferate and differentiate and contribute to regeneration of aged skeletal muscle.  
 There was a difference in gene expression and protein expression, as determined by 
immunofluorescence, of collagen I and III post-VML. The collagen constitutive rate of synthesis 
is very low due to the long half-life (45-70 days) (Rucklidge, Milne, McGaw, Milne, & Robins, 
1992). Therefore, changes in gene expression are a more accurate representation of the acute 
effects of VML. Collagen I and collagen III are produced from 1-2 different genes and coalesce 
into a triple-helix pro-collagen molecule. Further processing is done leading to the mature 
collagen molecule. Collagen is degraded by a family of enzymes referred to as matrix 
metalloproteinases (MMPs). There is evidence that muscle MMP expression differs as a function 
of age (Dennis et al., 2008; Robert et al., 1997; Sharples et al., 2012). Therefore, several factors 
can regulate collagen expression post-transcriptionally and explain the discrepancy between gene 




 In order to employ quantitative measures to assess myogenic capability and fibrosis, we 
calculated two ratios: the ratios of collagen I to MyoD and collagen I to collagen III expression. 
Due to MyoD’s role in regulating muscle differentiation and myogenesis, exploring the 
proportion of a pro-regenerative marker to a fibrotic marker such as collagen I can assist in 
assessing the degree of regeneration. Satellite cells/myoblasts are critical to optimal skeletal 
muscle regeneration. Upon activation satellite cells proliferate and differentiate into myoblasts 
and begin expressing myoD (Hawke & Garry, 2001). In aged animals, satellite cell number as 
well as activation and proliferation are depressed (Barani, Durieux, Sabido, & Freyssenet, 2003; 
Kadi, Charifi, Denis, & Lexell, 2004). This would reduce the inherent regenerative capacity of 
aged skeletal muscle. VML was associated with an increase in the Collagen I to MyoD ratio 
regardless of age. However, there was a much larger increase in this ratio in the aged VML 
group. The increase is suggestive of a switch from myogenesis to fibrosis. There are numerous 
studies that demonstrate increased collagen deposition and fibrosis following VML with limited 
skeletal muscle regeneration (Corona et al., 2014a; Corona, Wu, et al., 2013; VanDusen, 
Syverud, Williams, Lee, & Larkin, 2014).  In addition, increased intermuscular adipose tissue 
(IMAT) has been found to be related to decreased whole body glucose metabolism, particularly 
in individuals who have experienced an injury resulting in loss of muscle function (Addison, 
Marcus, Lastayo, & Ryan, 2014). However, the larger induction in the aged group suggests a 
more of an accelerated and more robust fibrotic response.  
 The ratio of collagen I to collagen III gene expression can provide insight in post-VML 
ECM composition changes. As skeletal muscle regeneration involves the migration of satellite 
cells and inflammatory cells through the ECM to the site of injury, the composition of the ECM 




an impaired ability of satellite cells to migrate into the VML site (Aurora et al., 2014). Collagen I 
is a triple helix that polymerizes into fibrils that are stabilized by covalent cross-links 
contributing to its high tensile strength. Collagen III forms a looser network and is ideal for 
maintaining structural integrity and distensibility of the collagen network. Higher ratios of 
collagen I to collagen III is indicative of a stiffer scar region due to the mechanical properties of 
collagen I whereas a lower ratio could mean greater flexibility and a greater tensility during 
recovery leading to a more well-defined tissue reformation. 3 months post-VML, muscle from 
aged rats had an increased collagen I to collagen III ratio whereas in young rats there was no 
difference. This increased ratio has been demonstrated in skin from aged individuals (Goldspink, 
Fernandes, Williams, & Wells, 1994). Due to the long half-life of collagen molecules (45-70 
days) this sustained response 3 months post-VML could lead to an altered collagen I and 
collagen III protein expression at a later time point. This would suggest an altered ECM 
composition that could ultimately affect the regenerative capacity of skeletal muscle. Aged tissue 
is associated with accumulation of advanced glycation end products (AGEs) and their receptors 
(RAGEs) (Odetti et al., 1998). AGEs have been demonstrated to induce expression of collagen I 
and inhibit collagen III expression (Tang et al., 2008). AGEs and RAGE signaling have been 
implicated in chronic inflammation which is a characteristic associated with aging (Chuah, Basir, 
Talib, Tie, & Nordin, 2013; Goto et al., 2004; Kislinger et al., 2001). Taken together, AGEs and 
chronic inflammation could alter the muscle microenvironment and contribute to the altered 
collagen III to collagen I ratio observed post-VML in aging skeletal muscle. As the functional 
outcome was similar between young and aged rats, the altered ECM response has implications 
for treatment strategies. This data implies treatment strategies in a young animal may not be 





In summary, this study is the first to describe the response to VML in muscle from aged 
rats. By characterizing and understanding the responses to VML by both young and aged muscle, 
various VML injury strategies can target areas that have a direct impact on myogenesis. With the 
age range of the young and aged rats being equivalent to the human age range of 9-18 years old 
and 54-63 years old, our aged model is effective in discriminating young vs aged responses to 
VML (Andreollo, Santos, Araujo, & Lopes, 2012). We clearly demonstrate an altered response 
to VML between young and aged rats. The aged rats had a much different ECM response as 
compared to the young rats. This would suggest that tissue engineering strategies aimed at 
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Figure 1.  Surgical VMLs are gross defect creations in the left TA muscle of the rat. Surgical site 
was cleaned and disinfected prior to a vertical incision that was made to expose underlying 
muscle (A). An 8mm biopsy punch was used to create a defect to a depth of 2mm and the 
amount of muscle removed is approximately equivalent to 20% of the TA weight (B). Surgical 
defects were created in the rat left hindlimb and the contralateral limbs were untouched, serving 
as internal controls. The surgical site was then sutured with 5-0 absorbable sutures (C).  
 
Figure 2.  Correlation of animal weight and TA weight. (A) Aged animal (n=8) terminal weight 
vs TA weight. (B) Young animal (n=12) terminal weight vs TA weight.  Linear regression 
analysis performed for all cases provided information to approximate TA weight given animal 
weight. From the TA weight, the size of the defect (20% of TA weight) can be determined. 
 
Figure 3.  Young and aged Fisher 344 rat weight (g) prior to surgery and at the end of the study 
period. The younger animals experienced significant weight gain post-surgery, whereas the aged 
animals lost weight. Values are mean+SEM. * represents p<0.05 Student’s t-test for the young 
group. 
 
Figure 4.  Peak tetanic force measurements of Young and Aged rats via electrophysiology. (A) 
Percutaneous needle electrodes were placed in the anterior compartment of the TA to stimulate 
the peroneal nerve. The knee was stabilized and the foot was attached to a muscle lever system 
for isometric measurements. (B) In order to account for normal growth over the 3-month period 
post-surgery, contractile force measurements were normalized to body weight (N/kg). The 
contralateral normal limbs for both age groups yielded similar values as well as showing a 
similar decrease in force production after VML injury. Values are mean+SEM. * represents 
p<0.05 two-way ANOVA for normal vs VML injury.  
 
Figure 5. Comparison of TA and EDL muscle weight between normal and VML injury groups 
between Young (n=12) and Aged (n=8) rats. Gross morphological images of young normal (A), 
young VML (B), aged normal (C), and aged VML (D) TA muscles.  At the end of the 3 month 
study period, terminal weights for TA (E) and EDL (F) of both young and aged normal and VML 
groups were measured. Values are mean+SEM.  # represents p<0.05 two-way ANOVA for 
young vs aged. * represents p<0.05 two-way ANOVA for normal vs VML injury.  
 
Figure 6. Comparison of histological cross-sections of young normal (A, B) and VML (C, D), 
aged normal (E, F) and VML (G, H) TA muscles.  The inset depicting the TA shows from where 
the histological cross-sections were taken. Masson’s trichrome stained sections imaged at 100X 
magnification (A, C, E, G) depict collagen in blue/purple colored regions whereas muscle is 




at 100X magnification (B, D, F, H).  * indicates the collagen I rich scar region in the young 
muscles treated with VML (D).  ** indicates the VML region for the aged group which is 
characterized by diffuse collagen I deposition and disorganized myofiber bundles compared to 
the young VML group (H).  Masson’s trichrome was stained using a commercially available kit. 
Primary antibodies used were anti-collagen I mouse IgG (1:500) and anti-myosin mouse IgG2B 
(1:10). Secondary antibodies used were goat anti-mouse IgG (H+L) Alexa Fluor 488 and goat 
anti-mouse IgG2B Alexa Fluor 594. 
 
Figure 7.  Representative TA cross-sections immunostained for Collagen I (A, green) and 
Collagen III (B, red). Stained images were then analyzed in ImageJ software to calculate % area 
of the stains as a function of cross-sectional area.  No difference was found for collagen I area 
(C) but a decrease in collagen III area was found for the young group after VML injury (D).  On 
the contrary, the aged group had an increase in collagen III following VML.  Primary antibody 
stains used were anti-collagen I mouse IgG (1:500) and anti-collagen III rabbit polyclonal 
(1:500). Secondary antibody stains used were goat anti-mouse IgG (H+L) Alexa Fluor 488 and 
goat anti-rabbit IgG (H+L) Alexa Fluor 594. * represents p<0.05 two-way ANOVA for normal 
vs VML injury.    
 
Figure 8. Rat TA muscle cross-sections of young (A) and aged (B) rats stained with H&E and 
imaged at 200X magnification. Average fiber cross-sectional areas were calculated using ImageJ 
software for young normal, young VML, aged normal, and aged VML groups (n=3, C). It was 
observed that fiber cross-sectional area decreases significantly with age, regardless of VML 
injury.  # represents p<0.05 two-way ANOVA for young vs aged.  
 
Figure 9.  Normal gene expression compared to expression in response to VML.  Expression of 
MyoD (A), Collagen I (B), Collagen III (C), ratio of Collagen I to MyoD (D), and ratio of 
Collagen I to Collagen III (E) are presented as fold-changes obtained using RT-PCR.  Except for 
MyoD, which experienced only a treatment effect, interaction effects of age and treatment were 
found for all other genes/ratios tested.  Values are mean+SEM. * represents p<0.05 two-way 
ANOVA for normal vs VML injury and # represents p<0.05 two-way ANOVA for young vs 
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In this study, the influence of age on effectiveness of regenerative repair for the treatment of 
volumetric muscle loss (VML) injury was explored. Tibialis anterior (TA) VML injuries were 
repaired in both 3-month and 18-month aged animal models (Fischer 344 rat) using allogeneic 
decellularized skeletal muscle (DSM) scaffolds supplemented with autologous minced muscle 
paste (MM). Within the 3-month animal group, TA peak contractile force was significantly 
improved (79% of normal) in response to DSM+MM repair. However, within the 18-month 
animal group, muscle force following repair (57% of normal) was not significantly different 
from unrepaired VML controls (59% of normal). Within the 3-month animal group, repair with 
DSM+MM generally reduced scarring at the site of VML repair, whereas scarring and a loss of 
contractile tissue was notable at the site of repair within the 18-month group. Within 3-month 
animals, expression of myogenic genes (MyoD, MyoG), ECM genes (Col I, Col III, TGF-ß), and 
key wound healing genes (TNF-α and IL-1ß) were increased. Alternatively, expression was 
unchanged across all genes examined within the 18-month animal group. The findings suggest 
that a decline in regenerative capacity and increased fibrosis with age may present an obstacle to 
regenerative medicine strategies targeting VML injury. 
 






This study compared the recovery following VML injury repair using a combination of minced 
muscle paste and decellularized muscle ECM carrier in both a younger (3 months) and older (18 
months) rat population. Currently, VML repair research is being conducted with the young 
patient population in mind but our group is the first to look at the effects of age on the efficacy of 
VML repair. Our findings highlight the importance of considering age-related changes in 






 Volumetric muscle loss (VML) injury is commonly characterized as the bulk loss (>20%) 
of muscle tissue resulting in incomplete or aberrant muscle regeneration. Current soft tissue 
repair techniques and traditional rehabilitation have not been able to reverse the pathological 
changes that occur following VML injury. To reverse the pathobiology of VML injury, the use 
of regenerative medicine strategies to recapitulate the cellular and structural cues during 
regeneration have shown efficacy in animal models (Corona, Henderson, Ward, & Greising, 
2017; Corona, Wu, et al., 2013; J. Dziki et al., 2016; Garg, Ward, et al., 2014; Goldman & 
Corona, 2017; Goldman, Henderson, Walters, & Corona, 2018; Li, Willett, Uhrig, Guldberg, & 
Warren, 2014; Nakayama et al., 2018). Among these strategies, our group has demonstrated that 
the implantation of a decellularized skeletal muscle scaffold (DSM) co-delivered with a minced 
muscle (MM) autograft paste is capable of recovering half of the contractile force lost to VML 
injury (B. Kasukonis, J. Kim, L. Brown, et al., 2016).  Other groups have shown similar 
improvements in muscle recovery using various combinations of scaffolds with and without 
myogenic cell sources (Corona et al., 2012; Corona et al., 2014b; Dziki, Sicari, Wolf, Cramer, & 
Badylak, 2016; Merritt, Cannon, et al., 2010a; Valentin et al., 2010). When taken as a whole, our 
findings and others suggest that the use of regenerative medicine may have therapeutic potential 
as a treatment for VML injury. 
 The examination of regenerative medicine strategies for VML repair has been limited 
thus far to young animal models (Gilbert-Honick, Ginn, et al., 2018; Goldman et al., 2018; 
Nakayama et al., 2018; Quarta et al., 2017). It remains unclear whether the VML findings 
observed in these animal models will be predictive of clinical performance in the elderly. It is 




of any VML treatment. Specifically, the decrease in myogenic capacity that occurs with age 
could present a significant hurdle to muscle regeneration in an older patient population (Conboy 
& Rando, 2005; Domingues-Faria, Vasson, Goncalves-Mendes, Boirie, & Walrand, 2016). 
Traditionally, battlefield injuries to the extremities have been the primary clinical target 
motivating the development of VML repair strategies (Mase et al., 2010; B. D. Owens et al., 
2008; J. G. Owens et al., 2011). Regarding civilian trauma, VML injuries are not as well-
documented or tracked due to the lack of a standard therapy (Corona, Wenke, & Ward, 2016). 
Despite this fact, there are approximately 150,000 documented cases of open fractures (type III 
open fracture) each year in the United States, with the majority of cases associated with the 
concomitant loss of the surrounding soft tissues (Court-Brown & McBirnie, 1995). Moreover, 
there is likely a high proportion of the VML-afflicted patient population (both civilian and 
military) suffering from chronic pain and disability due to a lack of a standard of care for VML. 
We suggest that an improved understanding of the relationship between age and VML treatment 
performance would provide valuable insights that could help elucidate the appropriateness of 
current VML repair strategies for a broader patient population.  
 As a first step towards reaching this level of understanding, our group has developed an 
aged rat VML model and demonstrated that age impacts muscle healing following VML injury 
(Kim et al., 2016).  Specifically, our findings suggested that extracellular matrix (ECM) gene 
expression and protein deposition is significantly altered following VML injury in an aged model 
(18 months), resulting in a more fibrotic environment when compared to non-aged controls (3 
months). While changes in muscle wound healing with age were identified and appeared 
consistent with findings in humans (Parker et al., 2017), the study did not examine whether these 




repair. The purpose of this study was to examine whether the improved functional outcomes that 
have been observed following VML repair in non-aged models are sensitive to aging.  
Specifically, this study was designed to test the hypothesis that age will dampen the beneficial 
effects of regenerative treatment. This study presents those performance results along with 
comparisons to non-aged animal model findings. 
 
B. Methods 
DSM Scaffold Preparation 
To prepare DSM samples for implantation, whole tibialis anterior (TA) muscle was 
decellularized using a previously reported (B. M. Kasukonis et al., 2016) infusion system 
(Figure 1). TA muscles were harvested from rats (Sprague Dawley) that had been euthanized at 
the completion of an unrelated study. The TA samples were infused overnight (approximately 12 
hours) with 1% SDS at a flow rate of 5mL/hr. Following infusion, samples were incubated 
overnight in a DNAse solution (1kU/ml DNAse in 10mM Tris-HCL buffer; 2.5mM MgCL2 + 
0.5mM CaCl2) and then incubated (8 hours) in a 1X penicillin/streptomycin solution to reduce 
the risk of infection. Samples were rinsed thoroughly (a total of six 24-hour wash steps) in PBS 
between each preparation step. Following completion of decellularization, the DNA 
concentration of representative DSM implants (n=4) was measured with the aid of a commercial 
quantification kit (Qubit, Fisher Scientific). DSM implants were lyophilized and stored at -20⁰C 







 Volumetric Muscle Loss Injury and Minced Muscle 
In vivo VML studies were performed using male Fischer 344 rats with ages of either 3 
months (20% of the median lifespan) or 18 months (75% of their median lifespan).  The 3-month 
rats were purchased commercially from Envigo (Indianapolis, IN) and the 18-month rats were 
obtained through the National Institute on Aging (Bethesda, MD). Surgical procedures and 
implant preparation methods were performed in accordance with protocols approved by the 
University of Arkansas IACUC (protocol #14044) and as described previously (B. Kasukonis, J. 
Kim, L. Brown, et al., 2016). Briefly, VML defects (8mmx3mm) were created in the tibialis 
anterior using a biopsy punch (Figure 2A,B). 25% of the removed defect plugs were retained for 
use as MM autografts following hand mincing of the removed muscle (Figure 2C). DSM 
scaffolds were fully coated in the minced muscle paste and then implanted into the VML defect 
site (Figure 2D-F).  Animals were randomly assigned to one of two treatment groups 
(n=8/treatment group): unrepaired VML defect (VML), or VML defect repaired with DSM 
scaffold supplemented with MM (DSM+MM).  All contralateral limbs were left untreated to 
serve as comparative controls.  All animals were housed for a 12-week recovery period. 
 
In vivo Contractile Torque Measurement 
 Peak tetanic contractions produced by the TA muscle were measured isometrically in 
vivo using procedures as previously described by Corona and familiar to our group (Corona, 
Garg, et al., 2013; B. Kasukonis, J. Kim, L. Brown, et al., 2016; Kim et al., 2016). Briefly, the 
lower limb of the animals were stabilized at 90º of knee flexion via a custom alignment jig. The 
foot was secured to the lever arm of a dual-mode lever system (Aurora Scientific). Prior to nerve 




longus (EHL) was performed to isolate the force contribution of the TA muscle. Percutaneous 
needle electrodes were inserted into the anterior compartment of the tibialis anterior muscle and 
the peroneal nerve was stimulated via physiological stimulator (Grass; S88). Optimal voltage (2-
5 V) was determined using a series of tetanic contractions (150Hz, 0.1 ms pulse width, 400ms 
train (3-month animals) and 200ms train (18-month animals)). The mean isometric torque values 
(N cm) were calculated from 5 consecutive contractions with 1 minute rest periods in between 
each contraction. The weight normalized (N cm/kg) and contralateral untreated limb normalized 
(% normal) force data is reported in the results section.  
 
Tissue Histology  
 VML and DSM+MM treated TA muscles along with contralateral untreated TA muscles 
were harvested and trimmed to remove fascia, rinsed in sterile PBS, dabbed dry, and then 
weighed. Harvested muscles were flash frozen in isopentane (2-methylbutane) chilled in liquid 
nitrogen, and stored at -80°C. Tissue cross-sections (8µm) of the repair site were obtained via 
cryostat (Leica BioSystems) maintained at a temperature between -25 and -20°C. Prior to 
immunostaining, slides were permeabilized in 0.1% 100X triton and then rinsed in phosphate-
buffered solution (PBS, pH 7.4). Sections were blocked in PBS containing 4% goat serum and 
0.05% sodium azide for 1h at room temperature prior to incubation in primary antibodies 
including mouse-anti-collagen I IgG (1:500, Sigma-Aldrich), rabbit polyclonal anti-collagen III 
(1:1000, Abcam), and mouse-anti-myosin IgG2B (MF-20, 1:10, Developmental Studies 
Hybridoma Bank) for 2h at room temperature. Following PBS washes, slides were incubated in 
the appropriate fluorescently labeled secondary antibodies (AlexaFluor, 1:500, Life 
Technologies) for 30 minutes at room temperature. Additional tissue sections were stained using 





Collagen type I accumulation within VML injured and DSM+MM repaired muscle tissue 
was quantified via immunostaining for collagen I (Sigma-Aldrich) with myosin heavy chain 
(Developmental Studies Hybridoma Bank) as a counter stain. Representative tissue sections 
collected from four animals per group were used for all calculations. A total of twelve sections (4 
animals x 3 sections/animal, each section separated by approximately 500-700µm) were imaged 
(100X) at the site of injury or repair. All images were converted to 8-bit greyscale and a uniform 
threshold was applied to isolate collagen type I positive tissue regions within each section. 
Tissue immunoreactivity to collagen I as a percentage of total tissue area (% Col I) was 
calculated using image analysis software (ImageJ, NIH) using established techniques familiar to 
our group (Kim et al., 2016). Similar image analysis methods were used to compute collagen III 
percent area (% Col III) and fiber cross-sectional area (µm2) using magnified (100X) collagen III 
images. Collagen III immunostained images were converted to greyscale and thresholded to 
isolate the borders of individual muscle fibers (typically 300+ fibers / field of view).  
 
Gene Expression 
 RT-PCR was performed using the protocol reported by Washington et al (Washington et 
al., 2013).  In prep for RT-PCR, TA muscle tissue (~30mg) was collected from the site of 
injury/treatment  (n=4 animals/group) and homogenized with Trizol (Ambion)/choloroform 
(Sigma Aldrich). Homogenized samples were treated with DNase (Invitrogen) and then RNA 
was extracted using an RNeasy kit (Invitrogen). After quantification of RNA with UV 
spectrophotometry (BioTek), cDNA was reverse transcribed from 1µg of total RNA (Invitrogen). 




MyoG, IL-1β, TNF-α, and 18S rRNA housekeeping were used to quantify the expression of 
desired genes. 18s rRNA expression was consistent between all groups. Experimental sample 
group expressions were normalized to 18S rRNA and then referenced to the contralateral normal 
limb. Gene expression levels are reported as fold change using the 2-(ΔΔCt) method. 
 
Statistical Analysis 
Data is presented as the mean ± standard deviation and was tested for normality using the 
Shapiro-Wilks Test.  All dependent variables (animal growth; TA and EDL muscle mass; peak 
tetanic force, %Col I and %Col III, fiber cross-sectional area) were analyzed using a two-way 
(age and treatment) ANOVA.  Post-hoc comparisons were performed using Tukey’s test and if 
present, interactions effects were reported.  Pre-planned comparison between 3-month and 18-
month repair groups were conducted by Student’s t-test. Chi-square analysis was performed to 
compare fiber area distributions.  All analyses were performed using commercial statistical 





 All animals tolerated the surgery well and post-surgical complications requiring 
euthanasia were absent.  After one week post-implantation, all animals were ambulatory with no 
discernable gait differences between treatment groups. There was a significant effect with age to 
decrease animal growth (p<0.0001). On average, the 3-month animals gained 101±17g by the 




28±29g by the end of the study period.  Although age significantly affected animal growth, we 
did not detect a significant effect on growth with treatment. Both the 3-month VML 
(8.8±1.7g/week) and DSM+MM (8.1±1.2g/week) groups gained weight at a similar rate. 
Similarly the 18-month VML and DSM+MM groups lost weight at comparable rates of -2.6±2.9 
g/week and -1.7±0.80 g/week respectively.  
 
Tibialis Anterior Appearance and Mass 
Compared to normal TA muscle morphology, untreated VML and DSM+MM repaired 
muscles collected from both 3-month and 18-month aged groups appeared atrophied when 
compared to contralateral normals and were characterized by a distinct defect visible at the site 
of VML injury or repair (Figure 3A and B).  An interaction effect of age and treatment (p=0.03) 
was detected for TA mass. 18-month TA samples across both VML and DSM+MM groups were 
on average 23% and 34% smaller than their 3-month counterparts, respectively. The 3-month 
VML and DSM+MM muscle masses were 81.7±6.3% and 87.2±8.8% of their normal 
contralateral TA mass respectively (Figure 3C) while their 18-month counterparts were 
75.1±7.8% and 72.1±5.4% of the normal contralateral mass, respectively (Figure 3C). Within 
the 3-month age group, DSM+MM repair lead to a 7% increase in muscle mass while repair in 
the 18-month group resulted in a 5% decrease in muscle mass.  
 
Peak Contractile Torque 
 In-situ muscle force recordings were characterized by a rapid rise in torque, followed by 
a stable tetanic peak torque plateau, and a similarly sharp descent to a resting state. Similar to the 




detected within the torque data (Figure 3D, p=0.02). Mean VML and DSM+MM peak torque 
values (percent contralateral normal) for the 3-month age group were on average 20% (5.6±1.2 
Ncm/kg vs. 4.6±1.1 Ncm/kg) and 47% greater (6.8±1.0 Ncm/kg vs. 4.2±0.6 Ncm/kg) 
respectively when compared to their 18-month counterpart torque values. In addition, the peak 
torque in response to DSM+MM repair within the 3-month age group was significantly increased 
when compared to the 3-month VML group (6.8±1.0 Ncm/kg vs. 5.6±1.2 Ncm/kg). Specifically, 
3-month mean peak torque values reached 79.9±11.2% of normal in response to DSM+MM 
repair (6.8±1.0 Ncm/kg vs. 9.0±1.3 Ncm/kg); a 45% recovery in peak torque when compared to 
3-month VML values (5.6±1.2 Ncm/kg vs. 9.0±1.3 Ncm/kg). Alternatively, within the 18-month 
age group, DSM+MM repair had a negligible effect on peak torque (57±8.7% of normal, 4.2±0.6 
Ncm/kg) when compared to VML values (58.6±14% of normal,4.6±1.1 Ncm/kg). However, a 
significant decrease in peak torque was detected in both 18-month VML and repair groups when 
compared to the 3-month DSM+MM repair group. 
 
Weight Change and Peak Torque Correlation 
When the relationship between peak TA torque and weight change (% of initial weight) 
was examined within the 3-month age group, we did not detect a correlation (Figure 4B, r2=-
0.07). However, within the 18-month animal group there was a modest positive correlation 
(Figure 4C, r2=0.49) between peak torque and body weight change. The findings suggest that 
increased weight loss during the 12-week recovery period was associated with decreased peak 
torque outcomes for the 18-month age group (Figure 4). The absence of a correlation between 
weight change and peak torque in the 3-month age group possibly suggests that peak torque 





 Among the transcription factors related to myogenesis (Figure 5), MyoD (p=0.006) and 
MyoG (p=0.03) were expressed significantly higher in the 3-month repair group compared to the 
18-month repair group by approximately 3-fold (4.52±1.43 fold change vs. 1.48±0.29 fold 
change) and 8-fold (16.3±9.8 fold change vs. 2.0±1.6 fold change), respectively. No difference 
was detected in Pax7 expression as both 3-month and 18-month groups exhibited muted 
expression (1.9±1.1 fold change vs. 1.7±0.3 fold change). 
 Significantly higher levels of expression of collagen I (p=0.044) and collagen III 
(p=0.047) were found in the 3-month repair group compared to the 18-month group. Collagen I 
was expressed approximately 35-fold higher in the 3-month repair group compared to the 18-
month repair group (88.6±51.2 fold change vs. 2.5±1.9 fold change). Collagen III was expressed 
600-fold higher in the 3-month repair group compared to 18-month repair (86.0±39.19 fold 
change vs. 0.1±0.0). Notably when examining the ratio of collagen I to collagen III gene 
expression, the 3-month repair group exhibited a significantly lower collagen I to collagen III 
ratio (p=0.009) of 1.1±0.2 whereas the 18-month repair group responded with a ratio of 
17.5±8.6. TGF-ß expression was also significantly higher in the 3-month group compared to the 
18-month repair group (10.5±4.9 fold change vs. 1.4±0.4 fold change, p=0.01).  
 Significant differences were detected in the expression of IL-1ß and TNF-α between the 
3-month and 18-month repair groups. The 3-month repair group was found to express IL-1ß at 
levels 8.5-fold higher than its 18-month counterpart (9.7±5.9 fold change vs. 1.1±0.4 fold 
change, p=0.02).  TNF-α was expressed approximately 13-fold higher in the 3-month repair 
group compared to the 18-month repair group (13.7±10.8 fold change vs. 1.2±1.2 fold change, 




two age groups (p=0.08), was expressed at elevated levels in the 3-month repair group compared 
to the 18-month repair group (5.3±3.9 fold change vs. 1.3±0.5 fold change).  
  
VML Site Histology 
 Both 3-month and 18-month normal TA histology was characterized by tightly apposed 
bundles of MHC positive myofibers extending to the anterior surface of the muscle (Figure 
6A,B “Normal”). When compared to normal muscle, both 3-month and 18-month VML wound 
site tissue was characterized by a fibrotic surface region and elevated collagen staining extending 
into the muscle body (Figure 6A,B “VML”). The repair site region was notably shallower than 
the initial VML defect for both 3-month and 18-month groups, typically extending a few 
hundred microns into the muscle, suggesting atrophy of the muscle at the injury site. Following 
DSM+MM repair, 18-month animal muscle was similarly characterized by a collagen enriched 
repair region, with the highest density near the anterior surface of the repair site (Figure 6B 
“Repair”).  Within the collagen dense region, there was diffuse and disorganized MHC positive 
tissue with increasing fiber disorganization towards the surface of the muscle.  3-month 
DSM+MM repair site tissue was notably devoid of collagen repair tissue and while the muscle as 
a whole was atrophied, the collagen staining at the fiber and bundle level appeared qualitatively 
similar to controls (Figure 6A “Repair”). There was no evidence of immature fibers with 
centrally located nuclei for both 3-month and 18-month groups, suggesting either negligible new 







Collagen I and III Area 
A main effect of age (p=0.0009) was detected for collagen I % area. Within the 3-month 
age group, collagen I % area measurements were similar across all treatment groups. 
Specifically, 3-month normal, VML, and DSM+MM repair tissue contained collagen I % areas 
of 6.2±2.0%, 6.5±1.6%, and 5.4±1.2%, respectively (Figure 7A-C,G). Alternatively, exhibiting 
collagen I % area measurements of approximately 2-3 folds higher than their 3-month 
counterparts, 18-month normal, VML, and DSM+MM repair tissues comprised on average 
10.4±4.5%, 17.9±4.5%, and 17.6+9.3% of the total tissue area, respectively (Figure 7D-F,G). 
In contrast to collagen I % area, a main effect of treatment was detected for collagen III 
% area (p=0.0454). 3-month normal, VML, and DSM+MM repair groups were comprised of 
collagen III % areas of 19.8±3.5%, 21.4±4.4%, and 16.9±1.2%, respectively (Figure 8C). 18-
month normal, VML, and DSM+MM groups were comprised of collagen III % areas of 
17.7±1.9%, 22.2±1.5%, and 18.4±0.9%, respectively (Figure 8C). Within both 3-month and 18-
month age groups, a significant decrease in collagen III % area was detected between VML and 
DSM+MM repair groups. 
 
Fiber Cross-Sectional Area 
The mean muscle fiber area at the site of injury (VML) or repair (DSM+MM) was not 
significantly different for either the 3-month or 18-month age groups (Figure 9). No effect of 
treatment was detected nor were fiber sizes significantly different between the age groups. Mean 
fiber diameter for both 3-month (2085±245µm2) and 18-month (1993±400µm2) DSM+MM 
repair tissue was within 10% of VML injured values for both 3-month (2123±200µm2) and 18-




sizes for 3-month and 18-month DSM+MM repair groups. A summary of the key outcome 
measures (mean ± standard deviation) is provided in Table 1.  
 
D. Discussion 
 In this in vivo study, we observed significant effects with age on the response to 
regenerative repair of VML injury as well as significant interactions between age and repair. 
Specifically, the repair of VML defects using a combination of decellularized skeletal muscle 
scaffolds and minced muscle paste recovered approximately half (45%) of the force lost to VML 
injury when examined in the 3-month old rat model (3 months = 12.5% of median lifespan), but 
was ineffective (recovery=-1%) when tested in the 18 month old model (18 months = 75% of 
median lifespan). The age-related decrease in regenerative therapy effectiveness is meaningful 
when one considers the broad age range of patients that could benefit from VML treatment 
strategies. Overall, the results of this study suggest that the successful translation of VML injury 
treatment strategies to the clinic may be compromised by patient age.  
 Generally, a sustained inflammatory response has been associated with chronic 
inflammatory myopathies and disorders such as muscular dystrophy and myositis, which have 
been shown to lead to excessive fibrosis and stagnation of the normal regenerative program 
(Loell & Lundberg, 2011; Porter et al., 2002). However, recent studies have also demonstrated 
important roles for inflammatory cytokines such as TNF-α and IL-1ß in the regulation of the 
regenerative process. TNF-α attracts satellite cells to the injury site as well as promotes satellite 
cell proliferation and myoblast differentiation via activation of NF-κß and p38 MAPK signaling, 
respectively (S. E. Chen, Jin, & Li, 2007; Peterson, Bakkar, & Guttridge, 2011). These findings 




was significant upregulation of TNF-α and MyoD in the 3-month repair group as well as a 
significant increase in peak torque values compared to the older 18-month repair group. The low 
expression of TNF-α in the 18-month repair group could be suggestive of low- or in-activation of 
p38 MAPK activity which has been demonstrated to downregulate the expression of muscle 
differentiation markers such as MyoD and MyoG (S. E. Chen et al., 2007; Zhan, Jin, Chen, 
Reecy, & Li, 2007). Similar to TNF-α, IL-1ß is able to stimulate migration, proliferation, and 
differentiation of mybolasts, albeit indirectly, by stimulating the secretion of IL-6 from skeletal 
muscle cells (Luo, Hershko, Robb, Wray, & Hasselgren, 2003; Munoz-Canoves, Scheele, 
Pedersen, & Serrano, 2013; Porter et al., 2002). Gene expression in the 3-month repair group 
compared to the 18-month group mirrors the observations of TNF-α expression and may speak to 
the aberrant inflammatory response and muscle homeostatic maintenance of the older 18-month 
rat group (Joe et al., 2010; Kami & Senba, 1998; C. Zhang et al., 2013).  
 In addition to an overall reduction in the pool of available satellite cells within aged 
muscle there is also a phenotypic shift of satellite cells from a myogenic to fibrogenic lineage (B. 
M. Carlson, 1995; Grounds, 1998b).  This shift in lineage is attributed to dysfunction in satellite 
cell proliferative capacity (Conboy et al., 2005) and divergence towards fibrogenicity (Brack et 
al., 2007b), which is largely influenced by soluble factors in the aging tissue microenvironment. 
The age-related shift in satellite cell behavior towards a pro-fibrotic phenotype is consistent with 
our observed results. Histological and quantitative %NCT measurements revealed regions of 
increased collagen deposition within and around the area of injury and repair when compared to 
the non-aged model repair site. Additionally, the heightened pro-fibrotic response is capable of 
further impairing muscle fiber regeneration and force recovery via deregulation of satellite cells 




2011a; Serrano et al., 2011). Furthermore, it has been demonstrated that increased collagen 
deposition can decrease growth factor diffusion within the repair site and hinder satellite cell 
migration, leading to incomplete regeneration at the site of injury (Hindi, Shin, Ogura, Li, & 
Kumar, 2013).  The composition of the ECM at the site of repair can also have a negative effect 
on muscle regeneration (Lehto, Sims, & Bailey, 1985). Within tissue collected at the site of 
repair from the 18-month rats, the ratio of collagen I to collagen III gene expression was 
markedly elevated with approximately a 17:1 ratio while tissue from the 3-month rats exhibited a 
ratio closer to 1:1. Unusually high ratios of collagen I to collagen III have been associated with 
hypertrophic scar formation in wound healing as well as decreased sensitivity to growth factors 
(Garner, Karmiol, Rodriguez, Smith, & Phan, 1993).  
The regenerative medicine strategy that was used as the test bed for the examination of 
age sensitivity to VML repair was similar in concept to strategies under examination by other 
groups. Specifically, we utilized a combination of allogeneic decellularized skeletal muscle 
scaffolds and autologous minced muscle paste to restore the architectural and cellular cues lost to 
VML injury. The regenerative capacity of minced muscle fragments has been demonstrated 
previously by Studitsky and Carlson in their respective seminal reports (B. M. Carlson, 1968; 
Studitsky, 1964) but not until recently has minced muscle been incorporated into tissue 
engineering strategies aimed at VML repair (Corona, Garg, et al., 2013; Goldman et al., 2018; B. 
Kasukonis, J. Kim, L. Brown, et al., 2016; Ward et al., 2015). Additionally, the effects of minced 
muscle transplantation on regeneration are comparable in its overall goal compared to the 
delivery of pure populations of progenitor cells explored by others (Merritt, Cannon, et al., 
2010a; Quarta et al., 2017). Similarly, the ECM scaffolds used in this study are comparable to 




al., 2014; Merritt, Cannon, et al., 2010a; Merritt, Hammers, et al., 2010; Sicari et al., 2012; 
Turner et al., 2012; Urciuolo et al., 2018). This is likely due to the consistency of the 
overwhelming inflammatory and fibrotic response to VML injury leading to functional deficits, 
regardless of scaffold composition or host species of origin.    The broad similarities between our 
test bed and others, provides confidence that the age-related differences we observed in this 
study are relevant to more recent cell- and tissue-based regenerative medicine strategies under 
investigation by research teams (Gilbert-Honick, Iyer, et al., 2018; Goldman et al., 2018; Qiu et 
al., 2018; Quarta et al., 2017) and would suggest that similar age-related deficiencies would exist 
for these strategies. 
 Lastly, a limitation to this study that deserves discussion is the lack of an early-post 
implantation time point that would provide the data needed to identify specific wound healing 
events responsible for the age-related differences in functional outcome. The 12-week endpoint 
examined in this study, while appropriate for the examination of functional recovery, misses the 
key pro-myogenic milestones that occur during the first few weeks of muscle healing (Tidball, 
2005b, 2017). In particular, the examination of acute time points may reveal key age-sensitive 
differences in cellular and soluble factor (cytokines and growth factors) responses that occur 
following regenerative VML repair (Tidball, 1995, 2011). The gene expression results measured 
in this study demonstrate that pro-myogenic transcription pathways and cytokines are elevated at 
12 weeks in the non-aged animal model suggesting ongoing regenerative processes, but it 
remains unclear whether the muted myogenic response observed at 12 weeks in the aged animal 
was similarly muted during early healing. Early time points could reveal whether all or only 
specific key myogenic milestones are impaired within the VML repair site of aging muscle, and 





 In summary, this study is the first to demonstrate an age-dependent response to repair of a 
VML injury utilizing a tissue-engineered therapy. Notably, the repair of VML defects using a 
combination of tissue scaffolds and minced muscle paste recovered approximately half of the 
force lost to VML injury when examined in a 3-month rat model, but was ineffective when tested 
in the 18-month model. The 18-month animal model was characterized by an increase in scarring 
at the site of repair and a reduction in the expression of key myogenic genes. When taken 
together the findings suggest that a decline in regenerative capacity with age may present an 
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Figure 1: Whole tibialis anterior (TA) muscles were decellularized using an infusion bioreactor. 
During decellularization, SDS solution was delivered to the mid-belly region of the TA muscle 
via a hypodermic needle and syringe pump (A). The bioreactor was designed to accommodate 
four side-by-side decellularization units each capable of accommodating a single muscle tissue 
sample (B). Representative whole TA muscle appearance prior to and following infusion 
decellularization treatment (C left and right), illustrates the appearance of the DSM scaffolds 
following removal of intracellular myoglobin. Infusion prepared DSM scaffolds, when viewed in 
thin section (scale bar = 100um) with H&E staining, retained the aligned network structure of 
native muscle ECM (D).  (arrow = approximate direction of muscle contraction) 
 
Figure 2: Surgical VML and repair procedure.  The surgical site was cleaned and disinfected and 
a 1-2 cm incision was made to expose the underlying TA muscle (A). A 8mm biopsy punch was 
used to create a VML injury to a depth of 3mm. Approximately 20% of the TA muscle was 
excised (B).  MM autografts were prepared using 25% (by mass) of the removed muscle plug. 
The muscle tissue was minced using a scalpel and scissors (C).  The resulting MM paste was 
used to coat a DSM scaffold prior to implantation into the defect site (D).  The MM coated DSM 
scaffold was packed into the defect with scaffold alignment oriented to direction of muscle 
contraction (E). The surgical site was closed using both deep and surface sutures (F). The 
uninjured contralateral limb served as a comparative control. 
 
Figure 3: Gross morphology of 3-month (A) and 18-month (B) normal, VML, and DSM+MM 
repaired TA muscles. Dashed circle indicates the approximate location and boundary of the 
defect site. TA muscle wet weight (C) and peak torque (D) was normalized to animal weight 
(Nmm/kg) and calculated relative to normal contralateral TA muscle values (%normal) for each 
animal tested. Representative in-vivo TA torque recording (D inset). Relative muscle wet weight 
and peak torque data are presented.  Data is presented as group means + SD; n=7-8/group; * 
denotes statistically significant (p<0.05) differences between groups.  
 
Figure 4: Animal weight was recorded at the time of surgery (initial) and sacrifice (final) for 
each age and treatment group.  Animal weight change (% initial) was quantified using initial and 
final animal weight values (A). Data is presented as group means + SD; n=7-8/group; * denotes 
statistically significant (p<0.05) differences between groups. Scatter plots, least square method 
linear correlation fits, and sample coefficients of determination (r2) for animal weight change 
versus peak torque data are shown for both the 3-month (B) and 18-month DSM+MM repair 
groups (C).  
 
Figure 5: Comparison of relative gene expression for 3-month and 18-month DSM+MM repair 
groups using RT-PCR. The expression of myogenic (Pax7, MyoD, MyoG), ECM (COL I and 




measured using muscle tissue harvested from the DSM+MM repair site.  Expression is presented 
as fold change normalized to contralateral normal muscle expression. Group means + SD are 
presented, n=4/group. * denotes statistically significant (p<0.05) differences between groups.  
 
Figure 6: TA muscle cross-sections were stained with Masson’s Trichrome.  Representative 3-
month (A) and 18-month (B) normal, VML, and DSM+MM repair groups are presented. 
Representative whole TA cross-sections and magnified (100X) images are shown. Arrows 
highlight regions and bands of fibrotic collagen accumulation. Inset indicates approximate 
location of magnified image within the TA cross-section. Arrow indicates anterior direction. 
Scale bar = 100µm unless noted.  
 
Figure 7: TA tissue cross-sections were immunostained for collagen I (green) and 
counterstained against MHC (red). Representative 3-month (A) and 18-month (B) normal, VML, 
and DSM+MM repaired tissue images are shown. Inset indicates approximate location of 
magnified (100X) image within TA tissue section. Arrow indicates anterior direction. Open 
arrows highlight regions and bands of fibrotic collagen I accumulation. Scale bar = 100µm. 
Cross-sections were quantified for area fraction of collagen type I (C). Group means + SD are 
presented; n=4/group. * denotes statistically significant (p<0.05) differences between groups.  
 
Figure 8: TA tissue cross-sections were immunostained for collagen III (red). Representative 3-
month (A) and 18-month (B) DSM+MM repair site images are shown. Inset indicates 
approximate location of magnified (100X) image within TA tissue section. Arrow indicates 
anterior direction. Scale bar = 100µm. Cross-sections were quantified for area fraction (%) 
collagen type III (C). Group means + SD are presented; n=4/group. * denotes statistically 
significant (p<0.05) differences between groups.  
 
Figure 9: Individual myofiber areas were measured from Collagen III stained tissue cross-
sections. Group data for myofiber cross-sectional area (A) and area frequency distribution are 
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It has been previously demonstrated that a combinatorial repair strategy for volumetric muscle 
loss (VML) consisting of autologous minced muscle (MM) grafts co-delivered with a 
decellularized muscle scaffold (DSM) was not able to promote a pro-myogenic environment 
leading to effective tissue repair nor restore muscle contractile function in an 18-month aged 
animal model (Fischer 344). In this study, the use of the anabolic steroid nandrolone decanoate 
(ND) was explored as an adjunct to DSM+MM repair in an aged model of VML injury 
(n=15/treatment group). We observed no significant improvements in peak isometric torque 
between ND(+) (64.5±18.3% of uninjured contralateral muscle) and ND(-) (80.9±37.9%) repair 
groups. Histological findings revealed a significant reduction in collagen dense repair tissue at 
the site of injury. These findings were also reflected in collagen I area fraction (%) 
measurements with both ND(+) uninjured (6.1+1.1%) and ND(+) repair (9.3+3.2%) groups 
having significantly lower collagen I area fraction compared to the ND(-) repair (15.6+5.5%) 
group. Gene expression data revealed no significant changes in myogenic gene expression with 
ND injection but did upregulate collagen III expression. The expression of transcription factors 
related to Notch (Notch1, Jag1) and insulin (TRIM72, FOXO1, IRS-1) signaling were found to 
be downregulated by age, independent of ND treatment. These findings suggest that ND 
treatment may not be an appropriate addition to existing VML repair strategies to enhance age-
associated decline in regenerative potential. 




A. Introduction  
 Volumetric muscle loss (VML) is a traumatic injury that overwhelms the regenerative 
ability of skeletal muscle leading to permanent functional loss and excessive scarring. Currently, 
surgical interventions for VML are limited to autologous muscle flap transfers which have been 
known to cause donor site morbidity, further exacerbating the patient (Fan et al., 2008; Lin, Lin, 
Yeh, & Chen, 2007; Vekris et al., 2008). However, the use of implantable biological scaffolds as 
a regenerative medicine strategy have shown encouraging results in small animal models 
(Corona et al., 2013; Corona, Ward, Baker, Walters, & Christ, 2014; Gentile et al., 2014; 
Kasukonis, Kim, Washington, & Wolchok, 2016). VML injuries can result from both battlefield 
(Corona, Rivera, Owens, Wenke, & Rathbone, 2015; Owens et al., 2008) and civilian trauma 
(Grogan, Hsu, & Skeletal Trauma Research, 2011; MacKenzie et al., 2000), with the latter 
encompassing a wide range of age groups. With current investigations into regenerative 
medicine strategies for the repair of VML being conducted primarily in young animal models, 
there still exists a need for investigations into how age affects regenerative outcomes following 
VML treatment. 
 There are well-documented aging-related changes in muscle function and quality 
including reduction in muscle mass, reduced metabolism, and increased fatty tissue infiltration 
into the muscle (Blaauw, Schiaffino, & Reggiani, 2013; Collino et al., 2013; Fielding et al., 
2011; Gheller, Riddle, Lem, & Thalacker-Mercer, 2016). Factors contributing to these changes 
have been shown to be a combination of intrinsic changes in muscle such as the deterioration of 
skeletal muscle quality (fiber composition, muscle capillarization, mitochondrial dysfunction) 
(Coggan et al., 1992; Conley, Jubrias, & Esselman, 2000; Croley et al., 2005; Miller, Robinson, 




intake and physical activity (Donini, Savina, & Cannella, 2003; Straight, Brady, & Evans, 2015; 
Thalacker-Mercer, Fleet, Craig, & Campbell, 2010). Coupled with the multi-factorial nature of 
VML injuries, regenerative medicine strategies have proven unsuccessful in eliciting a 
significant regenerative response in aging skeletal muscle as previously demonstrated by our 
group (J. Kim et al., 2019). A potential solution to combat the age-related changes in aging 
skeletal muscle is the use of exogenous testosterone. 
 The use of testosterone and other anabolic stimuli in aging animal models has been 
documented to improve muscle regeneration. Specifically, testosterone has been demonstrated in 
several studies to induce muscle hypertrophy via increased protein accumulation and myonuclear 
accretion in addition to rescuing aging muscle from wasting (Axell et al., 2006; Kadi, Bonnerud, 
Eriksson, & Thornell, 2000; Kovacheva, Hikim, Shen, Sinha, & Sinha-Hikim, 2010; Sinha-
Hikim et al., 2002; Sinha-Hikim, Cornford, Gaytan, Lee, & Bhasin, 2006). Results suggest that 
androgens can stimulate the proliferation of satellite cells and ultimately differentiation and 
fusion into myofibers. This is further supported by studies showing increased satellite cell 
numbers following treatment in numerous species including humans (Sinha-Hikim et al., 2006; 
Sinha-Hikim, Roth, Lee, & Bhasin, 2003), rodents(Joubert & Tobin, 1995), and chickens 
(Allouh, Jarrar, Asfour, Said, & Shaqoura, 2017). Testosterone has also demonstrated the ability 
to inhibit Notch signaling through its inhibitor, Numb, which has been shown to promote satellite 
cell differentiation during myogenic development and repair (Conboy & Rando, 2002; Jory et al., 
2009; Zilian et al., 2001). These findings are likely attributed to the role of the androgen receptor 
on muscle cell proliferation and differentiation in both in vitro and in vivo environments (Dalbo 
et al., 2017; Diel, Baadners, Schlupmann, Velders, & Schwarz, 2008; Hughes et al., 2016; D. K. 




 There still remains the question of whether a reversal of aging-related pathologies via 
testosterone treatment used in conjunction with ECM-based therapies to repair VML injuries will 
create an environment that is conducive to muscle regeneration. To that end, an aged animal 
model of VML developed by our group (Kim, Kasukonis, Brown, Washington, & Wolchok, 
2016) was used to investigate the response to VML repair with and without anabolic steroid 
supplementation.  Fischer 344 rats aged 18 months were used in this study, which represent the 
mature to early elderly rat lifespan (ref). The purpose of this study was to test the hypothesis that 
testosterone supplementation in conjunction with our minced muscle and ECM-based VML 
repair therapy will counteract age-related muscle wasting in addition to stimulating myogenic 
activity, thus creating an environment more receptive to regenerative treatment. This study 
presents the performance of our previously reported regenerative strategy (J. Kim et al., 2019), 
with and without testosterone supplementation in an aged animal model. 
 
B. Methods 
Anabolic Steroid Administration 
 The anabolic steroid nandrolone decanoate (ND) (Steraloids, Inc, Newport, RI) was used 
in this study due to its long half-life (6-12 days) and has been demonstrated to have potent 
myotrophic effects in skeletal muscle (Carson, Lee, McClung, & Hand, 2002; Tsika, Herrick, & 
Baldwin, 1987; Washington, Healey, Thompson, Lowe, & Carson, 2014). Sesame oil was used 
as a carrier for ND and was administered intramuscularly into the vastus lateralis muscle at a 
concentration of 9 mg/kg body weight once weekly. Animal weights were recorded prior to 




animal groups were administered depot injections of sesame oil intramuscularly. Both ND(+) 
and ND(-) groups were administered either ND or depot injections at the time of surgical 
treatment and once every 7 days following the date of injection. 
 
hDSM Preparation 
To prepare human DSM samples (hDSM) for implantation, whole human tibialis anterior 
(TA) muscle was portioned into smaller fragments for decellularization. TA muscles were 
donated from Science Care, Inc (Phoenix, AZ). The TA samples were incubated in 1% SDS for 
approximately 2 weeks with a fresh exchange of SDS every 24 hrs. Following infusion 
treatment, samples were incubated overnight in a DNAse solution (1kU/ml DNAse in a 10mM 
Tris-HCL buffer; 2.5mM MgCL2 + 0.5mM CaCl2) and then incubated (8 hours) in a 1X 
penicillin/streptomycin solution to reduce the risk of infection. Samples were rinsed thoroughly 
(a total of six 24-hour wash steps) in PBS between each preparation step. Following completion 
of the entire decellularization protocol, the hDSM implants were lyophilized and stored at -20⁰C.  
 
Volumetric Muscle Loss Injury and Minced Muscle 
In vivo VML studies were performed with aged (18 months) male Fisher 344 rats.   The 
aged rats were obtained through the National Institute on Aging (Bethesda, MD). Surgical 
procedures and implant preparation methods were performed in accordance with protocols 
approved by the University of Arkansas IACUC (protocol #18052) and guided by published 
methods. Anesthesia was administered using isoflurane (1-3%) in oxygen.  The implant site was 




and a partial thickness VML defect (8mm diameter x 3mm deep) was created using a sterile 
biopsy punch.  Defect site tissue was then removed and weighed to ensure consistent defect mass 
values (average defect weight = 93.4mg).  Defect mass values (20% of TA mass) were based on 
pilot study data measuring TA muscle mass (average TA mass = 470±17mg).  The removed 
defect plugs were retained for use as minced muscle (MM) autografts (25% of VML defect 
mass).  Animals were randomly assigned to one of two treatment groups (n=15/treatment group): 
VML defect repaired with hDSM scaffold supplemented with MM autografts followed by 
testosterone injection (ND(+)) or repair with no injection (ND(-)).  All contralateral limbs to the 
ND(+) and ND(-) only limbs served as internal controls for comparison and are denoted as the 
normal group in the study. 
 A single infusion-prepared DSM scaffold was cut to size (average DSM mass = 
4.9±0.7mg) using surgical scissors.  Separately, 25% of the defect muscle plug was hand-minced 
into a loose paste using a scalpel and scissors until MM fragments larger than ~1mm3 could not 
be visually detected.  The DSM scaffolds were then manually rolled in the MM autograft paste 
until all surfaces were visibly coated.  DSM+MM constructs were implanted into the VML 
defect. Care was taken to ensure DSM implant network alignment matched that of the 
surrounding muscle.  Unrepaired VML defects served as negative controls.  To remain consistent 
with previous MM repair techniques, the DSM scaffolds were sized to fill, but were not sutured 
to the surrounding tissue.  The deep fascia and skin layers were separately closed using 
interrupted stitches with a 5-0 adsorbable suture (Vicryl, Ethicon).  Post-operative analgesia 
consisted of 0.1mg/kg buprenorphine administered subcutaneously through injection twice daily 
for 2 days.  The anti-inflammatory medication Carprofen was readily available to the animals via 




cage after surgery.  Animal consumption of the gel was voluntary and any uneaten gel was 
removed from the cage at 1-week post-surgery.  Following surgery, animals were house in 
standard-sized rat cages with unrestricted movement and were allowed to bear weight on the 
operated extremity as tolerated.  All animals were housed for a 12-week recovery period. 
 
In-vivo Contractile Force Measurement 
Peak tetanic contractions produced by the TA muscle were measured isometrically in 
vivo using procedures described by Corona and familiar to our group (Corona et al., 2013; B. 
Kasukonis et al., 2016). Animals were anesthetized (isoflurane) and the lower limb was 
stabilized at 90° of knee flexion (tibia parallel to the benchtop) using a custom made alignment 
jig. The ankle was flexed to 90° and the foot was secured (surgical tape) to the lever arm of a 
dual-mode muscle lever systems (Aurora Scientific, Ontario, Canada,). To isolate the 
contribution of the TA during force measurement, distal tenotomies were performed on the 
extensor digitorum longus (EDL) and extensor halluces longus (EHL). TA peak isometric tetanic 
force was measured by stimulating the peroneal nerve with the aid of a physiological stimulator 
(Grass; S88). Optimal voltage (2 – 5 V) was determined using a series of tetanic contractions 
(150Hz, 0.1 ms pulse width, 200 ms train). Average peak tetanic force for each animal was 
calculated from an average of 5 contractions. All contractions were separated by one minute of 
rest. Raw peak tetanic contractile force (N) was recorded from both the treated and contralateral 
control limb of each animal and normalized to animal weight (N/kg). The weight normalized 
(N/kg) and contralateral limb normalized (% normal) force data is reported in the results section. 




dioxide inhalation in accordance with guidelines provided by the 2013 AVMA Panel on 
Euthanasia of Animals.  
 
Gene Expression 
 RT-PCR was performed using the protocol reported by Washington et al (Washington et 
al., 2013).  In preparation for RT-PCR, samples of muscle from the defect site of the right and 
left TA (n≤5 animals/group) were homogenized with Trizol (Ambion, Carlsbad, 
CA)/choloroform (Sigma Aldrich, St. Louis, MO). Samples were treated with DNase 
(Invitrogen, Carlsbad, CA) and then RNA was extracted using an RNAeasy kit (Invitrogen, 
Carlsbad, CA). After quantification of RNA with a plate reader (BioTek, Winooski, VT), RNA 
was converted to cDNA with a kit (Invitrogen, Carlsbad, CA). TAQMAN primers (Invitrogen, 
Carlsbad, CA) for Collagen I, Collagen III, TGF-β, IGF-1, Pax7, MyoD, MyoG, IL-1β, TNF-α, 
IFN-γ, TRIM72, IRS-1, FOXO1, Notch1, Jag1, and 18S rRNA housekeeping were used to 
quantify the expression of desired genes. Experimental sample group expressions were 
normalized to 18S rRNA and then referenced to the contralateral normal limb. Gene expression 
levels are reported as fold change using the 2-(ΔΔCt) method. 
 
Non-contractile Tissue and Fiber Cross-Sectional Area Measurements 
Collagen type I accumulation was quantified within normal and treated muscle tissue 
sections using measures of Collagen I (Sigma Aldrich, St. Louis, MO) immunoreactivity with 
myosin heavy chain (Developmental Studies Hybridoma Bank, Iowa City, IA) as a counter stain. 
Representative tissue sections were imaged (200X), converted to 8-bit greyscale, and a uniform 




each section. From each image, tissue immunoreactivity to collagen I as a percentage of total 
tissue area was calculated with the aid of image analysis software (ImageJ, NIH) and is reported 
in the results as percent non-contractile tissue (% NCT). Similar image analysis methods were 
used to compute mean muscle fiber cross-sectional area (µm2) using magnified (200X) collagen 
III immunoreactivity images. Collagen III immunostained images were similarly converted to 
greyscale and thresholded to isolate the borders of individual muscle fibers (typically 50+ fibers 
per image). Representative tissue sections collected from four animals per group were used for 
all calculations. Three sections were imaged and analyzed to calculate the mean %NCT and fiber 
cross-sectional area for each animal. A total of twelve images (4 animals X 3 sections/animal) 
were analyzed for each treatment group.  All image analysis was performed following a protocol 
established by our group (Kim et al., 2016) with set parameters to minimize any user bias. 
 
Serum Testosterone Analysis 
The Ultra-Sensitive Mouse & Rat LH ELISA is an in-house method based on a 
manuscript published by Steyn et al (Steyn et al., 2013). This assay allows for a LH 
measurement in 2.5 – 5ul of serum, plasma or whole blood. The capture monoclonal antibody 
(anti-bovine LH beta subunit, 518B7) is provided by Janet Roser, University of California. The 
detection polyclonal antibody (rabbit LH antiserum, AFP240580Rb) is provided by the National 
Hormone and Peptide Program (NHPP). HRP-conjugated polyclonal antibody (goat anti-rabbit) 
is purchased from DakoCytomation (Glostrup, Denmark; D048701-2). Mouse LH reference prep 
(AFP5306A; NHPP) is used as the assay standard. The Limit of Quantitation (Functional 
Sensitivity) is defined as the lowest concentration that demonstrates accuracy within 20% of 




serial dilutions of a defined sample pool. Intra-assay %CV is 2.2%. Inter-assay %CVs are 7.3% 
(Low QC, 0.13 ng/ml), 5.0% (Medium QC, 0.8 ng/ml) and 6.5% (High QC, 2.3 ng/ml). 
Functional sensitivity is 0.016 ng/ml. 
 
Statistical Analysis 
 Data is presented as the mean ± standard deviation and was tested for normality using the 
Shapiro-Wilks test. The following dependent variables were analyzed using a two-way ANOVA: 
body weight; TA mass; gastrocnemius mass; EDL mass; peak isometric torque; non-contractile 
tissue percentage, fiber cross-sectional area; myogenic, ECM, and inflammatory gene 
expression. Post-hoc comparisons were performed using Tukey’s HSD test and if detected, 
interaction effects were reported. Comparisons between 3-month ND(-) repair, 18-month ND(-) 
repair, and 18-month ND(+) repair groups were conducted via one-way ANOVA with a Tukey’s 
HSD post test. Comparison between ND(-) and ND(+) group means were conducted by 
Student’s t-test. Chi-square analysis was performed to compare body weight curves, survival 
curves, and fiber area frequency distributions. All analyses were performed using commercial 




Animal Growth  
 Following VML injury repair, all animals appeared to tolerate surgery well and were 
fully ambulatory within 1 week of the procedure. No surgical complications that required 




total of 18.1±25.2g while the ND(+) repair animals lost a total of 26.1±8.4g. ND(-) and ND(+) 
repair groups lost weight at similar rates of -2.3±3.2g/wk and -3.3±1.2g/wk, respectively (Figure 
2D). No statistical differences were found for both total weight loss and growth rate between the 
two groups. 
TA, EDL, and Gastrocnemius Muscle Mass 
 Compared to normal TA morphology, the repaired muscles for both the ND(-) and ND(+) 
groups appeared significantly atrophied with a visible defect at the site of VML repair (Figure 
3A). A main effect of treatment (p<0.0001) to reduce TA mass was detected. Post hoc analysis 
revealed that within their respective treatment groups, normal TA mass for the ND(+) (1.34±0.10 
g/kg, p<0.0001) and ND(-) (1.32±0.07 g/kg, p=0.0005) groups were significantly higher than 
their ND(-) counterparts (1.07±0.08 g/kg and 1.12±0.09 g/kg)(Figure 3B). However, no 
significant differences in TA mass were detected between the ND(+) and ND(-) groups.  
In the gastrocnemius muscles, a main effect of treatment (p=0.0002) was detected to 
increased gastrocnemius mass (Figure 3C). Specifically, ND(+) uninjured gastroc muscles 
weighed significantly less compared to ND(+) repair muscles (4.14±0.08 vs. 4.52±0.08, 
p=0.0074) while no significant differences were detected within the ND(-) group.  For EDL 
mass, an interaction effect between treatment and testosterone (p=0.0358) was detected to 
decrease EDL mass (Figure 3D). Post hoc analysis revealed that EDL mass from the ND(-) 







In vivo Peak Isometric Torque Measurements 
 In vivo torque readings were characterized by a rapid rise torque followed by a stable 
plateau at the peak value and then concluding with a sharp descent to a normal resting state 
(Figure 4A). Similar to our previous aging studies, there was a main effect of treatment to 
decrease peak isometric torque (p<0.0001)(Figure 4B). Post hoc analysis indicated that the 
ND(+) repair group TA produced significantly less force than its control counterpart (1.17±0.29 
N/kg vs 1.87±0.38 N/kg, p<0.0006). Despite the absence of a significant difference in peak 
torque between the ND(-) control and repair groups, a decreasing trend in force production was 
observed with VML repair. These findings are consistent with previous findings utilizing this 
aged animal model. Additionally, no difference was detected between % normal torque between 
the ND(+) (64.5±18.3%) and ND(-) groups (80.9±37.9%)(Figure 4C).  
 
Heart and Testes Mass   
Heart mass measurements revealed that there was a significant increase in mass in the 
ND(+) group compared to the ND(-) group (2.77±0.18 g/kg vs. 2.59±0.17 g/kg, 
p=0.0068)(Figure 5A). Additionally, it was revealed that ND injections significantly decreased 
testicular mass in the animals when compared to the ND(-) animal group (5.84±0.84g/kg BW vs. 








 Interestingly, serum testosterone concentration was detected to be significantly higher in 
the ND(-) group compared to the ND(+) repair group (p=0.0063)(Figure 5C). Specifically, the 
ND(-) repair group’s serum testosterone concentration (93.1±30.7 ng/dL) was approximately 
38% higher than the ND(+) repair group (63.5±11.4 ng/dL).  
 
Histology 
 Masson’s trichrome staining revealed tightly apposed muscle fibers throughout both 
ND(-) and ND(+) uninjured groups, with no sign of disorganized or abnormal tissue (Figure 6). 
However, the respective repair groups were characterized with areas of dense collagen-rich scar 
regions as well as diffuse non-contractile tissue infiltration extending medially from the anterior 
surface of the muscle. By comparison, however, the ND(-) repair group had significantly more 
scarring at the anterior surface than its ND(+) counterpart. Additionally, while the ND(+) repair 
group maintained myofiber presence within and surrounding the repair site, the ND(-) repair 
tissue was largely devoid of myofibers, suggesting a greater degree of atrophy compared to its 
ND(+) counterpart. 
 
Fiber Cross-sectional Area and Non-contractile Tissue Measurements 
 Regions immune-reactive to collagen I provided a semi-quantitative measure of scarring 
or percentage non-contractile tissue (Figure 7A).  Myofiber cross-sectional area distribution 




in the range of 1000-2000µm2. Though no significant differences were detected between fiber 
area distributions for all groups, the greatest difference in fiber area frequency (~7%) was 
observed in the 1000-2000µm2 range between the ND(+) repair (35.9%) and ND(+) uninjured 
(28%) groups while ND(-) uninjured and repair groups exhibited similar fiber area frequencies 
(32% vs. 32.4%).   Following statistical analysis, an interaction effect of treatment and drug was 
detected. Within the ND(-) group, a significant increase in percent non-contractile tissue was 
measured in the repair TA compared to the uninjured TA (15.6±5.5% vs. 6.4±0.8%, 
p<0.0001)(Figure 7C). Within the ND(+) however, no differences were detected between the 
uninjured and repair groups. Post hoc analysis revealed that both the ND(+) uninjured and 
ND(+) repair groups contained significantly less percentages of non-contractile tissue than the 
ND(-) repair group (6.1±1.1% and 9.3±3.2% vs. 15.6±5.5%, p<0.0001 and p=0.0046 
respectively). Interestingly, though no significant differences were detected in   No significant 
differences in myofiber cross-sectional area was detected with all groups containing similar 
mean cross-sectional areas ranging from 2100 µm2 to 2200 µm2 (Figure 7D). 
 
Gene Expression 
 Myogenic gene expression (Pax7, MyoD, MyoG, IGF-1) within the ND(-) and ND(+) 
was not found to be significantly different (Figure 8). However, though not significantly 
different, MyoD expression had an elevated trend in the ND(+) control group compared to the 
ND(+) repair group as well as their ND(-) counterparts. Overall, expression for myogenic genes 
was similarly muted across all groups.  Interestingly, among the inflammatory markers TNF-α, 
IFN-γ, and IL-1ß, IL-1ß was the only gene to be expressed at detectable levels. An effect of 




change vs. 4.2±3.6 fold change) and ND (0.6±0.5 fold change vs. 2.8±1.1 fold change) groups 
(p=0.0198).  
 Among ECM-related genes (Col I, Col III, TGF-ß), Col III was the only target to be 
differentially expressed, exhibiting an effect of treatment to increase its expression (Figure 8). 
Specifically, the ND(+) repair group (16.4±18.1 fold change) expressed Col III approximately 
47-fold higher than the ND control group (0.4±0.01 fold change). TGF-ß expression was not 
found to be significantly different across all groups, though there was a trend of increasing 
expression following repair for both non-ND and ND groups. An interesting trend in expression 
was found for Col I, though no significant differences were found. While treatment appeared to 
result in lower expression in the non-ND repair group compared to the non-ND control group, 
the opposite response was observed for the ND repair group compared to the ND control group 
with the ND repair group trending towards higher Col I expression by approximately 4-fold. 
 While examining the expression of genes related to IGF-1 signaling and atrophy 
(TRIM72, IRS-1, FOXO1), a main effect of age was detected to decrease the expression of IRS-
1 and FOXO1 (p<0.0001 and p<0.0001, respectively) in the 18-month ND(-) and ND(+) groups 
compared to the 3-month ND(-) counterpart (Figure 9). Specifically, FOXO1 was expressed 
approximately 33-fold and 50-fold lower in the 18-month non-ND (0.03±0.01 fold change, 
p<0.0001) and ND (0.02±0.01 fold change, p<0.0001) groups, respectively than the 3-month 
non-ND group (1.0±0.2 fold change). IRS-1 was expressed 100-fold lower in both the 18-month 
non-ND (0.01±0.01 fold change, p<0.0001) and ND (0.01±0.004 fold change, p<0.0001) groups 
compared to the 18-month non-ND group (1.0±0.1 fold change). No differences were found in 




month non-ND and ND groups (1.6±0.9 fold change and 1.1±0.3 fold change, respectively) 
compared to the 3-month non-ND counterpart (1.0±0.5 fold change). 
 Associated with satellite cell activity and myogenic regulation, the expression of the 
Notch signaling receptor Notch1 and its ligand, Jag1, were measured between 3-month –ND, 18-
month –ND, and 18-month ND treatment groups (Figure 9). No significant differences were 
detected between groups for both Notch1 and Jag1. However, an increasing trend of Notch1 
expression was observed in the 18-month ND group (1.38±1.30 fold change) compared to both 
18-month –ND (1.17±1.13 fold change) and 3-month –ND groups (1.00±0.56 fold change). 
Interestingly, Jag1 expression in both 3-month -ND and 18-month ND groups were similarly 
expressed at levels approximately 2.5 folds more than (1.00±0.27 vs. 0.94±0.92 fold change, 
respectively) the 18-month –ND group (0.39±0.25 fold change). 
 
D. Discussion 
 In this in vivo study we observed modest improvements in recovery following VML 
repair with testosterone administration in 18-month rats. Specifically, there appeared to be 
reduced scarring following VML repair in the ND treated animals compared to their -ND 
counterparts. However, no significant changes were found in force production and force recovery 
following VML repair as a result of ND administration. In addition, there were no observations 
to indicate muscle hypertrophy as a result of ND administration. These findings are meaningful 
when considering anabolic steroid supplementation to VML repair as they alone may not be able 
to elicit a strong regenerative response and overcome the dysfunctional environment formed by 




injury models in both young and aged animals have resulted in beneficial effects to myogenesis 
but the results have varied from model to model (Beiner, Jokl, Cholewicki, & Panjabi, 1999; 
Ferry et al., 1999; White, Baltgalvis, Sato, Wilson, & Carson, 2009). Overall, the results of this 
study suggest that the treatment strategy used would prove more effective if used in conjunction 
with rehabilitative strategies in order to improve muscle quality and create an environment that is 
more receptive to treatment and recovery.  
   The use of ND has been explored extensively as a means to combat muscle wasting as a 
result of various conditions including disuse atrophy (Camerino et al., 2015; Chen, Lin, Chen, & 
Hsu, 2013), sarcopenia (Serra et al., 2013), and cachexia (Gold et al., 2006; Mulligan et al., 
2005). These studies demonstrated improvements to body weight and lean body mass with the 
added benefit of improving physical activity in test subjects. However, we observed no such 
improvements to body weight maintenance within this study nor any improvements to peak 
tetanic contractions in the repaired TA muscles. Conflicting results across studies using ND as a 
therapeutic to combat wasting can be attributed to differences in species used in the studies, 
frequency of ND administration, and dosage, among other variables. Interestingly, it has also 
been reported that chronic administration of ND had no effects on body weight and in some 
cases decreased body weight (Oda & El-Ashmawy, 2012; Shahraki, Mirshekari, & Shahraki, 
2015), which is in agreeance with our observations. Additionally, consistent with the use of 
anabolic steroids, chronic ND use has also been reported to cause decreased bioavailable 
testosterone (Nagata et al., 1999; Takahashi, Tatsugi, & Kohno, 2004), impaired 
spermatogenesis, depletion of Leydig cells, and reduction in fertility (Svechnikov, Izzo, Landreh, 




 In both recreational and clinical use, testosterone has a well-documented effect of not 
only inducing skeletal muscle hypertrophy but also increasing the number of satellite cells and 
myonuclei in young and older subjects in a dose-dependent manner(Bouhlel, Joumaa, & Leoty, 
2003; Kadi et al., 2000; Sinha-Hikim et al., 2002; Sinha-Hikim et al., 2006; Sinha-Hikim et al., 
2003). Bhasin et al (Serra et al., 2013) also reported increased fiber cross-sectional area after 
treatment with testosterone, though fiber hypertrophy was limited to the early stages of myofiber 
regeneration following cardiotoxin injury.  The lack of peak tetanic contraction improvement 
observed in this study may be attributable to a lack of myofiber hypertrophy as evidenced by an 
absence of change in fiber cross-sectional area between treatment groups in the current study. It 
is likely that any regenerating fibers fully developed and matured by the end of the 8-week study 
endpoint. Non-contractile tissue percentages were observed to decrease following ND 
administration, which is in agreement with previous studies investigating the use of anabolic 
steroids in the clinic to aid in recovery following rotator cuff repair in sheep and rabbits (Gerber 
et al., 2015; Gerber, Meyer, Nuss, & Farshad, 2011). Gerber et al. found that administration of 
nandrolone decanoate immediately following rotator cuff tendon repair resulted in a significant 
reduction in intramuscular fat accumulation during recovery as well as attenuation of muscle 
atrophy. Taken together, these findings are confounding, given the ability of anabolic steroids to 
increase muscle protein synthesis and hypertrophy primarily through the activation of the 
mammalian target of rapamycin (mTOR) pathway (Basualto-Alarcon, Jorquera, Altamirano, 
Jaimovich, & Estrada, 2013; Favier, Benoit, & Freyssenet, 2008).  
 Androgens and anabolic steroids have been shown to regulate Wnt and Notch signaling 
pathways in skeletal muscle, which are crucial in determining myogenic stem cell fate and 




Rando, 2008; Brack et al., 2007; Conboy & Rando, 2002; Cossu & Borello, 1999). Further, 
Notch signaling is essential for the maintenance of satellite cell quiescence and renewal during 
postnatal myogenesis (Bjornson et al., 2012; Fukada et al., 2011; Mourikis et al., 2012). Our 
observations of Notch1 gene expression indicated no differences between the 3-month –ND, 18-
month –ND, and 18-month ND groups though there was an increasing trend of Notch1 
expression following ND administration. In addition, Jag1 expression was similar between the 3-
month –ND and 18-month ND groups, with both groups following a decreasing trend in 
expression. These results are in agreement with a study conducted by Carey et al. in which 
reduced expression of Notch signaling genes was only observed in human skeletal muscle from 
older individuals (60-75 years old) compared to muscle from younger men (18-25 years old) 
(Carey, Farnfield, Tarquinio, & Cameron-Smith, 2007). This suggests that ND administration in 
aging skeletal muscle following VML repair is able to stimulate Notch signaling.  However, the 
near basal levels of Pax7 expression in the 18-month ND group belie the observed Notch1 
expression in the same group. Moreover, the absence of myofiber hypertrophy and de novo fiber 
formation in both ND(-) and ND(+) treated groups suggests poor anabolic sensitivity in aging 
muscle. 
 A previous investigation into elderly human subjects’ response to anabolic stimuli 
revealed a reduced response of muscle protein synthesis to anabolic factors in addition to 
dysfunction in the activation of translation factors contributing to protein metabolism (Guillet et 
al., 2004). A similar resistant response to anabolic stimuli has been demonstrated in adult and old 
rats (Baillie & Garlick, 1992; Dardevet, Sornet, Attaix, Baracos, & Grizard, 1994). Based on the 
regulation of protein synthesis by insulin and amino acids (Shah, Anthony, Kimball, & Jefferson, 




1995), it is possible that the absence of muscle protein accretion observed in this study is due to a 
defect in the insulin signal transduction pathway. Dysfunction in insulin/IGF-1 signaling occurs 
via degradation of the insulin receptor substrate-1 (IRS-1) due to its role as a critical node 
through which subsequent activation of various signaling pathways occur. Aside from 
insulin/IGF-1 signaling, IRS-1 is also responsible for activation of the PI3k/AKT/mTOR 
pathway (Bodine et al., 2001; Bohni et al., 1999; Rommel et al., 2001). The mechanism of IRS-1 
degradation is still widely debated though a common observation by researchers is that it occurs 
through a negative feedback loop within the PI3K/AKT/mTOR signaling axis (Haruta et al., 
2000; A. V. Lee, Gooch, Oesterreich, Guler, & Yee, 2000; Tzatsos & Kandror, 2006; Zhande, 
Mitchell, Wu, & Sun, 2002). An alternative mechanism of IRS-1 degradation involves the 
muscle-specific mitsugumin 53 (MG53; also called TRIM72) marking IRS-1 for ubiquitination 
(C. S. Lee et al., 2010; Song et al., 2013). The low expression of IRS-1 and increasing trend in 
TRIM72 expression in the 18-month animals compared to their 3-month counterparts seems to 
suggest that ubiquitin-mediated degradation of IRS-1 may be occurring and supports the lack of 
animal growth and functional improvements observed in the study. These findings, however, 
present a new set of challenges in developing VML repair techniques in the elderly population as 
insulin/IGF-1 pathway dysfunction is closely associated with insulin resistance in metabolic 
syndrome and type 2 diabetes (Eckel, Grundy, & Zimmet, 2005). 
 The results of this study would have benefitted from the addition of earlier time points in 
order to investigate the mechanistic changes as a result of the VML repair treatment utilized. It 
has been well-established that muscle satellite cell contribution during regeneration accounts for 
the majority of the regenerative capacity of skeletal muscle (Conboy & Rando, 2005). During 




and as such, the effects of nandrolone on satellite cell activity as well as on myogenic cell cycle 
regulatory factors such as MRFs (Lu, Jenster, & Epner, 2000) were not captured within this 
study. An important factor of aging skeletal muscle that was not considered in this study is the 
role of metabolism and how perturbations to aging skeletal muscle metabolism modulate muscle 
stem cell function and homeostasis. Of particular interest is nutrition with a focus on calorie 
restriction as it has been well-documented to be an effective strategy in increasing satellite cell 
abundance in aging skeletal muscle as well as increasing mitochondrial abundance and inducing 
conservation of metabolic and longevity regulators (Barger, Walford, & Weindruch, 2003; 
Cerletti, Jang, Finley, Haigis, & Wagers, 2012; Shyh-Chang, Daley, & Cantley, 2013).   
 
E. Conclusion 
 In summary, the present study is the first to assess the treatment outcomes from 
administering nandrolone decanoate in conjunction with a minced muscle loaded decellularized 
muscle ECM scaffold to repair VML in aging rats. VML repair followed by nandrolone injection 
reduced collagen I accumulation at the defect site, which was reinforced with the downregulation 
of the transcription factor for collagen I and upregulation of collagen III. Further, 
downregulation of transcription factors related to Notch and insulin signaling independent of 
nandrolone injection but sensitive to age suggested dysfunction within these pathways, which 
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Figure 1: Surgical VML and repair procedure.  The surgical site was cleaned and disinfected and 
a 1-2 cm incision was made to expose the underlying TA muscle (A,B). An 8mm biopsy punch 
was used to create a VML injury to a depth of 3mm (C). Approximately 20% of the TA muscle 
was excised (D).  MM autografts were prepared using 50% (by mass) of the removed muscle 
plug and hand mincing with scissors and scalpel (E).  The resulting MM paste was used to coat a 
DSM scaffold prior to implantation into the defect site.  The MM coated DSM scaffold was 
packed into the defect with the scaffold oriented to the direction of muscle alignment (F). The 
surgical site was closed using both deep and surface sutures (G). Depending on treatment group, 
either ND or sesame oil depot injections were administered in the vastus lateralis muscle (H) 
followed by subcutaneous injection of buprenorphine. The uninjured contralateral limb served as 
a comparative control. 
Figure 2: Animal body mass and survival analysis. Animal weights as a percentage of initial 
weight was tracked throughout the study period (A). Survival curve for animals (n=15/group) 
over the 8-week study period is presented (B). Growth rate (C) was calculated on a weekly basis 
and final body weight at the end of 8 weeks was compared between all groups (D). 
Figure 3: Gross morphology of ND(-) uninjured, ND(-) repair, ND(+) uninjured, and ND(+) 
repair TA muscles. Dashed circle approximates the location of the defect site. TA (B), 
gastrocnemius (C), and EDL (D) wet weights were normalized to animal body weight (g/kg) for 
each group and presented as means + SD; n=7-13/group; * denotes statistically significant 
differences between groups (p<0.05). 
Figure 4: Representative in vivo peak force readings for each treatment group (A). Peak 
isometric torque was normalized to animal body weight (Nmm/kg) for each group (B)  and was 
also calculated relative to uninjured contralateral TA muscle values (% normal) for each animal 
tested (C). Data is presented as means + SD; n=7-13/group; * denotes statistically significant 
differences between groups (p<0.05). 
Figure 5: Animal heart (A) and testes (B) wet weights were normalized to body weight (g/kg). 
Additionally, serum isolated from whole blood was analyzed for serum testosterone 
concentrations for all animals tested (C). Data is presented as means + SD; n=7-13/group; * 
denotes statistically significant differences (p<0.05). 
Figure 6: TA muscle cross-sections stained with Masson’s Trichrome. Representative whole TA 
sections and magnified (100X). TA cross-sections were also immunostained with myosin heavy 
chain (red) and counterstained with collagen I (green). Open arrows highlight regions and bands 




Figure 7: Myofiber cross-sectional area and non-contractile tissue (%) was measured from TA 
muscle cross-sections immunostained for collagen I and collagen III (A). Images were acquired 
at a magnification of 100X. Fiber area frequency distributions (B) and group data for non-
contractile tissue (%)(C) and fiber cross-sectional area (D) are shown. Scale bar = 100µm. Data 
is presented as group means + SD; n=4/group; * indicates significant differences based on 
treatment and # indicates significant differences based on drug (ND) (p<0.05).  
Figure 8: Comparison of relative gene expression for ND(-) uninjured, ND(-) repair, ND(+) 
uninjured, and ND(+) repair groups using RT-PCR. The expression of myogenic (Pax7, MyoD, 
MyoG), ECM and ECM regulatory (collagen I, collagen III, TGF-ß), and inflammatory genes 
(IL-1ß, TNF-α, IGF-1) were measured using tissue harvested from the VML repair site. 
Expression is presented as log2 fold change normalized to ND(-) uninjured muscle expression. 
Data is presented as group means + SD; n=4/group; * indicates statistically significant 
differences based on treatment (uninjured vs. repair) and # indicates significant differences based 
on drug (ND(-) vs. ND(+)) (p<0.05). 
Figure 9: Comparison of relative gene expression for 3-month ND(-) repair, 18-month ND(-) 
repair, and 18-month ND(+) repair groups using RT-PCR. The expression of genes related to 
satellite cell activity (Notch-1, Jag-1) and insulin signaling (TRIM72, FOXO1, IRS-1) were 
measured using tissue harvested from the site of VML repair. Expressionis presented as log2 fold 
change normalized to 3-month ND(-) repair muscle expression. Data is presented as groups 








































































A. Future Directions 
 Age-associated changes in skeletal muscle have been well-documented for many 
decades, with the first studies focusing on morphological changes with aging  (Fudel'-Osipova, 
1963; Ingelmark & Gustafsson, 1957; Lohmann, Wielepp, & Nocker, 1957) and eventually 
moving towards understanding the mechanisms of dysfunction in aging muscle that preclude 
effective regeneration and function (Buliakova, 1987; Herrmann, 1987; Lewis & Schmalbruch, 
1995; Sadeh, 1988; Snow, 1977; White & Esser, 1989). With a wealth of foundational research 
available, it would be of great benefit to incorporate such mechanistic methodologies into aging 
VML repair investigations. It would not be unreasonable to assume that that the aging VML 
microenvironment would appear even more dysfunctional than in lesser injury models as VML 
has been demonstrated to result in an overwhelmingly inflammatory and fibrotic response 
resembling various pathological conditions such as muscle dystrophy (Greising et al., 2017; 
Larouche, Greising, Corona, & Aguilar, 2018; Mann et al., 2011). As there is no current research 
being pursued in age-associated changes in regeneration following VML injury and repair, 
understanding the broad changes in aging skeletal muscle and how they affect the regenerative 
process in a VML environment would be indispensable in the pursuit of developing effective 







 ECM, specifically skeletal muscle derived acellular scaffolds, has been previously 
demonstrated to provide a pro-myogenic environment, exerting control over cell migration, 
proliferation, and differentiation leading to constructive tissue remodeling and repair (Faulk, 
Johnson, Zhang, & Badylak, 2014; Perniconi et al., 2011). The mechanical and compositional 
characteristics of the ECM directly affect satellite cell activity as well as their self-renewal and 
proliferative capacity (Gilbert et al., 2010; Montarras et al., 2005; Urciuolo et al., 2013). 
Myogenic progenitors can also exert control over the local microenvironment (El Fahime, 
Torrente, Caron, Bresolin, & Tremblay, 2000; Guerin & Holland, 1995) as well as their own cell 
fate in a self-regulatory manner (Kuang, Gillespie, & Rudnicki, 2008). However, in an altered 
microenvironment as is observed with aging, there are alterations in ECM composition that may 
negatively affect cell behavior and function. ECM derived from senescent mesenchymal stem 
cells (MSCs) was found to have an altered composition of proteins implicated in cell-ECM 
interactions including laminin, collagens, TGF-ß, and LOXL-1 (Pohlers et al., 2009; Rodriguez, 
Rodriguez-Sinovas, & Martinez-Gonzalez, 2008). As a result, the altered ECM has been 
demonstrated to “re-program” gene expression patterns in cells such as fibroblasts and MSCs (H. 
R. Choi et al., 2011; Choi, Kurtz, & Stamm, 2011). However, the exact mechanism of these 
interactions are still unknown and warrant further investigation. 
 
Hormonal and Secretory Alterations  
 There are distinct changes in the levels of circulating hormones associated with the 




alterations affecting several hormonal networks involved in inflammation, muscle regeneration, 
and prtotein synthesis (Vitale, Cesari, & Mari, 2016). Significant reductions in the levels of 
circulating factors such as testosterone, IL-6, growth hormone (GH), and IGF-1 have been 
detected in serum samples from aged subjects (Gordon et al., 2014; Kojo et al., 2014; Sattler, 
2013). Epidemiological studies have shown that decreased levels of GH secretion are correlated 
with sarcopenia as well as other hallmarks of aging including increased adipose tissue 
accumulation, osteopenia, etc. (Thorley et al., 2015; Veldhuis, 2008). GH has also been shown to 
stimulate IGF-1, which can modulate myoblast proliferation (Brisson & Barton, 2012) and 
differentiation (Matheny & Nindl, 2011) through the signaling of the MAPK and ERK1/2 
pathways (Brisson & Barton, 2012; Troy et al., 2012). Also associated with IGF-1 is the 
androgen, testosterone, which promotes anabolism and IGF-1 secretion in muscle while reducing 
adipose-tissue formation (M. A. Gentile et al., 2010). In vitro treatment of C2C12 myoblasts 
with androgen-induced secreted factors (IGF-1Ea and mechano growth factor (MGF)) led to 
nuclear accumulation of ß-catenin, a pro-myogenic, anti-adipogenic stem cell regulatory factor 
(M. A. Gentile et al., 2010). In addition to changes in levels of circulating hormones with aging, 
the local muscle secretome is also affected, which may act on neighboring host cells in an 
autocrine/paracrine manner (Thorley et al., 2015).  
 
Stress Pathways 
 As satellite cells age they become more susceptible to apoptosis and senescence, 
rendering them less resistant to cellular stresses that limit their ability to function properly 




groups have identified multiple molecular pathways associated with cellular stress including p38 
MAPK (Kodama et al., 2013; Mandal, Blanpain, & Rossi, 2011), JAK-STAT3 (Park, Dahmer, & 
Quasney, 2012), and p16INK4A (Ramsey & Sharpless, 2006). Increased signaling in these stress 
pathways not only induce mitochondrial dysfunction and increase the production of reactive 
oxygen species leading to DNA damage, they have been demonstrated to limit the proliferative 
capacity of aged satellite cells as well as impairment of cell engraftment and myotube formation 
(Cerletti, Jang, Finley, Haigis, & Wagers, 2012). Some of these deleterious effects can be 
reversed, however, as was demonstrated in a study where introducing a p38 MAPK inhibitor to 
satellite cell cultures in vitro restored their proliferative ability while improving satellite cell 
engraftment and myotube formation when cells treated with the inhibitor were transplanted into 
immunodeficient mice compared to control groups (Charville et al., 2015). These observations 
provide a possible cause as to why DSM+MM treatment in a previous study presented in this 
dissertation was not able to elicit a significant myogenic response as was detected by RT-PCR 
and improve muscle force production. Nonetheless, pathways such as these that inhibit satellite 
cell functional output provide future therapeutic targets that may help mitigate cellular stress and 
rejuvenate their functional capabilities. 
 
B. Evaluation of Myogenesis in the Aging Niche 
 The current criteria for assessing the success of VML treatment strategies currently rely 
largely on functional measurements, histology, and the biomolecular profile of the treated 
muscle. However, for evaluating success in an aging model, the previously mentioned factors 




treatment in aging animals. As demonstrated by the significant differences in treatment outcomes 
presented in the studies in this dissertation, there is a need for investigating the source of 
dysfunction in the aging animals that prevent successful VML repair. By incorporating some of 
the techniques and molecular targets found in traditional gerontological and current VML 
research into future aged VML studies, a more comprehensive understanding of age-associated 
impedance to effective tissue repair can be obtained so that more effective treatment strategies 
addressing the multi-factorial nature of not only VML but age-associated decline in regenerative 
potential can be resolved.  
 
Histology 
 Current histological protocols allow for the evaluation of myogenesis, fibrosis and 
inflammation, angiogenesis, and innervation of skeletal muscle tissue. Immunofluorescence (IF) 
staining of muscle-specific motor proteins such as sarcomeric myosin heavy chain (MHC), 
embryonic myosin heavy chain (eMHC), and satellite cell related transcription factors such as 
Pax7 and Ki67 provide researchers with the ability to assess the degree of myogenesis and 
myofiber development and maturation while also providing information regarding satellite cell 
activation and proliferation. Angiogenesis can also be assessed via IF staining of angiogenic 
proteins such as vascular endothelial growth factor (VEGF), CD31, and anti-hypoxia-induced 
factor-1α (HIF-1α). A quantitative measure of innervation can be obtained by the use of α-
bungarotoxin, a competitive antagonist to the acetylcholine receptors located at neuromuscular 
junctions. Fibrosis can be assessed qualitatively via IF staining for collagen I or using dye based 




quantitative measures of fibrosis can be obtained using image analysis techniques to calculate the 
percentage of the muscle area occupied by immunopositive regions of collagen I. 
 An interesting addition to current histological protocols would be the use of muscle fiber 
typing as there have been documented changes to fiber type composition in response to external 
stimuli (Miljkovic, Lim, Miljkovic, & Frontera, 2015).  For instance, type I fibers are susceptible 
to atrophy induced by disuse or denervation whereas type II fibers are affected by pathological 
conditions such as cancer, diabetes, heart failure, and aging (Wang & Pessin, 2013). Based on 
information from fiber typing, potential targets within the microenvironment and signaling 
pathways involved in potentiating the compositional changes in aging muscle fibers can help 
guide the development of more effective treatment strategies.  
 
Biomolecular Analysis  
 There are a wide variety of quantitative methods available in the field of tissue 
engineering and biology that provide information on the biomolecular response in tissues to 
treatment strategies. In VML, one of the more commonly used analytical methods is RT-PCR for 
examining gene expression relating to myogenesis, inflammation, angiogenesis, and innervation. 
One disadvantage of PCR techniques, however, is that it only provides a single temporal 
snapshot of the biomolecular changes initiated in response to treatment. Moreover, relative gene 
expression at a certain time point may not account for potential post-transcriptional or post-
translational modifications following translocation of the factor to the nucleus. This raises the 
issue of genotype vs. phenotype and the difficulty in discerning whether the phenotypical 




issue however can be resolved with the incorporation of multiple time points, especially short 
time points, for an improved temporal understanding of the transcriptional response to treatment. 
As stated previously, the terminal differentiation of myoblasts and myofiber formation culminate 
at approximately 14 days post. Short time points would provide valuable information regarding 
satellite cell-mediated regeneration and could provide indications of dysfunction within the 
myogenic program. 
 Western blotting is another biomolecular analytical tool providing information on protein 
expression captured at a single time point. With the ability to detect single proteins of interest, 
the technique provides researchers with the ability to investigate cell signaling pathways, whose 
activation or inhibition is paramount for maintaining tissue homeostasis and regulating cellular 
function. The presence or absence of specific proteins involved signaling pathways will point to 
dysfunction or inhibition of the pathway, often leading to aberrant changes that result in limited 
cell functional output (e.g. reduced satellite cell activation, increased apoptosis, cellular 
senescence) that translate to poor treatment outcomes at the tissue level. 
 To date, very few groups in the VML field have leveraged the power of whole 
transcriptome sequencing techniques such as RNASeq (Aguilar et al., 2018). Though the 
technique has been around for approximately a decade, it was not until recently that it was 
applied in the field of skeletal muscle tissue engineering. The study performed by Aguilar et al. 
sequenced minced muscle graft repair tissue and control tissue from 3, 7, 14, 28, 56 days post-
injury, providing their group with a detailed and quantitative time course of tissue-level changes 
in response to regenerative therapy (Aguilar et al., 2018). The one unique aspect of RNASeq that 
will make it a ubiquitous technique used in research moving forward is the vast amount of data 




modifications, gene fusion, mutations, temporal changes in gene expression, and differences in 
expression between treatment groups (Maher et al., 2009). Such a powerful tool will be 
indispensable in furthering our understanding of major changes occurring within the tissue 
following VML repair and providing interesting targets for future therapies that may not be 
captured with traditional biomolecular techniques. 
  
Satellite Cell Engraftment 
 A question that remains with the aging VML repair studies presented in this dissertation 
is whether the transplanted cells in the form of the minced muscle graft that is co-delivered with 
DSM scaffolds actually contribute significantly to tissue repair. Studies have shown that the 
maintenance of the satellite cell niche improves the survival and engraftment capabilities of 
transplanted cells into a site of injury. Lesser injury models such as cryoinjury (Grounds & 
Yablonka-Reuveni, 1993) or myotoxin-induced injury models (Harris, 2003) result in local cell 
and myofiber death while preserving the satellite cell niche (basal lamina, nerves, vessels, etc.) 
which in principle should preserve engraftment, survival, and proliferation of transplanted 
satellite cells. A study performed by Boldrin et al. used genetically modified mice 
overexpressing ß-galactosidase (ß-gal) in myonuclei and satellite cells in order to identify donor 
cells within graft muscles (Boldrin, Neal, Zammit, Muntoni, & Morgan, 2012). The group 
injured muscle through various methods including myotoxin-induced injury and irradiation and 
found several interesting findings. If the grafted muscle’s host satellite cells survived the injury, 
they were able to more effectively contribute to tissue regeneration compared to the transplanted 




were able to take over tissue repair and contributed to the regeneration of de novo muscle tissue. 
They did observe, however, that if the engraftment of the transplanted cells were not prompt, 
engraftment was observed to be extremely poor implying that the satellite cell niche comprised 
of existing myofibers, ECM, and satellite cells are required to allow for donor cell engraftment 
and subsequent regenerative events to occur (Boldrin et al., 2012). These results suggest that 
transplanted cells in not only VML but the aging satellite cell niche would not be effective in 
contributing to myogenesis due to the VML-associated bulk loss of tissue (muscle tissue, nerves, 
vasculature, basal lamina, satellite cells) and age-associated perturbations to the niche as 
mentioned previously. It would be interesting to definitively demonstrate the engraftment 
capabilities of minced muscle grafts in aging VML models because it would provide specific 
targets within the niche that could be modulated or enhanced in order to augment tissue repair. 
 
Rehabilitation/Exercise 
 Exercise has been demonstrated in both rodents (Song, Kwak, & Lawler, 2006) and 
humans (Melov, Tarnopolsky, Beckman, Felkey, & Hubbard, 2007) to reverse or mitigate 
several age-associated changes in skeletal muscle. In both young(Carroll et al., 2015) and aged 
(Gosselin, Adams, Cotter, McCormick, & Thomas, 1998) rats, exercise has been demonstrated to 
reduce the amount of collagen cross-linking allowing for improved mechanical properties and 
mechanotransduction to resident satellite cells (Garg & Boppart, 2016), improved metabolism 
(Schultz et al., 2013), and increased satellite cell proliferation and differentiation (Smith & 
Merry, 2012). Until now, there have been only three published clinical reports in which 




pre- and post-repair (N. E. Gentile et al., 2014; Mase et al., 2010; Sicari et al., 2014). However, 
these studies reported mixed results in improvements in contractile output in the affected 
muscles. Interestingly, Corona et al. reported a significant increase (~100%) in the recovery of 
TA functional output following minced muscle graft repair combined with running wheel 
exercise when compared to minced graft repair only animals (Corona et al., 2013). However, 
Aurora et al. reported contrasting results when using an acellular porcine urinary bladder matrix 
in conjunction with rehabilitation therapy (Aurora, Roe, Corona, & Walters, 2015). Not only was 
the scaffold found to be unsuitable for regenerative purposes, physical rehabilitation did not 
improve functional response nor tissue remodeling (Aurora et al., 2015). Results from both 
studies suggest that in order for physical activity/rehabilitation to improve muscle function, the 
regenerative therapy used needs to be able to elicit a regenerative response resulting in the 
formation of de novo myofibers so that they may contribute to overall force production in the 
muscle. 
 
C. Remaining Challenges in Aging Myogenesis  
Androgen Insensitivity 
 Despite the fact that as a cohort aging men have lower levels of serum testosterone, many 
older men have normal to low-normal levels of testosterone, suggesting they are insensitive to 
the anabolic effects of testosterone (Kuhne, Mikulas, Paul, & Weidinger, 1989). This may be due 
in part to the observed reduction in androgen receptor numbers and weak affinity for the receptor 
associated with aging rats (Bhasin & Bremner, 1997; Haji, Kato, Nawata, & Ibayashi, 1981). In 




1979). In the last of the VML studies presented in this dissertation, the potent anabolic steroid 
nandrolone decanoate (ND) was administered in combination with DSM+MM for VML repair. 
The results from this study are consistent with what has been seen in aging rats and their 
insensitivity to androgens. There was no improvement in muscle functional output nor 
maintenance of body mass compared to control groups not receiving ND. However, there were 
improvements in animal survival rates and reduced fibrosis at the site of VML injury associated 
with the ND receiving repair groups. This could suggest that an aged rat model of VML may not 
be the appropriate model for exploring the regenerative effects of androgen/anabolic steroid 
therapy as there is an inherent bias towards insensitivity. Another possibility is that the anabolic 
steroid that was used in the study was not appropriate as chronic ND abused has been shown to 
reduce bioavailable testosterone in vivo (Barone et al., 2017). Further investigations exploring 
the intrinsic and extrinsic (environmental) changes in response to androgen/anabolic 
supplementation needs to be conducted to determine whether this form of therapy can be 
meaningful in long-term VML recovery and enhance regeneration in aging skeletal muscle. 
 
Innervation  
 One of the biggest challenges in skeletal muscle tissue engineering, especially in VML 
and aging VML research, is the permanent denervation of distal myofibers due to the bulk loss of 
the local muscle niche as well as excessive fibrotic deposition in the injury site. Though 
decellularlized scaffolds have the porous structure needed to accommodate proper cell migration 
and vascularization to occur, re-innervation can be a challenge if the distance between the ends 




attach to (Kuiken, Barlow, Hargrove, & Dumanian, 2017). Complicating neurogenesis with age 
are a confluence of changes that lead to poor innervation. These include decrease nerve 
conduction velocity, sensory discrimination, and decline in the amount of trophic and tropic 
factors secreted by Schwann cells (Verdu, Ceballos, Vilches, & Navarro, 2000). Perhaps one of 
the major changes affecting nerve regeneration in aging muscle is metabolism. The progressive 
reduction in neural blood supply (Kihara, Nickander, & Low, 1991) leads to low availability of 
nutrients supporting mitochondrial ATP production which is needed for axonal transport and 
polymerization of microtubules and neurofilaments (Brunetti, Miscena, Salviati, & Gaiti, 1987; 
Frolkis, Tanin, Marcinko, Kulchitsky, & Yasechko, 1985; McQuarrie, Brady, & Lasek, 1989). 
Secondary effects are decreased membrane excitability and action potential propagation, which 
may explain decrease in muscle output associated with aging (Adinolfi, Yamuy, Morales, & 
Chase, 1991).  
 Fortunately, a number of these adverse changes in the aging environment can be 
attenuated through the use of physical activity as previously mentioned. However, the use of 
rehabilitation/physical therapy regimens have yet to be explored in aging VML studies but these 
treatments have been demonstrated to be effective in young VML models (Quarta et al., 2018; 
Quarta et al., 2017). By pursuing an aggressive exercise regimen along with their repair strategy, 
Quarta et al. observed enhanced maturation of innervation and force production at 30 days 
following VML treatment. Further, the group also observed increased vascularization and 
reduced fibrosis in de novo tissue generated from repair (Quarta et al., 2017). The discrepancy 
between Quarta et al. and other groups that may have not observed such improvements may lie 
in the treatment methodologies used. Quarta et al. used multi-cellular (freshly isolated satellite 




mentioned studies either used pure cell-based (minced muscle graft) or scaffold based 
(decellularized ECM) for treatment. Regardless, Quarta et al.’s results demonstrate the 
synergistic effects of physical exercise and regenerative therapy in VML repair and presents a 
very promising therapeutic strategy that has the possibility to be translated into the clinic fairly 
easily. Moreover, these results provide an additional treatment methodology that can be easily 
incorporated into future aging VML repair research that has the capability of addressing many of 
the factors, not just innervation, in the aging microenvironment that preclude effective 
regeneration. 
 
Clinical Designation of Volumetric Muscle Loss 
 Due to the lack of a clinical standard of care for volumetric muscle loss injuries, the 
majority of extremity traumas involving massive soft tissue loss go undocumented as VML 
injuries and are categorized rather as varying degrees of open fractures (Lin, Lin, Yeh, & Chen, 
2007), compartment syndrome (Badge & Hemmady, 2011), or general limb injury (Dziki et al., 
2016). Current emphasis in the clinic for severe extremity trauma is addressing bone healing, 
despite the fact that upon successful limb salvage following bone repair there exists soft-tissue 
associated functional deficits leading to chronic disability. This lack of VML documentation and 
limited number of relevant clinical case studies act as hindrances in the development of clinically 
relevant treatments for the future. Due to the disconnect between clinicians and academic 
researchers, a shared database where clinical case studies can be shared between the two groups 
may prove invaluable in identifying real-world VML trauma and provide researchers with new 





Adinolfi, A. M., Yamuy, J., Morales, F. R., & Chase, M. H. (1991). Segmental demyelination in 
peripheral nerves of old cats. Neurobiol Aging, 12(2), 175-179.  
Aguilar, C. A., Greising, S. M., Watts, A., Goldman, S. M., Peragallo, C., Zook, C., . . . Corona, 
B. T. (2018). Multiscale analysis of a regenerative therapy for treatment of volumetric 
muscle loss injury. Cell Death Discov, 4, 33. doi: 10.1038/s41420-018-0027-8 
Aurora, A., Roe, J. L., Corona, B. T., & Walters, T. J. (2015). An acellular biologic scaffold does 
not regenerate appreciable de novo muscle tissue in rat models of volumetric muscle loss 
injury. Biomaterials, 67, 393-407. doi: 10.1016/j.biomaterials.2015.07.040 
Badge, R., & Hemmady, M. (2011). Forearm Compartment Syndrome following Thrombolytic 
Therapy for Massive Pulmonary Embolism: A Case Report and Review of Literature. 
Case Rep Orthop, 2011, 678525. doi: 10.1155/2011/678525 
Barone, R., Pitruzzella, A., Marino Gammazza, A., Rappa, F., Salerno, M., Barone, F., . . . 
Pomara, C. (2017). Nandrolone decanoate interferes with testosterone biosynthesis 
altering blood-testis barrier components. J Cell Mol Med, 21(8), 1636-1647. doi: 
10.1111/jcmm.13092 
Bhasin, S., & Bremner, W. J. (1997). Clinical review 85: Emerging issues in androgen 
replacement therapy. J Clin Endocrinol Metab, 82(1), 3-8. doi: 10.1210/jcem.82.1.3640 
Boldrin, L., Neal, A., Zammit, P. S., Muntoni, F., & Morgan, J. E. (2012). Donor satellite cell 
engraftment is significantly augmented when the host niche is preserved and endogenous 
satellite cells are incapacitated. Stem Cells, 30(9), 1971-1984. doi: 10.1002/stem.1158 
Brisson, B. K., & Barton, E. R. (2012). Insulin-like growth factor-I E-peptide activity is 
dependent on the IGF-I receptor. PLoS One, 7(9), e45588. doi: 
10.1371/journal.pone.0045588 
Brunetti, M., Miscena, A., Salviati, A., & Gaiti, A. (1987). Effect of aging on the rate of axonal 
transport of choline-phosphoglycerides. Neurochem Res, 12(1), 61-65.  
Buliakova, N. V. (1987). [The role of tissue regulators in skeletal muscle regeneration in animals 




Carroll, C. C., Martineau, K., Arthur, K. A., Huynh, R. T., Volper, B. D., & Broderick, T. L. 
(2015). The effect of chronic treadmill exercise and acetaminophen on collagen and 
cross-linking in rat skeletal muscle and heart. Am J Physiol Regul Integr Comp Physiol, 
308(4), R294-299. doi: 10.1152/ajpregu.00374.2014 
Cerletti, M., Jang, Y. C., Finley, L. W., Haigis, M. C., & Wagers, A. J. (2012). Short-term 
calorie restriction enhances skeletal muscle stem cell function. Cell Stem Cell, 10(5), 
515-519. doi: 10.1016/j.stem.2012.04.002 
Chakkalakal, J. V., Jones, K. M., Basson, M. A., & Brack, A. S. (2012). The aged niche disrupts 
muscle stem cell quiescence. Nature, 490(7420), 355-360. doi: 10.1038/nature11438 
Charville, G. W., Cheung, T. H., Yoo, B., Santos, P. J., Lee, G. K., Shrager, J. B., & Rando, T. 
A. (2015). Ex Vivo Expansion and In Vivo Self-Renewal of Human Muscle Stem Cells. 
Stem Cell Reports, 5(4), 621-632. doi: 10.1016/j.stemcr.2015.08.004 
Choi, H. R., Cho, K. A., Kang, H. T., Lee, J. B., Kaeberlein, M., Suh, Y., . . . Park, S. C. (2011). 
Restoration of senescent human diploid fibroblasts by modulation of the extracellular 
matrix. Aging Cell, 10(1), 148-157. doi: 10.1111/j.1474-9726.2010.00654.x 
Choi, Y. H., Kurtz, A., & Stamm, C. (2011). Mesenchymal stem cells for cardiac cell therapy. 
Hum Gene Ther, 22(1), 3-17. doi: 10.1089/hum.2010.211 
Corona, B. T., Garg, K., Ward, C. L., McDaniel, J. S., Walters, T. J., & Rathbone, C. R. (2013). 
Autologous minced muscle grafts: a tissue engineering therapy for the volumetric loss of 
skeletal muscle. Am J Physiol Cell Physiol, 305(7), C761-775. doi: 
10.1152/ajpcell.00189.2013 
Dziki, J., Badylak, S., Yabroudi, M., Sicari, B., Ambrosio, F., Stearns, K., . . . Rubin, J. P. 
(2016). An acellular biologic scaffold treatment for volumetric muscle loss: results of a 
13-patient cohort study. NPJ Regen Med, 1, 16008. doi: 10.1038/npjregenmed.2016.8 
El Fahime, E., Torrente, Y., Caron, N. J., Bresolin, M. D., & Tremblay, J. P. (2000). In vivo 
migration of transplanted myoblasts requires matrix metalloproteinase activity. Exp Cell 
Res, 258(2), 279-287. doi: 10.1006/excr.2000.4962 
Faulk, D. M., Johnson, S. A., Zhang, L., & Badylak, S. F. (2014). Role of the extracellular 





Frolkis, V. V., Tanin, S. A., Marcinko, V. I., Kulchitsky, O. K., & Yasechko, A. V. (1985). 
Axoplasmic transport of substances in motoneuronal axons of the spinal cord in old age. 
Mech Ageing Dev, 29(1), 19-28.  
Fudel'-Osipova, S. I. (1963). [Some biomorphological regularities in aging of skeletal muscles]. 
Vestn Akad Med Nauk SSSR, 18, 60-70.  
Garg, K., & Boppart, M. D. (2016). Influence of exercise and aging on extracellular matrix 
composition in the skeletal muscle stem cell niche. J Appl Physiol (1985), 121(5), 1053-
1058. doi: 10.1152/japplphysiol.00594.2016 
Gentile, M. A., Nantermet, P. V., Vogel, R. L., Phillips, R., Holder, D., Hodor, P., . . . Ray, W. J. 
(2010). Androgen-mediated improvement of body composition and muscle function 
involves a novel early transcriptional program including IGF1, mechano growth factor, 
and induction of {beta}-catenin. J Mol Endocrinol, 44(1), 55-73. doi: 10.1677/JME-09-
0048 
Gentile, N. E., Stearns, K. M., Brown, E. H., Rubin, J. P., Boninger, M. L., Dearth, C. L., . . . 
Badylak, S. F. (2014). Targeted rehabilitation after extracellular matrix scaffold 
transplantation for the treatment of volumetric muscle loss. Am J Phys Med Rehabil, 
93(11 Suppl 3), S79-87. doi: 10.1097/PHM.0000000000000145 
Gilbert, P. M., Havenstrite, K. L., Magnusson, K. E., Sacco, A., Leonardi, N. A., Kraft, P., . . . 
Blau, H. M. (2010). Substrate elasticity regulates skeletal muscle stem cell self-renewal 
in culture. Science, 329(5995), 1078-1081. doi: 10.1126/science.1191035 
Gordon, S. E., Kraemer, W. J., Looney, D. P., Flanagan, S. D., Comstock, B. A., & Hymer, W. 
C. (2014). The influence of age and exercise modality on growth hormone bioactivity in 
women. Growth Horm IGF Res, 24(2-3), 95-103. doi: 10.1016/j.ghir.2014.03.005 
Gosselin, L. E., Adams, C., Cotter, T. A., McCormick, R. J., & Thomas, D. P. (1998). Effect of 
exercise training on passive stiffness in locomotor skeletal muscle: role of extracellular 
matrix. J Appl Physiol (1985), 85(3), 1011-1016. doi: 10.1152/jappl.1998.85.3.1011 
Greenstein, B. D. (1979). Androgen receptors in the rat brain, anterior pituitary gland and ventral 
prostate gland: effects of orchidectomy and ageing. J Endocrinol, 81(1), 75-81.  
Greising, S. M., Rivera, J. C., Goldman, S. M., Watts, A., Aguilar, C. A., & Corona, B. T. 
(2017). Unwavering Pathobiology of Volumetric Muscle Loss Injury. Sci Rep, 7(1), 




Grounds, M. D., & Yablonka-Reuveni, Z. (1993). Molecular and cell biology of skeletal muscle 
regeneration. Mol Cell Biol Hum Dis Ser, 3, 210-256.  
Guerin, C. W., & Holland, P. C. (1995). Synthesis and secretion of matrix-degrading 
metalloproteases by human skeletal muscle satellite cells. Dev Dyn, 202(1), 91-99. doi: 
10.1002/aja.1002020109 
Haji, M., Kato, K. I., Nawata, H., & Ibayashi, H. (1981). Age-related changes in the 
concentrations of cytosol receptors for sex steroid hormones in the hypothalamus and 
pituitary gland of the rat. Brain Res, 204(2), 373-386.  
Harris, J. B. (2003). Myotoxic phospholipases A2 and the regeneration of skeletal muscles. 
Toxicon, 42(8), 933-945. doi: 10.1016/j.toxicon.2003.11.011 
Herrmann, V. (1987). [Histogenesis, degeneration, regeneration and adaptation, aging and 
compensation in the skeletal muscles]. Zentralbl Allg Pathol, 133(5), 391-411.  
Ingelmark, B. E., & Gustafsson, L. (1957). The aging of calf muscles in women; a morphological 
and roentgenological study. Acta Morphol Neerl Scand, 1(2), 173-187.  
Kihara, M., Nickander, K. K., & Low, P. A. (1991). The effect of aging on endoneurial blood 
flow, hyperemic response and oxygen-free radicals in rat sciatic nerve. Brain Res, 562(1), 
1-5.  
Kodama, R., Kato, M., Furuta, S., Ueno, S., Zhang, Y., Matsuno, K., . . . Kamata, T. (2013). 
ROS-generating oxidases Nox1 and Nox4 contribute to oncogenic Ras-induced 
premature senescence. Genes Cells, 18(1), 32-41. doi: 10.1111/gtc.12015 
Kojo, G., Yoshida, T., Ohkawa, S., Odamaki, M., Kato, A., Takita, T., . . . Kumagai, H. (2014). 
Association of serum total testosterone concentration with skeletal muscle mass in men 
under hemodialysis. Int Urol Nephrol, 46(5), 985-991. doi: 10.1007/s11255-013-0543-7 
Kuang, S., Gillespie, M. A., & Rudnicki, M. A. (2008). Niche regulation of muscle satellite cell 
self-renewal and differentiation. Cell Stem Cell, 2(1), 22-31. doi: 
10.1016/j.stem.2007.12.012 
Kuhne, K. D., Mikulas, J., Paul, W., & Weidinger, V. (1989). [Measuring the age dependent 





Kuiken, T. A., Barlow, A. K., Hargrove, L., & Dumanian, G. A. (2017). Targeted Muscle 
Reinnervation for the Upper and Lower Extremity. Tech Orthop, 32(2), 109-116. doi: 
10.1097/BTO.0000000000000194 
Larouche, J., Greising, S. M., Corona, B. T., & Aguilar, C. A. (2018). Robust inflammatory and 
fibrotic signaling following volumetric muscle loss: a barrier to muscle regeneration. Cell 
Death Dis, 9(3), 409. doi: 10.1038/s41419-018-0455-7 
Lewis, D. M., & Schmalbruch, H. (1995). Effects of age on aneural regeneration of soleus 
muscle in rat. J Physiol, 488 ( Pt 2), 483-492.  
Lin, C. H., Lin, Y. T., Yeh, J. T., & Chen, C. T. (2007). Free functioning muscle transfer for 
lower extremity posttraumatic composite structure and functional defect. Plast Reconstr 
Surg, 119(7), 2118-2126. doi: 10.1097/01.prs.0000260595.85557.41 
Lohmann, D., Wielepp, G., & Nocker, J. (1957). [Changes of the skeletal muscles with age in 
man]. Z Alternsforsch, 10(3), 233-238.  
Maher, C. A., Kumar-Sinha, C., Cao, X., Kalyana-Sundaram, S., Han, B., Jing, X., . . . 
Chinnaiyan, A. M. (2009). Transcriptome sequencing to detect gene fusions in cancer. 
Nature, 458(7234), 97-101. doi: 10.1038/nature07638 
Mandal, P. K., Blanpain, C., & Rossi, D. J. (2011). DNA damage response in adult stem cells: 
pathways and consequences. Nat Rev Mol Cell Biol, 12(3), 198-202. doi: 
10.1038/nrm3060 
Mann, C. J., Perdiguero, E., Kharraz, Y., Aguilar, S., Pessina, P., Serrano, A. L., & Munoz-
Canoves, P. (2011). Aberrant repair and fibrosis development in skeletal muscle. Skelet 
Muscle, 1(1), 21. doi: 10.1186/2044-5040-1-21 
Mase, V. J., Jr., Hsu, J. R., Wolf, S. E., Wenke, J. C., Baer, D. G., Owens, J., . . . Walters, T. J. 
(2010). Clinical application of an acellular biologic scaffold for surgical repair of a large, 
traumatic quadriceps femoris muscle defect. Orthopedics, 33(7), 511. doi: 
10.3928/01477447-20100526-24 
Matheny, R. W., Jr., & Nindl, B. C. (2011). Loss of IGF-IEa or IGF-IEb impairs myogenic 




McQuarrie, I. G., Brady, S. T., & Lasek, R. J. (1989). Retardation in the slow axonal transport of 
cytoskeletal elements during maturation and aging. Neurobiol Aging, 10(4), 359-365.  
Melov, S., Tarnopolsky, M. A., Beckman, K., Felkey, K., & Hubbard, A. (2007). Resistance 
exercise reverses aging in human skeletal muscle. PLoS One, 2(5), e465. doi: 
10.1371/journal.pone.0000465 
Miljkovic, N., Lim, J. Y., Miljkovic, I., & Frontera, W. R. (2015). Aging of skeletal muscle 
fibers. Ann Rehabil Med, 39(2), 155-162. doi: 10.5535/arm.2015.39.2.155 
Montarras, D., Morgan, J., Collins, C., Relaix, F., Zaffran, S., Cumano, A., . . . Buckingham, M. 
(2005). Direct isolation of satellite cells for skeletal muscle regeneration. Science, 
309(5743), 2064-2067. doi: 10.1126/science.1114758 
Park, S. K., Dahmer, M. K., & Quasney, M. W. (2012). MAPK and JAK-STAT signaling 
pathways are involved in the oxidative stress-induced decrease in expression of surfactant 
protein genes. Cell Physiol Biochem, 30(2), 334-346. doi: 10.1159/000339068 
Perniconi, B., Costa, A., Aulino, P., Teodori, L., Adamo, S., & Coletti, D. (2011). The pro-
myogenic environment provided by whole organ scale acellular scaffolds from skeletal 
muscle. Biomaterials, 32(31), 7870-7882. doi: 10.1016/j.biomaterials.2011.07.016 
Pohlers, D., Brenmoehl, J., Loffler, I., Muller, C. K., Leipner, C., Schultze-Mosgau, S., . . . Wolf, 
G. (2009). TGF-beta and fibrosis in different organs - molecular pathway imprints. 
Biochim Biophys Acta, 1792(8), 746-756. doi: 10.1016/j.bbadis.2009.06.004 
Quarta, M., Cromie Lear, M. J., Blonigan, J., Paine, P., Chacon, R., & Rando, T. A. (2018). 
Biomechanics show stem cell necessity for effective treatment of volumetric muscle loss 
using bioengineered constructs. NPJ Regen Med, 3, 18. doi: 10.1038/s41536-018-0057-0 
Quarta, M., Cromie, M., Chacon, R., Blonigan, J., Garcia, V., Akimenko, I., . . . Rando, T. A. 
(2017). Bioengineered constructs combined with exercise enhance stem cell-mediated 
treatment of volumetric muscle loss. Nat Commun, 8, 15613. doi: 10.1038/ncomms15613 
Ramsey, M. R., & Sharpless, N. E. (2006). ROS as a tumour suppressor? Nat Cell Biol, 8(11), 




Rodriguez, C., Rodriguez-Sinovas, A., & Martinez-Gonzalez, J. (2008). Lysyl oxidase as a 
potential therapeutic target. Drug News Perspect, 21(4), 218-224. doi: 
10.1358/dnp.2008.21.4.1213351 
Sadeh, M. (1988). Effects of aging on skeletal muscle regeneration. J Neurol Sci, 87(1), 67-74.  
Sattler, F. R. (2013). Growth hormone in the aging male. Best Pract Res Clin Endocrinol Metab, 
27(4), 541-555. doi: 10.1016/j.beem.2013.05.003 
Schultz, R. L., Kullman, E. L., Waters, R. P., Huang, H., Kirwan, J. P., Gerdes, A. M., & 
Swallow, J. G. (2013). Metabolic adaptations of skeletal muscle to voluntary wheel 
running exercise in hypertensive heart failure rats. Physiol Res, 62(4), 361-369.  
Sicari, B. M., Rubin, J. P., Dearth, C. L., Wolf, M. T., Ambrosio, F., Boninger, M., . . . Badylak, 
S. F. (2014). An acellular biologic scaffold promotes skeletal muscle formation in mice 
and humans with volumetric muscle loss. Sci Transl Med, 6(234), 234ra258. doi: 
10.1126/scitranslmed.3008085 
Smith, H. K., & Merry, T. L. (2012). Voluntary resistance wheel exercise during post-natal 
growth in rats enhances skeletal muscle satellite cell and myonuclear content at 
adulthood. Acta Physiol (Oxf), 204(3), 393-402. doi: 10.1111/j.1748-1716.2011.02350.x 
Snow, M. H. (1977). The effects of aging on satellite cells in skeletal muscles of mice and rats. 
Cell Tissue Res, 185(3), 399-408.  
Song, W., Kwak, H. B., & Lawler, J. M. (2006). Exercise training attenuates age-induced 
changes in apoptotic signaling in rat skeletal muscle. Antioxid Redox Signal, 8(3-4), 517-
528. doi: 10.1089/ars.2006.8.517 
Sousa-Victor, P., Gutarra, S., Garcia-Prat, L., Rodriguez-Ubreva, J., Ortet, L., Ruiz-Bonilla, V., . 
. . Munoz-Canoves, P. (2014). Geriatric muscle stem cells switch reversible quiescence 
into senescence. Nature, 506(7488), 316-321. doi: 10.1038/nature13013 
Thorley, M., Malatras, A., Duddy, W., Le Gall, L., Mouly, V., Butler Browne, G., & Duguez, S. 
(2015). Changes in Communication between Muscle Stem Cells and their Environment 
with Aging. J Neuromuscul Dis, 2(3), 205-217. doi: 10.3233/JND-150097 
Troy, A., Cadwallader, A. B., Fedorov, Y., Tyner, K., Tanaka, K. K., & Olwin, B. B. (2012). 




asymmetric activation of p38alpha/beta MAPK. Cell Stem Cell, 11(4), 541-553. doi: 
10.1016/j.stem.2012.05.025 
Urciuolo, A., Quarta, M., Morbidoni, V., Gattazzo, F., Molon, S., Grumati, P., . . . Bonaldo, P. 
(2013). Collagen VI regulates satellite cell self-renewal and muscle regeneration. Nat 
Commun, 4, 1964. doi: 10.1038/ncomms2964 
Veldhuis, J. D. (2008). Aging and hormones of the hypothalamo-pituitary axis: gonadotropic 
axis in men and somatotropic axes in men and women. Ageing Res Rev, 7(3), 189-208. 
doi: 10.1016/j.arr.2007.12.005 
Verdu, E., Ceballos, D., Vilches, J. J., & Navarro, X. (2000). Influence of aging on peripheral 
nerve function and regeneration. J Peripher Nerv Syst, 5(4), 191-208.  
Vitale, G., Cesari, M., & Mari, D. (2016). Aging of the endocrine system and its potential impact 
on sarcopenia. Eur J Intern Med, 35, 10-15. doi: 10.1016/j.ejim.2016.07.017 
Wang, Y., & Pessin, J. E. (2013). Mechanisms for fiber-type specificity of skeletal muscle 
atrophy. Curr Opin Clin Nutr Metab Care, 16(3), 243-250. doi: 
10.1097/MCO.0b013e328360272d 
White, T. P., & Esser, K. A. (1989). Satellite cell and growth factor involvement in skeletal 
muscle growth. Med Sci Sports Exerc, 21(5 Suppl), S158-163.  
  
 
227 
 
Appendix 
 
  
 
228 
 
 
 
 
229 
 
 
 
230 
 
 
